A Study of Macrophages in the Aging Liver and in the Host Response to Engineered Lung Scaffolds by Stahl, Elizabeth C.
 A STUDY OF MACROPHAGES IN THE AGING LIVER AND IN THE HOST 
RESPONSE TO ENGINEERED LUNG SCAFFOLDS 
 
 
 
 
 
 
 
by 
Elizabeth C. Stahl 
BS, University of Pittsburgh, 2013 
 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
the School of Medicine in partial fulfillment  
of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
2019 
 
 ii 
UNIVERSITY OF PITTSBURGH 
SCHOOL OF MEDICINE 
 
 
 
 
 
 
 
 
This dissertation was presented 
 
by 
 
 
Elizabeth C. Stahl 
 
 
 
It was defended on 
December 7, 2018 
and approved by 
Satdarshan P. Monga MD, Professor, Department of Pathology 
Andrew Duncan PhD, Assistant Professor, Department of Pathology 
Wendy Mars PhD, Associate Professor, Department of Pathology 
Donna Stolz PhD, Associate Professor, Department of Cell Biology 
William Wagner PhD, Professor, Department of Bioengineering 
Dissertation Director: Bryan Brown PhD, Assistant Professor, Department of Bioengineering 
 
 
 iii 
Copyright © by Elizabeth C. Stahl 
2019 
 iv 
 
 
 
 
Macrophages are innate immune cells that contribute to tissue remodeling and homeostasis, 
respond to foreign antigens, and regulate the recruitment and activation of auxiliary immune 
cells. In chronic disease or a foreign body reaction, macrophages drive inflammation, leading to 
tissue damage and fibrosis. As such, understanding the developmental and phenotypic diversity 
of macrophages is of interest in both the pathobiology of disease as well as the design of novel 
therapeutics and materials. This dissertation examines macrophage biology in two contexts: the 
aging liver and the host response to engineered lung scaffolds.  
 The liver contains two subsets of macrophages: a stable population of embryonically-
derived Kupffer cells and a transient population of monocyte-derived macrophages. The 
dynamics of hepatic macrophages during the process of aging is unknown and may influence the 
development of chronic liver disease. Studies presented here demonstrate an increase in hepatic 
macrophages from naturally aged (19-months-old) mice compared to young counterparts (3-
months-old). Macrophages from aged livers express significantly greater amounts of CD11b 
surface antigen and upregulate arginase strongly after exposure to interleukin-4, suggesting 
monocytic origins and a predisposition towards an alternatively activated phenotype. Aged livers 
also exhibit increased triglycerides and pro-inflammatory signals, including monocyte 
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chemoattractant protein (MCP-1). Inhibiting MCP-1 signaling reduced lipids and inflammation 
but did not significantly alter the macrophage population. Additional methods to modulate 
hepatic macrophages remain to be studied in the context of age-associated pathologies.  
 Following implantation of biomaterials, macrophages are recruited and polarize to a 
classical or alternatively activated phenotype, which can influence the outcome of the foreign 
body response. A positive outcome is associated with reduced inflammation and is crucial for the 
success of animal-derived organs to be used for xenotransplantation. Studies presented herein 
demonstrate that the removal of the foreign Gal-epitope from decellularized porcine lung 
scaffolds improves the host response in non-human primates, in part by reducing CD86 
expression on macrophages and preventing substantial adaptive immune recognition upon 
reimplantation.  
Taken together, these studies further the understanding of macrophage biology in the 
aging liver and in the host response to Gal-epitopes and demonstrate novel strategies to reduce 
inflammation in chronic disease and tissue engineering contexts.   
 
 
 vi 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS ....................................................................................................... XI 
1.0 INTRODUCTION ........................................................................................................ 1 
1.1 THE MACROPHAGE ........................................................................................ 1 
1.1.1 Primitive and Definitive Development of Macrophages............................ 2 
1.1.2 Polarization of Macrophages ....................................................................... 4 
1.1.3 Significance of Macrophages in Health and Disease ................................. 6 
1.2 THE HOST RESPONSE TO BIOMATERIALS ............................................. 8 
1.2.1 Implantable Biomaterials ............................................................................. 8 
1.2.2 Whole Organ Decellularization for Tissue Engineering ........................... 9 
1.2.3 The Alpha-Gal Antigen in Decellularized Biomaterials .......................... 11 
1.2.4 Macrophages in the Host Response to Acellular Scaffolds ..................... 12 
1.3 AGING AND THE IMMUNE SYSTEM ......................................................... 13 
1.3.1 The Adaptive Immune System and Aging ................................................ 14 
1.3.2 The Innate Immune System and Aging .................................................... 15 
1.3.2.1 Macrophages and Monocytes ............................................................. 16 
1.3.2.2 Host Response to Synthetic Biomaterials.......................................... 21 
1.4 LIVER SPECIFIC MACROPHAGE POPULATIONS ................................ 23 
1.4.1 Hepatic Macrophages ................................................................................. 24 
 vii 
1.4.1.1 Kupffer Cells ....................................................................................... 24 
1.4.1.2 Infiltrating Monocyte Derived Macrophages ................................... 25 
1.4.1.3 Roles in Health and Disease ............................................................... 26 
1.4.2 Effects of Aging on Liver Parenchymal and Non-Parenchymal Cells ... 28 
1.4.3 Aging and Fatty Liver Disease ................................................................... 31 
2.0 A STUDY OF MACROPHAGES IN THE AGING LIVER .................................. 35 
2.1 INTRODUCTION ............................................................................................. 35 
2.2 METHODS ......................................................................................................... 37 
2.3 RESULTS ........................................................................................................... 40 
2.4 DISCUSSION ..................................................................................................... 61 
3.0 THE HOST RESPONSE TO ENGINEERED LUNG SCAFFOLDS ................... 66 
3.1 INTRODUCTION ............................................................................................. 66 
3.2 METHODS ......................................................................................................... 69 
3.3 RESULTS ........................................................................................................... 73 
3.4 DISCUSSION ..................................................................................................... 97 
4.0 GENERAL DISCUSSION ...................................................................................... 104 
4.1 SIGNIFICANCE .............................................................................................. 104 
4.2 FUTURE DIRECTIONS AND CONCLUDING REMARKS ..................... 107 
APPENDIX A ............................................................................................................................ 110 
APPENDIX B ............................................................................................................................ 117 
APPENDIX C ............................................................................................................................ 128 
BIBLIOGRAPHY ..................................................................................................................... 132 
 viii 
 LIST OF TABLES 
 
Table 1. Body Weight, Liver Biochemistry, and Serum Lipids in Young and Aged WT Mice 
(NIA) ............................................................................................................................................. 40 
Table 2. Fatty Acid Profile of Triglycerides in Young and Aged Livers ..................................... 45 
Table 3. Body Weight, Liver Biochemistry, and Serum Lipids in Young and Aged WT Mice 
(JAX)............................................................................................................................................. 54 
Table 4.  Body Weight, Liver Biochemistry, and Serum Lipids in Young and Aged CCR2 KO 
Mice (JAX) ................................................................................................................................... 55 
Table 5. Differentially Expressed Genes in Aged Hepatocyte Fractions Compared to Young 
Identified by RNA-Seq ............................................................................................................... 117 
Table 6. Chem12 Data from Rhesus Macaques Implanted with Lung Scaffolds ....................... 128 
Table 7. Chem12 Data (cont.) from Rhesus Macaques Implanted with Lung Scaffolds ........... 130 
 ix 
LIST OF FIGURES 
 
Figure 1. Macrophage Polarization. ................................................................................................ 5 
Figure 2. Whole Liver Decellularization. ..................................................................................... 10 
Figure 3. The Host Response to Polypropylene Mesh in Aged Mice ........................................... 22 
Figure 4. Aging and Mechanisms of Liver Disease. ..................................................................... 32 
Figure 5. Aged livers exhibit signs of steatosis. ........................................................................... 42 
Figure 6. Apoptosis and fibrosis in young and aged livers. .......................................................... 44 
Figure 7. Aged livers have robust inflammatory signatures. ........................................................ 46 
Figure 8. Macrophages accumulate in the uninjured, aged liver and exhibit similar polarization 
capacity. ........................................................................................................................................ 48 
Figure 9. Gating strategy and time course of F4/80+ flow cytometry. ......................................... 50 
Figure 10. Macrophage polarization staining in vitro. .................................................................. 51 
Figure 11. Macrophages in aged livers have increased CD11b+ subsets. ..................................... 53 
Figure 12. Aged CCR2 knockout mice exhibit reduced steatosis and inflammation, but no change 
in accumulated macrophage populations. ..................................................................................... 56 
Figure 13. Endotoxin and 16S rRNA levels in aged hepatic blood. ............................................. 58 
Figure 14. RNA-Seq reveals robust changes in inflammatory and metabolic gene signatures of 
aged livers. .................................................................................................................................... 59 
 x 
Figure 15. IPA Canonical Pathways Map. .................................................................................... 60 
Figure 16. Lung construct implantation and harvest schematic. .................................................. 74 
Figure 17. Relative body weight of rhesus macaques during study ............................................. 75 
Figure 18. Change from baseline in complete blood counts post-implantation ........................... 76 
Figure 19. Production of Gal-specific antibodies in response to implanted lung constructs ........ 78 
Figure 20. Degradation of elastin over time in lung implants ...................................................... 80 
Figure 21. Qualitative assessment of tissue remodeling and biocompatibility in the implantation 
study .............................................................................................................................................. 81 
Figure 22. Qualitative assessment of tissue remodeling and biocompatibility in the re-
implantation study ......................................................................................................................... 84 
Figure 23. Representative IHC for implantation study, one-week post-implantation .................. 87 
Figure 24. Representative IHC for implantation study, eight weeks post-implantation ............... 88 
Figure 25. Quantitative assessment of specific cell subsets in the implantation study................. 89 
Figure 26. Representative IHC for re-implantation study, one-week post re-implantation .......... 91 
Figure 27. Representative IHC in re-implantation study, eight weeks post re-implantation ........ 93 
Figure 28. Quantitative assessment of specific cell subsets in the re-implantation study ............ 94 
Figure 29. Comparison of the adaptive immune response between the implantation and re-
implantation studies ...................................................................................................................... 96 
 xi 
ACKNOWLEDGEMENTS 
There are several people I would like to acknowledge who have guided my research and shaped 
my graduate school experience. First, I would like to thank my primary research advisor, Dr. 
Bryan Brown, who has given me every opportunity to explore my interests and passions in the 
lab, the freedom to design my own experiments, write funding proposals, attend national and 
international meetings, and pursue extracurricular activities. Thank you for a very productive 
graduate school experience and everything you have taught me. Second, I’d like to thank my co-
mentor, Dr. Andy Duncan. I feel so blessed that your lab and office are located on our floor and 
we were able to form a strong collaboration and friendship between our research groups. I truly 
could not have completed this work without your intellectual contributions and guidance. Thank 
you for adopting me as a co-mentee, allowing me to present in your lab meetings, and always 
leading by example to help me to become a better thinker, writer, and scientist.  
I am very thankful to the rest of my committee for their support, direction, and thoughtful 
comments that have led me to the completion of this work. Thank you to Dr. Donna Stolz and 
Dr. William Wagner for your creative and critical insights that have elevated the research in this 
dissertation. Thank you also to Dr. Wendy Mars for being an outstanding advocate for my 
personal and professional success. Thank you especially to Dr. Paul Monga, my committee chair, 
who has gone above and beyond expectations as a truly outstanding mentor from supporting my 
 xii 
research training by sponsoring proposals and welcoming me into a larger community of peers 
and scientists in the Department of Pathology and beyond.  
Next, I need to thank my friends and peers who really made the day-to-day experience of 
graduate school so special. Thank you to Chelsea Merkel, Morgan Preziosi, Aliyah Weinstein, 
Mondraya Howard, Justin Wendzicki, Ali Nagle, Megan Sullivan for your support and 
friendship in graduate school and beyond. Thank you also to life-long friends I made in my BioE 
undergrad program, Marshall and Devin. Thank you especially to the members of the Brown lab 
family who have made every day an adventure: Aimon Iftikhar, Alexis Nolfi, Clint Skillen, 
Michael Buckenmeyer, Samuel LoPresti, Travis Prest, Marty Haschak, Tyler Meder, Branimir 
Popovich, and Elaine Becker, as well as past undergraduate students Brandon Burger and Andrea 
Hartman. Thank you to the members of the Duncan lab for your support and friendship: Evan 
Delgado, Patrick Wilkinson, Frances Alencastro, Nairita Roy, and Maddie Leek. I also would 
like to thank my past mentors and friends in the Badylak lab, especially Chris Medberry, Lisa 
Carey-Lohmueller, Jenna Dziki, and Lindsey Saldin. A big thank you to Dr. Badylak, Dr. Lisa 
Butterfield, Dr. Johnny Huard, Dr. Helena Kuivaniemi and members of their laboratories who 
supported my early scientific development and helped me to arrive here today.  
Most importantly, I would like to thank my family for their unwavering support and 
encouragement throughout the past nine years. My parents, Karen and Barry, have always taken 
a sincere interest in my education and research. Thank you for teaching me at an early age how 
to be a leader and to persevere. I would not have done a PhD without your encouragement. I 
have so many additional family members to thank for their love and support, for always checking 
in on my progress, and sending me back to Pittsburgh with food and gifts. I certainly cannot fit 
everyone’s name here, but I must give a special acknowledgement to my Grandma, my uncles 
 xiii 
Rick, Eric, Tony, and John, aunts Laurie, Kelly, Barb, Mary, Cheryl, Patricia, and Elaine, and 
my cousins Nikole, Mark, Amanda, and Melissa. I can’t wait to see where the future takes me 
next, but I know you will always be there to support and guide me.
 1 
1.0  INTRODUCTION 
Chapter 1 is adapted from three published review articles: 
Stahl EC1, Brown BN1. Cell Therapy Strategies to Combat Immunosenescence. 
Organogenesis. 2015; 11(4):159-72. 
Brown BN1, Haschak MJ1, LoPresti ST1, Stahl EC1. Effects of age-related shifts in 
cellular function and local microenvironment upon the innate immune response to 
implants. Seminars in Immunology. 2017; 29:24-32. 
Stahl EC1, Haschak MJ1, Popovich B1, Brown BN1. Macrophages in the Aging Liver 
and Age-Related Liver Disease. Frontiers in Immunology (accepted Nov. 2018).  
1 McGowan Institute for Regenerative Medicine, Department of Bioengineering, 
Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 
1.1 THE MACROPHAGE 
‘Macrophage’ is derived from the Greek word “large eater,” named by Ilya Metchnikoff, the 
father of cellular immunity, in the late 1800s (Metchnikoff, 1891). Metchnikoff observed heavily 
vacuolated cells engulfing cellular debris, a process known as phagocytosis, and considered this 
the defining feature of the macrophage. The term ‘macrophage’ was thereafter used to describe 
several cell types including erythrophagocytes and histiocytes. Macrophages were later 
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reclassified under the reticulo-endothelial system by Ashhoff in 1924, to include several tissue-
resident macrophage populations (Aschoff, 1924). It was not until the 1930s, that the monocyte 
was identified in the blood as the circulating precursor of the macrophage (Ebert, 1939). By the 
late 1960s, the understanding of the mononuclear phagocyte system was developed under the 
premise that all macrophages are derived from blood monocytes (van Furth et al., 1972).  
Nearly 50 years later, with the advent of advanced lineage tracing technologies, several 
groups have determined that the origin of many tissue-resident macrophages are embryonic, and 
these populations can be maintained independently of monocytes under steady-state conditions 
(Ginhoux et al., 2010; Schulz et al., 2012; Yona et al., 2013). The revised mononuclear 
phagocyte system now encompasses three broad families of cells: embryonic-derived 
macrophages, monocyte-derived cells, and common dendritic cell precursor-derived cells  
(Guilliams et al., 2014). The function of the macrophage is also now understood to extend 
beyond phagocytosis and includes antigen presentation, cytokine signaling, and growth factor 
production (Murray & Wynn, 2011). Macrophages play important roles in tissue development, 
homeostasis, regeneration, wound healing, infection clearance, and disease that will be discussed 
further in this chapter.  
1.1.1 Primitive and Definitive Development of Macrophages 
Macrophage development begins in the extraembryonic yolk sac from erythro-myeloid 
progenitors, a process known as primitive hematopoiesis, prior to the appearance of 
hematopoietic stem cells or monocytic precursors (Dey, Allen, & Hankey-Giblin, 2014; van de 
Laar et al., 2016). After a transient wave of primitive hematopoiesis, hematopoietic stem cells 
appear in the aorto-gonado-mesonephric region and migrate to the fetal liver, marking the start of 
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definitive hematopoiesis and development of naïve macrophages through monocytic precursors 
(Dey et al., 2014). Definitive hematopoiesis remains in the fetal liver until approximately E18 in 
mice or 12 weeks post-conception in humans, after which hematopoietic stem cells migrate to 
the bone marrow niche, where they will remain throughout adulthood (L. D. Wang & Wagers, 
2011) .  
Macrophages can be subdivided into embryonic-derived or monocyte-derived 
populations. Embryonic-derived macrophages include Kupffer cells (liver), microglia (brain), 
and at various times during development alveolar macrophages (lungs), osteoclasts (bone), and 
Langerhans's cells (skin) (Murray & Wynn, 2011). Kupffer cells and microglia are colonized 
from a single developmental source (i.e. yolk sac macrophages), whereas Langerhans’s cells are 
originally derived from yolk sac macrophages and are later replaced by fetal liver monocytes 
(Hoeffel et al., 2012; Yona et al., 2013). Resident tissue macrophages, including Kupffer cells, 
large peritoneal macrophages, and pleural macrophages, have been shown to undergo 
proliferation in response to Th2 cytokines, such as interleukin-4, and can be maintained 
independently of monocytic input (Jenkins et al., 2011).  
Alternatively, macrophages residing in certain organs, such as the gut, spleen, and 
kidney, are replaced regularly by bone marrow derived monocytes (Scott et al., 2016; Yona et 
al., 2013). Infiltrating macrophages can be derived from either classical (CD14+CD16- human, 
Ly6Chi mouse) or non-classical (CD14+CD16+ human, Ly6Clo mouse) monocytes, which 
extravasate into tissue sites under chemokine concentration gradient guidance (Dey et al., 2014; 
Ingersoll et al., 2010). Following extravasation, monocytes differentiate into macrophages whose 
functionality are largely based on the integration of the various signaling molecules present in 
the local microenvironment, reviewed here: (Lavin, Mortha, Rahman, & Merad, 2015). 
 4 
Macrophages residing in a particular tissue maintain their phenotype through a process 
known as tissue imprinting, whereby epigenetic changes in the enhancer regions of the genome 
regulate gene expression (Amit, Winter, & Jung, 2016). Monocyte-derived macrophages have 
the capacity to take on a seemingly identical phenotype to Kupffer cells, including self-renewal, 
when the niche is made available through experimental manipulation (Scott et al., 2016); 
however, the physiological relevance of these depletion experiments remains unclear. The 
frequency of tissue resident macrophages varies considerably based on the tissue, and it has been 
reported that approximately 80% of total tissue resident macrophages are located in the liver 
(Kakinuma, Kimura, & Watanabe, 2017). 
1.1.2 Polarization of Macrophages 
In addition to developmental heterogeneity, macrophages are extraordinarily dynamic cells that 
exhibit various phenotypes ranging on a spectrum from a pro-inflammatory, classically activated 
“M1” polarization state to an anti-inflammatory, alternatively activated “M2” polarization state 
(Mills, Kincaid, Alt, Heilman, & Hill, 2000; Murray et al., 2014), as shown in Figure 1 (adapted 
from (Stahl, Haschak, Popovic, & Brown, 2018) in accordance with the Creative Commons 
license). 
The paradigm of macrophage polarization is thought to begin with a quiescent or patrolling 
“M0” cell, that may be derived from either circulating monocytes or tissue-resident populations. 
The transition from M0 to M1 can be stimulated by bacterial products, such as 
lipopolysaccharide (LPS), or from Th1 cytokines, such as interferon-gamma, resulting in a cell 
that has pro-inflammatory and anti-tumorigenic properties. The transition from M0 to M2 can be 
stimulated by Th2 cytokines, such as interleukin-4, resulting in a cell that has anti-inflammatory 
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or immunotolerant properties. Polarization to these extreme phenotypes can be stimulated in 
vitro, but the scenario in vivo is often more complex leading to a spectrum of phenotypes, which 
may concurrently express both pro and anti-inflammatory phenotypic traits (Martinez & Gordon, 
2014; Murray et al., 2014). 
 
Figure 1. Macrophage Polarization.  
 
In general, M1 polarization leads to production of canonical pro-inflammatory cytokines (IL-
1, IL-6, IL-12, TNF, IL-23, IL-27), reactive oxygen species such as nitric oxide, and chemokines 
(CCL2, CCL5, CXCL9, CXCL10, CXCL11, IL-8), which are particularly important following 
injury or infection (Murray et al., 2014). The production of pro-inflammatory cytokines may be 
inflammasome-independent or dependent. Inflammasome formation is induced by damage-
associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs) 
binding to nod-like receptors or to Pyrin receptor family members on the surface of macrophages 
(Schroder & Tschopp, 2010). Docking proteins assemble and recruit pro-caspase 1, where 
proximity-based autoproteolytic cleavage catalyzes the activation of caspase-1 (Kapetanovic, 
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Bokil, & Sweet, 2015; Sutterwala, Haasken, & Cassel, 2014) Caspase-1 activation subsequently 
catalyzes the cleavage of the pro-forms of IL-1β and IL-18 into activated forms (Winkler & 
Rosen-Wolff, 2015).  
Alternatively, M2 macrophages appear from interaction with Th2 cytokines (IL-4, IL-5, IL-
13, IL-25), which can occur following helminth infection and in the resolution phase of injury or 
infection. In an injury setting, M2-polarized macrophages typically appear following M1-
polarized macrophages and serve as a counterbalance to resolve inflammation and promote tissue 
repair (Novak & Koh, 2013). The M2 polarization state leads to secretion of cytokines 
commonly associated with anti-inflammatory properties, such as IL-10, as well as various 
matrix-modulatory factors including transforming growth factor-β (TGF-β) and matrix 
metalloproteases (MMPs) (Sica, Erreni, Allavena, & Porta, 2015).  
The overproduction of remodeling growth factors can lead to excessive deposition of matrix 
proteins (i.e. fibrosis), or excessive angiogenesis and immunosuppression in the case of tumor-
associated macrophages (TAMs) (Liu & Cao, 2015). Therefore, the temporal regulation of the 
M1 and M2 macrophage response is extremely important for an appropriate outcome following 
injury and infection and often becomes dysregulated in disease.  
1.1.3 Significance of Macrophages in Health and Disease 
The routine role of the tissue-resident macrophage is to maintain homeostasis through 
surveillance of danger signals and the removal of dying cells through phagocytosis. 
Macrophages survey materials through engagement with pattern recognition receptors, including 
toll-like receptors (TLRs), C-type lectin receptors (CLRs), scavenger receptors, retinoic-acid 
inducible gene 1-like helicase receptors (RLRs), and NOD-like receptors (NLRs), which can 
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distinguish foreign substances and dead or dying cells from self (Murray & Wynn, 2011). 
Macrophages also express complement and Fc receptors that bind opsonin molecules, C3b, and 
antibodies to enhance phagocytosis. Dysregulation of macrophage surveillance and response 
properties have been associated with several autoimmune diseases including rheumatoid arthritis, 
systemic lupus erythromatosus, multiple sclerosis, and Sjogren’s syndrome (Laria et al., 2016).      
 Macrophages are also important for normal tissue development. Mice deficient in PU.1, 
CSF1R, or CSF1 transcription factors required for primitive macrophage development displayed 
increased perinatal mortality, reduced postnatal survival, and stunted growth due to 
dysregulation of vascular growth and patterning (Epelman, Lavine, & Randolph, 2014). 
Depletion of osteoclasts specifically leads to defective long-bone formation, tooth eruption, and 
osteoporosis (Epelman, Lavine, & Randolph, 2014). Macrophages also play important protective 
roles during prenatal development and in adulthood against infectious pathogens as first 
responders to bacterial threats, reviewed here (Benoit, Desnues, & Mege, 2008). 
In classic wound healing experiments, depletion of macrophages, but not neutrophils, 
resulted in impaired clearance of debris and disturbance in the healing process (Leibovich SJ, 
1975). More recent studies have shown that depleting macrophages expressing lysozyme-M or 
CD11b causes a delay in wound closure and granulation tissue formation, as well as reduced 
angiogenesis and collagen synthesis (Koh & DiPietro, 2011). Macrophages also regulate the 
appropriate regeneration of liver and muscle following injury by clearing debris and secreting 
cytokines and growth factors that orchestrate repair (Wynn & Vannella, 2016). The removal of 
macrophages severely impairs these processes. Taken together, one can appreciate the important 
and diverse roles that macrophages play as innate immune cells in host defense, development, 
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wound healing, and in disease. The role of macrophages in the aging liver and the host response 
to engineered lung scaffolds is the main topic of this dissertation and will be discussed further.  
1.2 THE HOST RESPONSE TO BIOMATERIALS  
1.2.1 Implantable Biomaterials 
A biomaterial is any substance designed to control or augment the biological environment within 
the body (Campoccia, Montanaro, & Arciola, 2013). First generation biomaterials (bone cement, 
stainless steel) were chosen for being mechanically stable and inert; these materials were 
functional but did not interface well with tissues. Second generation biomaterials were designed 
to be more closely integrated with the mechanical properties of the tissue they served to augment 
(titanium, bioglass, synthetic polymers) and evade immune detection (Fishman JM, 2015). 
However, more modern biomaterials are adapted for multiple tissue mechanics and implantation 
methods (injectable hydrogels, porous scaffolds, fibrous meshes, sponges, microspheres) and can 
be loaded with cargo to mediate specific biological effects, including manipulation of the 
immune system for desired outcomes (Badylak & Gilbert, 2008). Ultimately, the 
immunogenicity of a biomaterial is integral to its successful implementation (Fishman JM, 
2015). 
Biomaterials can be further classified as synthetic or natural. Synthetic biomaterials, as 
the name suggests, are composed of units that are chemically synthesized. Advantages of 
synthetic biomaterials are control over design and manufacturing and “off the shelf” availability 
(Fishman JM, 2015). However, depending on the material, there may be increased likelihood of 
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foreign body reaction and less compatibility with native tissue architecture and mechanics. 
Natural biomaterials are derived from organic sources, i.e. plants and animals. Several natural 
polymers have been studied as scaffolds for tissue engineering applications including alginate, 
gelatin, and collagen. Decellularizing tissues to expose “nature’s template,” the extracellular 
matrix, has been studied extensively in tissue engineering applications (Badylak & Gilbert, 
2008).   
1.2.2 Whole Organ Decellularization for Tissue Engineering 
Decellularization is the removal of cellular material from organs and tissues, resulting in an 
acellular material composed of extracellular matrix (ECM). ECM scaffolds are advantageous 
biomaterials for tissue engineering applications as they have a low immunogenicity and retain 
bioactive signaling molecules that can direct site-appropriate repair (Gilbert, Sellaro, & Badylak, 
2006).  
The ECM itself is composed of proteins, glycosaminoglycans, proteoglycans and other 
molecules secreted by tissue resident cells that provide a physical and chemical 
microenvironment (Brown & Badylak, 2014). Cells interact with the matrix through an 
assortment of binding proteins including integrins, discoidin domain receptors, and syndecans, 
which transmit signals in a reciprocally dynamic way (Frantz, Stewart, & Weaver, 2010). 
Currently, many acellular products composed of ECM are FDA approved and used in 
clinical applications such as tissue reconstruction, heart valve replacement, and hernia repair 
(Londono & Badylak, 2015). Once implanted, non-crosslinked acellular sheets or powders are 
degraded and replaced with cells from the host, acting as a scaffold to direct site-appropriate 
tissue remodeling (Brown & Badylak, 2014). More complex, three-dimensional ECM constructs 
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can be generated by whole organ decellularization, where the native vasculature is perfused with 
decellularization solutions (detergents, enzymes) generating “ghost organs” as shown in Figure 
2. Animal derived tissues are a viable source for decellularized materials, particularly pig organs, 
because they are relatively easy to source, retain evolutionarily conserved proteins, and are of 
similar size to human organs (Ezzelarab, Ayares, & Cooper, 2005). 
 
Figure 2. Whole Liver Decellularization. 
Three-dimensional extracellular matrix constructs can be generated by whole organ decellularization. In this 
illustrative example, murine livers were perfused in situ with a saline solution to blanch the liver of blood (top: 
lateral, bottom: dorsal), followed by Triton-X detergent to remove cellular material over 1-3 hours, then excised as a 
proof of concept of whole organ decellularization. 
 
Three-dimensional scaffolds would then be recellularized with autologous cells to 
generate a fully functional organ, which has shown preclinical success in animal models 
(Bonvillain et al., 2012; Faulk, Johnson, Zhang, & Badylak, 2014; Ott et al., 2010). However, 
several hurdles remain before tissue engineered organs are clinically adopted, including scaling 
up recellularization, maintaining cell survival and patency of blood vessels, and demonstrating 
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biocompatibility. Importantly, ECM sourced from pigs may retain non-conserved antigens, such 
as the alpha-Gal carbohydrate epitope. Humans and new world monkeys, which evolved with a 
mutation in the alpha-Gal depositing enzyme, respond to the antigen with a pro-inflammatory 
host response and poorer downstream outcomes.  
1.2.3 The Alpha-Gal Antigen in Decellularized Biomaterials 
Although decellularization techniques aim to remove cellular antigens, the presence of the 
porcine alpha-Gal epitope has been detected in acellular heart valves, anterior cruciate ligament, 
and small intestine submucosa implants used clinically (Konakci et al., 2005; McPherson, Liang, 
Record, & Badylak, 2000; Stone, Abdel-Motal, Walgenbach, Turek, & Galili, 2007). The Gal 
epitope is associated with glycoproteins and glycolipids and has been detected on ECM proteins 
including fibrinogen and laminin (Galili, Shohet, Kobrin, Stults, & Macher, 1988; Spiro & 
Bhoyroo, 1984; Thall & Galili, 1990; Towbin et al., 1987). The persistence of the Gal epitope in 
decellularized constructs have been suggested to result in long-term degeneration and 
calcification of heart valves in patients (Badylak & Gilbert, 2008; Konakci et al., 2005).  
Once a biomaterial is implanted, a well-defined series of events are orchestrated, known 
as the host response. The host immune response to decellularized tissues from wild type and 
alpha-Gal knockout porcine tissues have been assessed in some applications (Daly et al., 2009; 
Helder et al., 2017; M. S. Kim, Lim, & Kim, 2016), but other applications remain to demonstrate 
the biocompatibility of these materials.  
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1.2.4 Macrophages in the Host Response to Acellular Scaffolds 
The host immune response to implantable materials has been well studied over the last five 
decades. The foreign body reaction is now a well-recognized predictor of the downstream 
success or failure of implants, and has several conserved early stages, regardless of material type 
or downstream outcome (Brown, Ratner, Goodman, Amar, & Badylak, 2012).  
Following implantation, all materials undergo some degree of protein adsorption, an early 
neutrophil response, and subsequent invasion of the implantation site by mononuclear 
phagocytes. While this represents an oversimplification of a complex process (which has been 
reviewed at length elsewhere (Anderson, 1988; Anderson, Rodriguez, & Chang, 2008; 
Klopfleisch & Jung, 2016), the view that these events that eventually lead to a negative 
inflammatory response at the implant surface has led to a number of approaches to evade the 
early host immune response. While some techniques have undoubtedly shown promise, 
prevention of long-term interaction of protein or cells with implants has yet to be demonstrated. 
Recently, many studies have suggested that the interaction of host immune cells with 
implanted materials may be an integral and beneficial component of the response that leads to a 
positive remodeling outcome (Brown, Ratner, et al., 2012; Brown, Sicari, & Badylak, 2014). Just 
as macrophages have now been shown to be capable of affecting both beneficial and detrimental 
outcomes in the processes of wound healing and cancer (Mills, 2012; Murray & Wynn, 2011), it 
is now well recognized that macrophage populations that interact with implants also have 
heterogeneous phenotypes and functions which are predictive of downstream outcomes.  
An early shift from an “M1” pro-inflammatory macrophage phenotype to a more “M2-
like” anti-inflammatory phenotype is associated with improved implant integration and/or tissue 
regeneration, depending upon the type of implant and its intended purpose (i.e. permanent 
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implants versus regenerative medicine-based approaches to tissue reconstruction) (Brown, 
Londono, et al., 2012; Brown, Valentin, Stewart-Akers, McCabe, & Badylak, 2009; Guo, 
Merkel, Sterling, Davidson, & Guelcher, 2015; Hachim, LoPresti, Yates, & Brown, 2017; 
Keeney et al., 2013; Mokarram, Merchant, Mukhatyar, Patel, & Bellamkonda, 2012; Spiller et 
al., 2015; Sussman, Halpin, Muster, Moon, & Ratner, 2014).  
ECM scaffolds initiate the foreign body response and have been shown to promote M2 
macrophage polarization, in part dependent on Th2 cytokine response, leading to constructive 
tissue remodeling (Keane & Badylak, 2015). However, the biology of the host response in 
understudied groups, such as the elderly or patients with comorbidities, likely differs from the 
host response of young, healthy individuals. With aging, the immune system undergoes 
immunosenescence, an understudied area in the biology of macrophages in the host response and 
tissue homeostasis.  
1.3 AGING AND THE IMMUNE SYSTEM 
Aging has been shown to influence the functions of both innate and adaptive immune cells in 
scenarios such as wound healing, the response to pathogens, and vaccination: a process termed 
“immunosenescence”. Immunosenescence is associated with an increased susceptibility of 
elderly populations to develop infection, autoimmune disease, and cancer (Sebastián, Lloberas, 
& Celada, 2009). While the term ‘senescence’ typically refers to cells that have irreversibly 
exited the cell cycle (Hayflick, 1965; Williams, 1957), immunosenescence does not specifically 
refer to growth arrest. Immunosenescence manifests as altered numbers of circulating cells, 
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delayed migration of cells to sites of infection or injury, and disrupted effector responses, 
reviewed here (Aw, Silva, & Palmer, 2007; Stahl & Brown, 2015).  
1.3.1 The Adaptive Immune System and Aging 
The effector cells of the adaptive immune system, T-cells and B-cells, are derived from 
lymphoid progenitors in the bone marrow and mature in secondary lymphoid tissues, such as the 
spleen and thymus. The adaptive immune system provides acquired antigen-specific immunity, 
leading to highly effective cell destruction, immune regulation, and memory.  
Generation of the adaptive immune system is robust in young, healthy individuals, 
establishing a diverse immune repertoire. However, lymphopoiesis is significantly diminished in 
elderly individuals, in part due to involution of the thymus and a skewing of hematopoietic 
progenitor cells towards the myeloid lineage (Linton & Dorshkind, 2004; Lynch et al., 2009; 
Rossi et al., 2005). As a result, the number of T-cell and B-cell progenitors in the bone marrow 
and thymus are markedly reduced with age (Johnson, Owen, & Witte, 2002; Miller & Allman, 
2003; Min, Montecino-Rodriguez, & Dorshkind, 2004; Montecino-Rodriguez, Berent-Maoz, & 
Dorshkind, 2013).  
Advanced age is specifically associated with low numbers of naïve T-cells, persistent 
memory T-cells, and reduced diversity of the T-cell receptor (TCR) repertoire, with a large 
proportion of TCRs directed towards persistent cytomegalovirus (CMV) infection (Blackman & 
Woodland, 2011; Cicin-Sain et al., 2012; Olsson et al., 2000; Wikby et al., 2002). Meanwhile, B-
cell precursors do not proliferate as extensively in elderly mice as they do in young mice and 
undergo higher rates of apoptosis (Min, Montecino-Rodriguez, & Dorshkind, 2006). Changes in 
the bone marrow, including decreased secretion of interleukin-7 (IL-7) by stromal cells, have 
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been implicated in the reduction of B-cell development in aged individuals (Labrie, Sah, Allman, 
Cancro, & Gerstein, 2004; Stephan, Reilly, & Witte, 1998). 
The functions of adaptive immune cells are also impaired with aging. T-cell activation 
occurs following interaction with antigen-presenting cells forming an immune synapse. Several 
defects in this synapse have been reported with aging, including glycosylation of costimulatory 
molecules, such as CD28, and changes in lipid membrane properties (Nguyen, Espinoza, & 
Taub, 2004; Weng, Akbar, & Goronzy, 2009). Perhaps the single most important consequence of 
synapse dysfunction with aging is reduced production of interleukin-2 (IL-2), as exogenous IL-2 
has been shown to rescue many of the age-related deficits of T-cell activation (Haynes & 
Lefebvre, 2011; Haynes, Linton, Eaton, Tonkonogy, & Swain, 1999). The reduction in T helper 
2 subsets also reduces the regenerative response seen during normal biomaterial remodeling in 
aged individuals (Sadtler et al., 2016). Similarly, B-cells exhibit impaired class switching with 
aging, limiting the specific phenotypes of antibody producing B-cells crucial for responding to 
invading pathogens (Frasca et al., 2008). These deficits in lymphocyte cell number and function 
are likely responsible for the reduced response to vaccination and ability to clear infections 
observed in elderly populations and are active areas of ongoing research.   
1.3.2 The Innate Immune System and Aging 
Innate immune cells include granulocytes (neutrophils, eosinophils, basophils, mast cells), innate 
lymphoid cells (natural killer cells), and antigen presenting cells (dendritic cells, macrophages) 
(Klose & Artis, 2016; Medzhitov & Janeway, 1997). Each of these innate immune cells provides 
a highly regulated, specific function that orchestrates tissue wound repair and response to foreign 
antigens with the ultimate goal of restoring tissue homeostasis.  
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Neutrophils are the first responders during injury, infection, and the foreign body 
reaction. While the number of neutrophils and their phagocytic capacity is reported to be largely 
preserved in the elderly, delays in migration and reduction of respiratory burst have been 
reported (Fulop et al., 2004). Growing evidence suggests that dendritic cell activation is impaired 
in aging, along with impaired capacity to cross tissue barriers, and to induce cytokine production 
from T-cells (Rhee, Zhong, Reizis, Cheong, & Veillette, 2014; Steinmann, Klaus, & Muller-
Hermelink, 1985). With aging, natural killer cells have been reported to demonstrate diminished 
target binding leading to changes in effector function, such as release of granzyme, perforin, and 
other cytokines (Solana et al., 2012).  
1.3.2.1 Macrophages and Monocytes 
The process of aging has been more extensively studied on macrophage populations but is highly 
context and tissue specific, often resulting in conflicting reports in the literature. Although the 
output of immune cells from the bone marrow is weighted towards myeloid lineage with aging, 
the absolute numbers of monocytes are unchanged between young and aged individuals. (Hearps 
et al., 2012; Seidler, Zimmermann, Bartneck, Trautwein, & Tacke, 2010). An increased 
percentage of non-classical monocytes (CD14+ CD16++), and a reduction in classical monocytes 
(CD14+ CD16-) has been reported in aged humans (Hearps et al., 2012; Seidler et al., 2010).  
Like other innate immune cells, macrophage recruitment is delayed in aging, possibly due to a 
reduction in expression of the integrin very late antigen-4 (VLA-4) on monocytes, and vascular 
cell adhesion molecule-1 (VCAM-1) on endothelial cells (Ashcroft, Horan, & Ferguson, 1998).  
Furthermore, a reduction in major histocompatibility complex (MHC-II) expression has been 
observed in both human and murine macrophages, leading to a reduction in antigen-presentation 
capacity and cross-talk with the adaptive immune system (Herrero et al., 2002; Zissel, Schlaak, 
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& Muller-Quernheim, 1999). Toll-like receptors, including TLR-1, TLR-2, and TLR-4, are 
reported to decrease on aged peritoneal and splenic macrophages, perhaps contributing to the 
susceptibility of the elderly to bacterial, mycotic, and viral infections (Boehmer, Meehan, Cutro, 
& Kovacs, 2005; van Duin et al., 2007). 
Phagocytic clearance of extracellular pathogens tends to be attenuated in aged 
macrophage populations as well (Linehan et al., 2014). While no difference in phagocytic 
capacity was found between young and aged bone marrow derived macrophages, peritoneal 
macrophages exhibit an age-associated decline in phagocytic capacity and antigen presentation 
(Linehan et al., 2014). When young peritoneal macrophages were transplanted into aged 
peritoneal space, the young cells also exhibited reduced phagocytic and antigen presentation 
capabilities, suggesting cell extrinsic mechanisms (Linehan et al., 2014). Alveolar macrophages 
isolated from aged individuals have been shown to exhibit reduced phagocytic capacity as well 
as attenuated expression of genes associated with macrophage proliferation (C. K. Wong et al., 
2017). This reduction both in cell number and phagocytic ability likely contributes to the age-
related mortality risk following pathogen infection, such as in the case of an influenza lung 
infection model (C. K. Wong et al., 2017). In the liver, there have been mixed reports on the 
maintenance of Kupffer cell phagocytosis, where one study reported a deficit (Brouwer & 
Knook, 1983) and another reported an increase in phagocytosis with aging (Hilmer, Cogger, & 
Le Couteur, 2007). 
Autophagy, or the intracellular degradation of damaged proteins and organelles in 
autophagosomes, is one such process which has been shown to become dysregulated with 
increasing age in macrophage populations (Stranks et al., 2015). Deletion of autophagy genes 
Atg5 and Atg7 in bone marrow-derived macrophages resulted in decreased antigen presentation 
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capacity, impaired maturation, altered mitochondrial metabolism, downregulation of surface 
receptors such as TLR-4, and increased secretion of pro-inflammatory cytokines (Rubinsztein, 
Marino, & Kroemer, 2011; Stranks et al., 2015). The phenotype of these autophagy deficient 
bone marrow macrophages closely mimics that of macrophages isolated from aged individuals 
(Stranks et al., 2015), which may be driven by the hypermethylation of autophagy associated 
genes (Khalil et al., 2016). It remains to be seen if restoring autophagic flux to aged 
macrophages can improve their function and polarization status, however caloric restriction has 
been shown to improve both longevity and autophagic capacity of cells in animal models 
(Trepanowski, Canale, Marshall, Kabir, & Bloomer, 2011). 
The reduction in autophagosome activity prevents the degradation of both inflammasome 
components and damaged mitochondria and can thereby promote chronic activation of pro-
inflammatory signals in aged cells (Rubinsztein et al., 2011). This phenomenon has been termed 
“inflamm-aging,” one of the hallmarks of aging, and has been strongly correlated to morbidity 
(Puzianowska-Kuznicka et al., 2016). The release of radical oxygen species from damaged 
mitochondria or M1-polarized macrophages can then oxidize proteins, lipids, and DNA (Abais, 
Xia, Zhang, Boini, & Li, 2015; Cichoz-Lach & Michalak, 2014; Kapetanovic et al., 2015), 
further exacerbating inflammasome activation in aging and leading to systemic inflammation 
(Cecilio, Costa, Simioni, Gabriel, & Tamashiro, 2011; Dimitrijevic et al., 2013; Suchy, Labuzek, 
Buldak, Szkudlapski, & Okopien, 2014).  
Bone marrow-derived macrophages isolated from aged murine and human donors have been 
shown to produce greater concentrations of nitric oxide and reactive oxidative species than 
macrophages isolated from young donors (Suchy et al., 2014). However, this upregulation in the 
secretion of reactive oxidative species was not observed following pro-inflammatory stimulation 
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of peritoneal macrophages (Cecilio et al., 2011; Dimitrijevic et al., 2013). Despite these increases 
in nitric oxide and reactive oxygen species, M2 macrophages have been found to accumulate in 
aged skeletal muscle and result in the detrimental replacement of muscle fibers with fibrotic 
tissue over time (Y. Wang, Wehling-Henricks, Samengo, & Tidball, 2015). 
The gene signature of macrophages isolated from bone marrow and polarized to M1 or M2 
phenotypes was mostly unchanged between young and aged mice, with the exception of 
increased Fizz-1 (M2 marker) expression on aged cells (Mahbub, Deburghgraeve, & Kovacs, 
2012). However, macrophages isolated from mouse spleen had a reduction in both M1 and M2 
gene expression patterns when stimulated with polarizing cytokines (Mahbub et al., 2012). Work 
from our group also demonstrates only marginal differences between young and aged bone 
marrow derived macrophages polarized in vitro, including a slight increase in nitric oxide 
production (Hachim, Wang, et al., 2017). However, when bone marrow derived macrophages are 
pre-exposed to degradation products from young and aged extracellular matrix or “tissue cues,” 
differences in function arise following polarization with M1-inducing cytokines, again 
suggesting that cues in the microenvironment may be driving some of the cellular dysfunction 
(LoPresti & Brown, 2018). 
Non-immune cell types can also contribute to the age-associated immune dysfunction. 
With age, increasingly large numbers of pre-adipocytes differentiate into mature adipocytes, with 
enhanced secretion of leptin, TNF-α, and IL-6, and reduced secretion of adiponectin, promoting 
M1 phenotypes (Garg, Delaney, Shi, & Yung, 2014; Tchkonia et al., 2010; Urs et al., 2004). 
Numerous DAMPs, which have been shown to promote inflammasome formation and activation, 
also have age-related increases in concentration, including cholesterol (Duewell et al., 2010), 
amyloid-β (Murphy, Grehan, & Lynch, 2014; K. Wang et al., 2017), hydroxyapatite crystals (Jin 
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et al., 2011), purine catabolic end products such as uric acid (Chen et al., 2006), and ATP 
(Mariathasan et al., 2006). More recently, the effect of the aging gut microbiome on macrophage 
function has been considered (Thevaranjan et al., 2017). Raising mice under germ-free 
conditions preserves the bactericidal capacity of alveolar macrophages and reduces secretion of 
IL-6 in old age, mediated by reduced dysbiosis and improved gut permeability (Thevaranjan et 
al., 2017). Finally, age-related alterations in the T cell compartment can shift the relative Th1 
and Th2 cytokine concentrations and directly impact macrophage polarization (Onyema et al., 
2015; van der Geest et al., 2014). 
The morphology of macrophages can also be influenced by the aging process. Microglia 
have been shown to increase cell soma volume while reducing the length of cellular processes in 
aged brains (Hefendehl et al., 2014). These morphological changes reduce the capability of the 
microglia to interact with neural cells and perform routine surveillance of the local 
microenvironment (Hefendehl et al., 2014). While microglial population sizes increase to 
account for this reduction in cell process size (Dey et al., 2014), the population expansion tends 
to occur in a non-homogenous manner, disrupting the uniform microglial distributions 
commonly observed in young animals (Hefendehl et al., 2014). In addition, aged microglia 
exhibit enhanced secretion of reactive oxidative species following central nervous system injury 
through upregulation of NADPH oxidase 2 (von Leden, Khayrullina, Moritz, & Byrnes, 2017), 
and secrete more IL-1β, mediated by hypomethylation of CpG sites in the IL-1β proximal 
promoter (Cho et al., 2015).  
The infiltration of monocyte-derived macrophages to multiple tissue sites has been 
observed in age-related diseases, including Alzheimer’s disease (Malm, Koistinaho, Muona, 
Magga, & Koistinaho, 2010), which leads to increased inflammation and phagocytosis. In the 
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cardiovascular system, the tissue resident macrophage population (yolk-sac derived, M2-like) is 
replaced by bone marrow-derived macrophages over time in murine models (Epelman, Lavine, 
Beaudin, et al., 2014; Pinto et al., 2014). This shift in macrophage populations contributes to 
deleterious outcomes following cardiac injury, such as chronic inflammation, fibrotic scar 
deposition, and reduced re-vascularization of ischemic tissue following injury (Lavine et al., 
2014; Pinto et al., 2014). Similarly, peritoneal macrophages derived from embryonic origins are 
replaced by circulating monocytes over time, which do not recapitulate expression of Tim-4 in 
murine models (Bain et al., 2016). Presently, the replacement of embryonic macrophage 
populations with monocyte-derived cells and consequences thereof are unknown in certain 
organs, including the liver. 
1.3.2.2 Host Response to Synthetic Biomaterials 
There are few, if any reports in the literature which have investigated the host response to 
implants in aged animals. However, a recent study from our group sought to elucidate the 
impacts of aging upon the host response to polypropylene mesh implanted into 8-week (young) 
and 18-month-old (aged) mice (Hachim, Wang, et al., 2017). The findings of the study suggested 
that the host macrophage response to polypropylene mesh implants was delayed, dysregulated, 
and unresolved in the aged animals as compared to the young.   
Briefly, we observed decreased recruitment of macrophages to the site of subcutaneous 
implantation in the aged animals at 3- and 7-days post-implantation (Figure 3a, b). The 
population which was present in the aged animals was found to be expressing significantly more 
iNOS and less arginase than was observed in young animals, indicating a more M1 skewed 
response (Figure 3c-f).  
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Figure 3. The Host Response to Polypropylene Mesh in Aged Mice 
The early host response to implanted materials in young and aged C57BL/6 mice. (a) Images of H&E-stained tissue 
cross-sections and (b) total cell counts (DAPI) surrounding single mesh fibers at 3, 7, and 14 days. Scale bars 
represent 200 mm. Fluorescence microscopy images of (c) Arginase-1 (red) CD68 (green) co-immunolabeling and 
(e) iNOS (red) CD68 (green) co-immunolabeling at a single mesh fiber at 3, 7, and 14 days. Scale bars represent 50 
mm. Cell count image analysis of (d) Arg-1+, Arg-1+ CD68+ cells and (f) iNOS+, iNOS+ CD68+ cells at 3, 7, and 14 
days. Bars represent the mean ± SEM. Statistical significance as (*) p < 0.05, (**) p < 0.01, (***) p < 0.001, (****) 
p < 0.0001. All other differences are nonsignificant (n = 7). 
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Analysis of tissue remodeling outcomes at 90 days demonstrated similar composition and 
thickness of the tissue capsule surrounding the implants; however, 18-month-old animals were 
observed to have a significantly greater number of cells within the tissue capsule, suggesting an 
unresolved inflammatory response. These results correlate well with the findings of 
dysregulated, and unresolved host responses in studies of the response pathogen and in wound 
healing in aged individuals.  
In summary, several age-related deficits have been identified in specific tissue-resident 
macrophage populations in a context dependent manner. Studies have largely focused on easily 
accessible sources of tissue-resident macrophages, such as bone marrow, peritoneal cavity, and 
alveolar macrophages. However, macrophages residing in the liver are less commonly studied, 
despite being the largest pool of tissue resident macrophages in the body. Future work directed at 
identifying changes in liver resident macrophages will be crucial for understanding the 
development of age-related liver disease and the host response to infection and implanted 
materials.   
1.4 LIVER SPECIFIC MACROPHAGE POPULATIONS 
The liver is an important immunological organ, serving as a surveillance system for gut-derived 
pathogens and producing several key immune components – complement, acute phase, and 
coagulation proteins (Crispe, 2009; Robinson, Harmon, & O'Farrelly, 2016). While hepatocytes 
and certain non-parenchymal cells possess some inherent immunological properties (see reviews 
(Zhou, Xu, & Gao, 2016) and (P. A. Knolle & Wohlleber, 2016)), multiple populations of CD45+ 
immune cells are transiently or permanently located in the liver.  
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The healthy liver is home to several populations of lymphocytes, including natural killer 
(NK) cells, NK T-cells, B-cells, mucosal associated T-cells and γδ-T-cells (Doherty et al., 1999; 
Dusseaux et al., 2011; Kenna et al., 2004; Kenna et al., 2003).  In humans, 40% of the resident 
lymphocyte population are composed of NK cells, while in mice 40% of the resident 
lymphocytes are NK T-cells. Innate immune cells also have a large presence in the liver. The 
majority of immune cells in the liver are myeloid derived cells, including dendritic cells and 
macrophages (Gao, Jeong, & Tian, 2008; Thomson & Knolle, 2010).  
1.4.1 Hepatic Macrophages 
Hepatic macrophages include both cells derived from circulating monocytes, which are present 
at various levels during homeostasis and inflammation, and the resident tissue macrophage, 
known as the Kupffer cell (KC) (Gomez Perdiguero et al., 2015; Schulz et al., 2012; Yona et al., 
2013).  KCs are the most highly represented immune cell, comprising nearly one-third of non-
parenchymal cells in the liver (Bilzer, Roggel, & Gerbes, 2006). 
1.4.1.1 Kupffer Cells 
The KC is a primitive cell, appearing early during embryogenesis (E9.5-E12.5 in mice), derived 
primarily from the yolk sac (Gomez Perdiguero et al., 2015; Hoeffel et al., 2015; Mass et al., 
2016). Importantly, the KC population is maintained through self-proliferation, with minimal 
input from circulating monocytes during homeostasis (Gomez Perdiguero et al., 2015; Jenkins et 
al., 2011; Schulz et al., 2012; Yona et al., 2013). 
The Kupffer cell is the key detector of commensal or pathogenic microbial signals, danger 
signals, and tumor cells moving through the hepatic circulation (Bilzer et al., 2006; Kinoshita et 
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al., 2010; Movita et al., 2012).  KCs are located along the hepatic sinusoids allowing for the low-
pressure blood supply come into contact with both KCs and hepatocytes through the fenestrated 
endothelium (Robinson et al., 2016). KCs express the complement receptor CR1g, which binds 
complement fragments C3b and iC3b, allowing phagocytosis of complement C3-opsonized 
particles even under low-pressure blood flow (Helmy et al., 2006; Zeng et al., 2016). Bacterial 
clearance by KCs is crucial for host defense as 80% of blood-borne bacteria accumulate in the 
liver and are destroyed there (Bilzer et al., 2006; Kinoshita et al., 2010; Movita et al., 2012).  
DAMPs and PAMPs are present in relatively high concentrations in blood entering the liver 
from the gut, via the portal vein, and engage with pattern recognition receptors, including Toll-
like receptors, on the surface of macrophages and hepatocytes (Janeway, 1992; Kubes & Mehal, 
2012; Takeuchi & Akira, 2010). With low levels of bacterial endotoxins, KCs promote immune 
tolerance by secreting anti-inflammatory factors including IL-10, TGF-β, and prostaglandin-E2 
(PGE2), thereby inducing regulatory T-cells (Ju & Tacke, 2016; P. Knolle et al., 1995). In the 
presence of higher concentrations of damage or pathogen-associated signaling molecules, KCs 
can become polarized towards an M1 phenotype and produce a variety of inflammatory 
cytokines including IL-1, IL-6, IL-12, TNF-α (Bilzer et al., 2006; Kinoshita et al., 2010; Movita 
et al., 2012). Several liver diseases are influenced by KC activation and expansion, but their 
individual role has been difficult to dissect from more recently identified macrophage 
populations in the liver.  
1.4.1.2 Infiltrating Monocyte Derived Macrophages 
Within the past decade, the heterogeneity of hepatic macrophages, i.e. Kupffer cells and 
monocyte-derived macrophages, has become an emerging topic in hepatology. Fate tracing 
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experiments in the brain first determined that resident microglia are established prenatally and 
maintained independently from monocyte input, which was later translated to the liver (Ginhoux 
et al., 2010). Holt et al. were among the first to identify two populations of macrophages in the 
liver (Holt, Cheng, & Ju, 2008). Through bone marrow chimera experiments, cells expressing 
F4/80hiCD11blo were identified as KCs, while cells expressing F4/80loCD11bhi were found to be 
derived from circulating monocytic progenitors (Holt et al., 2008). Shortly after, Klein et al. 
classified two macrophage populations in the liver: KCs as immobile, “sessile” macrophages and 
monocyte-derived macrophages as motile cells (Klein et al., 2007).  
In most cases, murine monocyte-derived macrophages in the liver are derived from an influx 
of bone marrow derived, Ly6Chi monocytes, primarily driven by monocyte chemoattractant 
protein, which can be produced by KCs, stellate cells, or hepatocytes (also known as CCR2-
CCL2 interactions) (Dal-Secco et al., 2015; Mossanen et al., 2016). Secondary pathways of 
monocyte recruitment to the liver are CXCR3-CXCL10, CCR1-CCL5, and CCR8-CCL1 
dependent (Heymann et al., 2012; Seki, De Minicis, Gwak, et al., 2009; Zhang et al., 2016). 
Murine monocyte-derived macrophages may also be derived from Ly6Clo monocytes trafficking 
from the spleen, which express CD11b, but are thought to take on a more patrolling or regulatory 
macrophage phenotype (Swirski et al., 2009). Phagocytes from the peritoneal cavity, which 
express F4/80, CD11b, and GATA6, have been shown to cross into the liver after subcapsular 
liver lesion (J. Wang & Kubes, 2016), but it remains unclear if this infiltration occurs in other 
liver injury settings.  
1.4.1.3 Roles in Health and Disease 
Kinoshita et al. determined that murine monocyte-derived macrophages and KCs could be 
distinguished by CD11b and CD68 expression, respectively (Kinoshita et al., 2010). The 
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CD11bhi monocyte-derived macrophages were radiosensitive and particularly efficient at 
producing IL-12, protecting the host against tumor xenografts, while the CD68hi KCs were 
radioresistant and highly efficient at phagocytosis, protecting the host against bacterial challenge 
(Kinoshita et al., 2010). The use of these differentiating markers has been expanded to several 
disease models, identifying a damaging role of TNF/FasL production by CD11b+ monocyte-
derived macrophages in carbon-tetrachloride acute liver injury and hepatitis in 
hypercholesterolemic mice (Nakashima et al., 2013; Sato et al., 2014). The CD11b+ monocyte-
derived macrophages were also found to accumulate in the liver following repeated 
lipopolysaccharide injections, but suppressed TNF efflux into the systemic circulation, thereby 
reducing lethal septicemia (Kinoshita et al., 2017). In addition, the CD11b+ monocyte-derived 
macrophages were recruited during diet-induced steatohepatitis in FGF5 deficient mice and 
following partial hepatectomy, where they were crucial for liver regeneration (Nakashima et al., 
2016; Nishiyama et al., 2015). Others have observed that monocyte derived cells protect the liver 
from iron toxicity in hemolytic anemia by ingesting senescent and dying erythrocytes (Theurl et 
al., 2016).  
More recently, the C-type lectin, Clec4f, has been identified as a selective murine KC marker 
(Scott et al., 2016). Interesting, ablating KCs via Clec4f-driven diphtheria toxin causes an influx 
of monocyte-derived macrophages, which can differentiate into nearly identical KCs when this 
“niche” is made available. Only 12 genes remained differentially expressed between monocyte 
derived KCs and embryonically derived KCs, including CD209f, CD163, C2, CCR3, Timd4, and 
Snrpn at the time points examined (Scott et al., 2016).  
Taken together, KCs and monocyte-derived macrophages play heterogenous roles in various 
liver disease states and cannot be considered wholly harmful or beneficial without deciphering 
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the given context. Importantly, infiltrating monocytes may also differentiate into dendritic cells, 
which play distinct immunostimulatory and antigen presentation roles in the liver (Kingham et 
al., 2007). The heterogeneity of hepatic macrophages is less well defined in humans as compared 
to murine animal models. The role of these diverse hepatic macrophage populations in a given 
disease context is just beginning to be understood and has not yet been examined in the natural 
aging process, a major risk factor for several chronic liver diseases.  
1.4.2 Effects of Aging on Liver Parenchymal and Non-Parenchymal Cells 
The process of aging is closely associated with a number of degenerative modifications in the 
liver, where hepatic structure and cell function are observed to decline. Both hepatocytes and 
macrophages exhibit deficits in mitochondrial function, linked to a decline in autophagy and 
production of pro-inflammatory molecules (I. H. Kim, Kisseleva, & Brenner, 2015; Salminen, 
Kaarniranta, & Kauppinen, 2012). While the effects of aging on hepatic macrophages have not 
been well characterized on a cellular and molecular level, several studies have examined 
macrophages from alternative tissue sources and may offer some insight about hepatic 
macrophages (see section 1.3.2.1, page 16).  
Several studies have shown that the volume of blood in the liver decreases in elderly 
individuals, leading to a total volume loss of 20%-40% (Zeeh & Platt, 2002). In addition, the 
thickness of liver sinusoidal endothelial cells fenestrations increases, limiting the exchange of 
molecules to and from the liver (McLean et al., 2003). At the serum level, aging is associated 
with reductions in albumin and bilirubin, increases in alkaline phosphatase, and minimal changes 
in aminotransferase levels (Tietz, Shuey, & Wekstein, 1992). The metabolism of cholesterol in 
the liver also decreases, leading to increased blood cholesterol and neutral fat levels over time 
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(Tietz et al., 1992). However, more recent investigations suggest the most essential change in 
liver aging is loss of the functional liver cell mass (Wakabayashi, Nishiyama, Ushiyama, Maeba, 
& Maeta, 2002).  
Changes in the morphology of hepatocytes may be related to increased polyploidy, 
accumulation of lipofuscin in the cytoplasm, and declining surface area of endoplasmic 
reticulum and number of mitochondria, ultimately negatively affecting the function of 
hepatocytes (Hohn & Grune, 2013; I. H. Kim et al., 2015; Sastre et al., 1996). The oxidative 
capacity of the liver declines with aging, reducing the capacity to metabolize certain drugs such 
as benzodiazepines (American Geriatrics Society Beers Criteria Update Expert, 2012). The 
decline in hepatocyte mitochondrial function has been suggested to enhance the vulnerability of 
aged livers to acute injury and to cause delays in liver regeneration (Poulose & Raju, 2014). In 
addition, aging livers are known to accumulate a multiprotein complex (C/EBPalpha-Brm-
HDAC1) that silences elongation factor 2 (E2F)-dependent promoters, thereby reducing 
proliferation and regenerative capacity of hepatocytes (G. L. Wang et al., 2008).  
The reduction in proliferation of aged hepatocytes may also be related to an increase in 
senescent cells with aging. Senescent cells accumulate in the liver during aging and in chronic 
liver disease; and may include hepatocytes, cholangiocytes, stellate cells, and immune cells 
(reviewed here: (A. D. Aravinthan & Alexander, 2016)). Cells become senescent as a result of 
replicative exhaustion (telomere shortening), DNA damage, or oxidative stress, among other 
mechanisms (Ben-Porath & Weinberg, 2005). Senescent cells are characterized by the 
expression of cell cycle inhibitors p21, p16, and p53, which prevent replication and apoptosis, as 
well as secretion of pro-inflammatory cytokines that signal for their removal but can lead to 
tissue damage when chronically expressed (Campisi, 1996; Coppe et al., 2008). Senescent 
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hepatocytes accumulate with age and appear as an almost “universal phenomenon” in chronic 
liver diseases including hepatitis B and C infection, alcoholic and non-alcoholic liver disease, 
and genetic haemochromatosis (A. D. Aravinthan & Alexander, 2016). Furthermore, senescent 
hepatocytes undergo metabolic changes, such as increased transport of conjugated bilirubin into 
the hepatic sinusoids and insulin resistance through dysregulated glucose transporter expression 
and Akt signaling among others (A. Aravinthan et al., 2015). Interestingly, the length of 
telomeres was found to be conserved in aged hepatocytes and bile duct cholangiocytes but 
decreased in aged Kupffer cells and stellate cells, suggesting cell-specific mechanisms of 
senescent phenotype acquisition in the liver (Verma et al., 2012). 
Overall, the effects of aging on non-parenchymal cell subsets, particularly hepatic 
macrophages, is an understudied area. Hilmer et al. determined that the number and basal 
activity of Kupffer cells was increased with old age in a rat model (Hilmer et al., 2007), however 
this work was performed before the heterogeneity of liver macrophages was fully understood. 
Similarly, Singh et al. identified a change in liver macrophage distribution with aging, where old 
mice had more F4/80+ macrophages located in large lymphoid structures (also containing T-cells 
and B-cells), and a reduction in the number of spindle shaped macrophages throughout the 
parenchyma (Singh et al., 2008).  
Recent work by Maeso-Diaz et. al characterized molecular changes in LSECs, stellate cells, 
and hepatic macrophages in the livers of aged rats (Maeso-Diaz et al., 2018). The authors 
identified a significant deregulation of LSEC phenotype with aging as demonstrated by 
downregulation of vasodilatory pathways (nitric oxide, heme oxygenase), increase in oxidative 
stress, and decrease in angiocrine markers (stabilin-2, CD32b, and VEGFR2) (Maeso-Diaz et al., 
2018). Aged stellate cells had increased markers of activation (alpha smooth muscle actin and 
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collagen I), increased intracellular lipid stores, and alterations in retinoid metabolism (Maeso-
Diaz et al., 2018). Finally, the authors noted an increase in recruitment of proinflammatory cells 
in aged livers, including increased IL-6 expression in isolated hepatic macrophages, but no 
change in the traditional macrophage polarization markers (Maeso-Diaz et al., 2018). Human 
livers showed similar trends in downregulation of endothelial markers, but substantial work 
remains to extend and decode these findings in both aged murine and human systems.  
1.4.3 Aging and Fatty Liver Disease 
Aging is a major risk factor for the development and prognosis of several chronic liver diseases 
and conditions, including nonalcoholic fatty liver disease, alcoholic liver disease, hepatitis C, and 
an increased susceptibility to develop fibrosis and cirrhosis (Sheedfar, Di Biase, Koonen, & 
Vinciguerra, 2013). The reduced capacity of aged livers to regenerate and to tolerate 
transplantation leads to increased risk of mortality from chronic liver diseases, as demonstrated 
in Figure 4 (adapted from (Stahl et al., 2018) in accordance with the Creative Commons 
license).   
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Figure 4. Aging and Mechanisms of Liver Disease. 
 
In the context of this dissertation, steatosis associated with non-alcoholic fatty liver disease is 
the most relevant chronic liver disease associated with aging and inflammation. Non-alcoholic 
fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are leading causes of 
chronic liver disease globally and are projected to become the leading indication for liver 
transplantation in the United States (Mikolasevic et al., 2018; R. J. Wong et al., 2015; Younossi 
et al., 2016). NAFLD often presents with metabolic syndrome, such as obesity and excessive 
visceral fat, hyperlipidemia, hypertension, insulin resistance and an increased secretion of pro-
inflammatory cytokines (Barzilai, Huffman, Muzumdar, & Bartke, 2012). All of these 
components of metabolic syndrome are generally observed in elderly populations and many 
studies find increased rates of NAFLD among elderly people compared with their younger 
counterparts (Frith, Day, Henderson, Burt, & Newton, 2009; Koehler et al., 2012; Noureddin et 
al., 2013).  
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The mechanism for developing age-related steatosis is not fully understood but has been 
attributed to hepatocyte senescence driving a reduction in mitochondrial metabolism (Ogrodnik 
et al., 2017), decreased transport of insulin across the sinusoidal endothelium (Mohamad et al., 
2016), reduction in autophagic flux (Gonzalez-Rodriguez et al., 2014), or chronic low-level 
inflammation (Duval et al., 2010; Kumar et al., 2013), leading to the build-up of toxic free fatty 
acids in the liver. Lifestyle choices, such as high fat diet (HFD), may also lead to the 
development of NAFLD in aged individuals. Work by Fontana et. al showed that mice were 
equally susceptible to steatosis following HFD regardless of age. However, the older mice 
exhibited more severe hepatocellular injury and inflammation following administration of HFD 
that was attributed to increased M1 macrophage polarization in both the liver and white adipose 
tissues (Fontana et al., 2013). 
As in other chronic liver diseases, macrophages accumulate in the livers of NAFLD 
patients (Wan et al., 2014). Experimental mouse models have shown an accumulation of Ly6C+ 
monocytes is a critical step in the development of progressive fibrosis from steatohepatitis in a 
CCL2-dependent mechanism (Tacke, 2017). In addition, lipids and free fatty acids contribute to 
DAMP-induced Kupffer cell activation (Reid et al., 2016). Patients with low-grade steatosis 
were found to have higher mRNA expression of M2 markers, CD206 and CD163, compared to 
patients with advanced steatosis. The M2 macrophages were hypothesized to promote apoptosis 
of M1 polarized hepatic macrophages and protect against disease progression of NAFLD or 
alcoholic hepatitis (Wan et al., 2014). Interestingly, soluble CD163 (sCD163), a marker of M1 
macrophage polarization, increases systemically with severity of NAFLD in human patients 
(Kazankov et al., 2015), again suggesting that M1 polarization is associated with more advanced 
stages of the disease.  
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Both Kupffer cells and infiltrating monocytes are implicated to various levels in the etiology 
of chronic liver disease, however the distinction between these two cell populations is less clear 
in human clinical liver samples compared to animal studies. Importantly, most models of chronic 
liver disease are induced in young, healthy animals through genetic manipulation or by 
administering specific diets or chemical toxins. Findings from these animal studies are important 
to identify novel mechanisms regulating liver disease but may not prove relevant or all-
encompassing when translating the findings to older, human populations, as evidenced by the 
moderate success of several anti-fibrotic therapies in clinical trials (Cohen-Naftaly & Friedman, 
2011). Distinguishing between the biology of aging and age-associated pathologies can be a 
difficult task but is an important effort in the field of hepatology. Additional studies are needed 
to assess the effect of aging on the liver prior to the onset of age-associated pathologies in order 
to dissect mechanisms of aging from the manifestation of the pathology itself. 
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2.0  A STUDY OF MACROPHAGES IN THE AGING LIVER 
Chapter 2 is adapted from one primary research article, presently in under revision at the time of 
submission of this dissertation: 
Stahl EC1, Delgado ER1,2, Alencastro F1,2, LoPresti ST1,3, Wilkinson PD1,2, Roy N1,2, 
Haschak MJ1,3, Monga SP1,2,4, Duncan AW1,2,4, Brown BN*1,2,3,4. (2018) Inflammation and 
ectopic fat deposition in the aging murine liver is influenced by CCR2. (submitted October 
2018).  
1McGowan Institute for Regenerative Medicine, 2Department of Pathology, 3Department 
of Bioengineering, 4Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 
2.1 INTRODUCTION 
Non-alcoholic steatohepatitis (NASH) is the leading causes of chronic liver disease in the world 
and is currently the second leading indication for liver transplantation in the United States 
(Mikolasevic et al., 2018; R. J. Wong et al., 2015; Younossi et al., 2016). Importantly, the 
prevalence of the non-alcoholic fatty liver disease (NAFLD) including NASH increases with age 
(Mikolasevic et al., 2018). Individuals over the age of 60 exhibit a 200% increase in liver 
triglyceride content compared to young individuals when matched for body mass index, fat 
percentage, physical activity, smoking, and medical history (K. F. Petersen et al., 2003). With an 
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aging population, the number of individuals requiring a liver transplant is expected to increase, 
while the number of healthy donor organs available for transplant is anticipated to decrease as 
hepatic steatosis risk factors, e.g. obesity and type-two diabetes mellitus, continue to rise, further 
exacerbating the disparities in liver transplantation (Mikolasevic et al., 2018). 
The mechanism for developing age-related steatosis is not fully understood but was 
recently attributed to hepatocyte senescence driving a reduction in mitochondrial fatty acid 
metabolism (Ogrodnik et al., 2017). Progression of NAFLD/NASH in aged individuals may also 
be related to decreased transport of insulin across the sinusoidal endothelium (Mohamad et al., 
2016), reduction in autophagic flux (Gonzalez-Rodriguez et al., 2014), or chronic low-level 
inflammation originating from adipose tissue or local immune cells (Duval et al., 2010; Kumar et 
al., 2013), leading to the build-up of toxic free fatty acids in the liver. 
Hepatic macrophages are strongly implicated in the development and progression of 
NAFLD/NASH (Bieghs, Rensen, Hofker, & Shiri-Sverdlov, 2012; Lanthier, 2015; Tacke & 
Zimmermann, 2014). Liver-resident macrophages, known as Kupffer cells (KCs), are the largest 
population of immune cells in the liver, comprising up to one-third of the non-parenchymal cell 
population. KCs are derived from the embryonic yolk sac and are maintained by self-renewal. 
Alternatively, monocyte-derived macrophages have been found to hone to the liver under 
chemotactic stimulus (Ju & Tacke, 2016). When mice were fed a high-fat or high-cholesterol 
diet, the balance of hepatic macrophages was found to shift toward monocyte-derived cells 
(F4/80loCD68-CD11bhi) and away from the resident KC population (F4/80hiCD68+CD11blo) 
(Nakashima et al., 2016). Hepatic macrophages are known to secrete IL-1β, TNFα, and CCL5 
during steatosis, which may promote apoptosis of hepatocytes, as well as CCL2 (MCP-1), which 
can also be produced by hepatocytes to recruit monocytes (Tacke, 2017). The production of 
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CCL2 is regulated by the canonical NFκB signaling pathway and is inversely correlated to LXR-
RXR signaling in both macrophages and hepatocytes (Chinenov, Gupte, & Rogatsky, 2013).  
The present study characterizes hepatic steatosis in aged mice and identifies phenotypical 
and functional changes in the liver macrophage compartment, toward a better understanding of 
mechanisms underlying the development of fatty liver disease and inflammation in the natural 
aging process.  
2.2 METHODS 
Animal Models. The Institutional Care and Use Committee (IACUC) of the University of 
Pittsburgh approved all mouse experiments. C57BL/6 wild-type (WT) mice were obtained at 2-
months and 18-months of age from the National Institute of Aging (NIA) Rodent Colony 
(Charles River Laboratories, Wilmington, MA), where they were maintained on NIH 31 diet 
(Ziegler Bros, Inc. Garners, PA) and used for experiments one month after arrival. CCR2 
knockout mice (B6.129S4-CCr2<tm1lfc>) or WT controls were obtained from The Jackson 
Laboratory (Bar Harbor, ME), where they were maintained on JL Rat and Mouse Auto 6F 5K52 
feed (LabDiet, St. Louis, MO) as retired breeders (7-8 months of age), and were then aged in-
house at the University of Pittsburgh for an additional 11-12 months, where they were 
maintained on Prolab Isopro RMH 3000 feed (LabDiet).  
Female mice were included exclusively in this study, as sex-specific differences in the 
age of onset of NAFLD/NASH have been noted in the literature and (Ballestri et al., 2017). 
Females are more likely to develop NAFLD/NASH with aging and post-menopause, while males 
are less well associated with age as a risk factor for developing NAFLD/NASH (Ballestri et al., 
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2017). Mice were maintained on a standard 12-hour light and 12-hour dark system at the 
University of Pittsburgh specific-pathogen free animal facility. Mice were housed in Optimice 
cages (AnimalCare Systems, Centennial, CO) with Sani-Chip Coarse bedding (P. J. Murphy, 
Montville, NJ) and provided ad libitum access to water and standard mouse chow (LabDiet, St. 
Louis, MO, Purina ISO Pro Rodent 3000). Mice were provided huts and running wheels for 
enrichment. 
Harvest of liver tissues. Mice were weighed and sacrificed by CO2 inhalation followed 
by cervical dislocation, in accordance with University of Pittsburgh IACUC standards. Livers 
were excised and rinsed in PBS. Liver mass was recorded. Small pieces of liver were dissected 
and (a) fixed in 2% paraformaldehyde (Acros Organics, Fisher Scientific, Pittsburgh, PA) for 2 
hours, followed by 60% sucrose (Fisher Scientific, Pittsburgh, PA) overnight, then embedded in 
Optimal Cutting Temperature (Fisher Scientific, Pittsburgh, PA), or (b) fixed in 10% neutral 
buffered formalin (Fisher Scientific, Pittsburgh, PA) and embedded into paraffin blocks by the 
McGowan Institute for Regenerative Medicine histology core, or (c) snap frozen in liquid 
nitrogen and stored at -80 degrees Celsius for later analysis of RNA, protein, or lipids.  
Primary liver cell isolation. Primary hepatocytes were isolated using a two-step 
collagenase perfusion (Overturf et al., 1996). Briefly, following general anesthesia induction, a 
catheter was inserted into the portal vein or inferior vena cava and 0.3 mg/ml collagenase II 
(Worthington, Lakewood, NJ) was circulated through the liver. Digested livers were placed in 
Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal bovine serum (Corning, 
Tewksburg, MA) passed through 100 and 70μm cell strainers and washed twice using low-speed 
centrifugation (50xg for 3 min) to remove non-parenchymal cells (NPCs). Hepatocyte viability, 
determined by trypan blue staining, was typically >80%, with purity >90%. Hepatocytes were 
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stored in RNA-later (Fisher Scientific, Pittsburgh, PA) or radioimmunoprecipitation assay buffer 
(RIPA, 1% IgePAL, 0.5% sodium deoxycholate, 0.1% SDS, Sigma-Aldrich, St. Louis, MO, with 
Pierce protease and phosphatase inhibitor mini tablet, ThermoScientific, Waltham, MA) at -20 
degrees Celsius for RNA/protein analysis at a later time.  NPCs were used for flow cytometry 
(see supporting methods) or were further purified to collect hepatic macrophages. Briefly, NPCs 
were blocked with Fc receptor (1:100, rat anti-mouse CD16/32, BD Biosciences, San Jose, CA), 
stained with F4/80-PE (1:20, rat anti-mouse (BM8), eBioscience, ThermoFisher Scientific, 
Waltham, MA), and incubated with anti-PE microbeads (1:10, Miltenyi Biotec, Auburn, CA). 
Cells were applied to LS columns on the QuadroMACS separator (Miltenyi Biotec, Auburn, CA) 
and washed three times to remove non-tagged NPCs. F4/80+ cells were eluted and counted. 
Viability of collected F4/80+ cells was typically >85%, with purity >95%. 
Statistical analysis. When comparing young and aged samples (WT or KO), a two-tailed 
Student’s t-test was used, unless otherwise stated. One-way ANOVA was used to compare 
polarization of macrophages, with Tukey’s multiple comparisons, unless otherwise stated. Two-
way ANOVA was used to detect differences in the proportions of CD11b and CD68 populations 
between young and aged mice, with Sidak’s multiple comparisons test. P values < 0.05 were 
considered significant. 
Additional methods can be found Appendix A (page 110).   
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2.3 RESULTS 
Aged mice exhibit increased body weight, liver weight, and elevated serum ALT levels 
Aged female mice (19-months-old) obtained from the National Institute of Aging animal 
repository showed a 1.3-fold increase in total body weight and liver weight compared to young 
female mice (3-months-old) (Table 1). The liver to body weight ratio remained proportional 
between the age groups (4.7 – 5.0% total body mass).  
To evaluate hepatic injury and function, serum levels of alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), bilirubin, and albumin were measured in the aging female 
mice (Table 1). There were marginal but significant increases in serum ALT and AST while 
serum albumin and bilirubin were unchanged, suggesting some level of hepatocyte injury. 
Furthermore, serum cholesterol was increased significantly while serum triglyceride levels were 
unchanged.  
 
Table 1. Body Weight, Liver Biochemistry, and Serum Lipids in Young and Aged WT Mice (NIA) 
 Young  
(3 mo., n=5-7) 
Aged  
(19 mo., n=5-6) Significance 
Body weight (grams) 22.0 ± 1.4 29.2 ± 4.0 p<0.01 
Liver weight (grams) 1.04 ± 0.2 1.33 ± 0.2 p<0.05 
Liver:Body weight ratio 4.72 ± 0.9 4.98 ± 0.4 p=0.62 
Serum Alanine Aminotransferase (IU/L) 23.0 ± 5.5 45.3 ± 24 p<0.01 
Serum Aspartate Aminotransferase (IU/L) 40.3 ± 7.6 62.0 ± 27 p=0.05 
Serum Bilirubin (mg/dL) 0.21 ± 0.1 0.17 ± 0.1 p=0.22 
Serum Albumin (g/dL) 2.50 ± 0.3 2.48 ± 0.2 p=0.78 
Serum Cholesterol (mg/dL) 59.6 ± 11 78.8 ± 28 p=0.05 
Serum Triglycerides (mg/dL) 69.6 ± 28 66.7 ± 20 p=0.88 
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Livers from aged mice show signs of steatosis in the absence of injury 
Macroscopically, livers from 19-month-old mice appear similar to those from 3-month-
old mice, with no evidence of gross tumor, fibrosis or cirrhosis, although aged livers are larger 
with slight pallor (Figure 5A). Microscopically, the aged livers showed modest microvesicular 
steatosis both by Oil Red O staining and by H&E (Figure 5B).  
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Figure 5. Aged livers exhibit signs of steatosis. 
(A) Representative photos of 3-month-old and 19-month-old livers, scale bar: 1cm. (B) Representative images of Oil 
Red O and H&E staining demonstrate an increase in hepatic lipids in 19-month-old livers (quantification bottom, 
n=4-5, ** p<0.01, scale bar: 50µm). (C) Quantification of hepatic triglycerides and cholesterol per milligram of liver 
tissue (n=4, *p<0.05, *** p<0.001). (D) Quantification of total hepatic bile acids (n=3). (E) Glucose tolerance test 
(n=4) showed no change in fasting glucose levels or blood glucose over time Data are displayed as mean ± standard 
deviation. 
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To further investigate the lipid content in the aged livers, the amount of total cholesterol 
and triglycerides were measured in mice fasted for six hours to control for dietary intake. Aged 
livers showed a 1.5-fold and a significant increase in cholesterol content per milligram of liver 
weight and a 1.9-fold and a significant increase in triglyceride content per milligram of liver 
tissue when compared to the young livers (Figure 5C). The types of fatty acids composing the 
triglycerides and their relative proportions were unchanged between the age groups (Table 2). In 
addition, the concentration of total bile acids in the livers was similar between the two age 
groups, suggesting no deficits in bile acid production and metabolism or signs of cholestasis 
(Figure 5D). TUNEL staining showed minimal apoptotic hepatocytes or non-parenchymal cells, 
and picrosirius red staining also showed lack of any fibrosis in either young or aged liver 
samples (Figure 6). 
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Figure 6. Apoptosis and fibrosis in young and aged livers. 
(A) Representative images of TUNEL staining for apoptosis (red) counterstained with hematoxylin (blue) to 
visualize nuclei. Cells undergoing apoptosis were identified in both young and aged livers at similar frequencies and 
in a variety of cell populations including hepatocytes, non-parenchymal cells, and clusters of immune cells (n=5). 
(B) Representative images of Picrosirius red staining for connective tissue (red). Most connective tissue was 
identified around large vasculature with no quantitative difference between the young and aged livers (n=4). Scale 
bar = 50 µm. Data are displayed as mean ± standard deviation. 
 
In order to assess potential confounding effects of metabolic syndrome on lipid storage in 
the liver, an intraperitoneal glucose tolerance test was performed on the 3-month-old and 19-
month-old mice after fasting for six hours. Basal glucose concentrations were similar between 
the age groups and both age groups metabolized glucose comparably, suggesting preserved 
glucose tolerance (Figure 5E).  Overall, these studies demonstrate basal hepatic steatosis in the 
unmanipulated, aged mice without notable differences in bile acid and glucose homeostasis.  
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Table 2. Fatty Acid Profile of Triglycerides in Young and Aged Livers 
Fatty Acids 3 mo. (% total) 
19 mo. 
(% total) Significance 
14:0 0.62 ± 0.05 0.53 ± 0.04 p<0.05  
16:0 24.65 ± 1.34 23.73 ± 1.75 p=0.44 
16:1 2.20 ± 0.37 2.22 ± 0.35 p=0.94 
18:0 3.35 ± 0.36 3.34 ± 0.49 p=0.98 
18:1ω9 35.59 ± 1.66 36.62 ± 1.80 p=0.43 
18:1ω7 2.04 ± 0.15 1.87 ± 0.13 p=0.13 
18:2 20.17 ± 1.26 21.45 ± 1.35 p=0.21 
18:3ω6 0.39 ± 0.06 0.49 ± 0.07 p=0.07 
18:3ω3 0.84 ± 0.10 0.87 ± 0.14 p=0.76 
20:3ω6 0.74 ± 0.11 0.64 ± 0.04 p=0.10 
20:4 1.58 ± 0.13 1.67 ± 0.36 p=0.65 
20:5 0.67 ± 0.14 0.79 ± 0.21 p=0.38 
22:4ω6 0.48 ± 0.04 0.51 ± 0.11 p=0.61 
22:5ω6 0.21 ± 0.04 0.15 ± 0.04 p=0.13 
22:5ω3 1.11 ± 0.19 0.84 ± 0.18 p=0.09 
22:6 5.44 ± 0.89 4.35 ± 0.47 p=0.07 
 
Livers from aged mice show signs of spontaneous inflammation in the absence of injury 
We next assessed the aging livers for the presence of any inflammation. Whole liver 
tissue, hepatocytes, and hepatic macrophages were isolated from the 3-month-old and 19-month-
old mice. qRT-PCR showed an increase in the chemokine CCL2 in aged whole liver samples 
(+3-fold) and aged hepatocytes (+10-fold), but no change in aged F480+ hepatic macrophages 
compared to young samples (Figure 7A).  
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Figure 7. Aged livers have robust inflammatory signatures. 
(A) Significant increase in mRNA levels of CCL2 were detected in 19-month-old whole livers and hepatocytes, but 
not hepatic macrophages, normalized to beta-actin housekeeping gene and 3-month-old controls (n=3-4, **p<0.01) 
(B) ELISA for CCL2 in hepatocyte protein lysates normalized to 3-month-old controls (n=3, **p<0.01) (C) 
Representative western blot and quantification for phosphorylated p65 (Ser 536), phosphorylated p50 (Ser 337), 
CCL2, and GADPH normalized to 3-month-old controls (n=3, **p<0.01, *** p<0.001) (D) Significant increases in 
mRNA levels of TNF-alpha, interleukin-1 beta, and interleukin-6, were detected in 19-month-old hepatocyte cell 
fractions, normalized to beta-actin housekeeping gene and 3-month-old controls (n=6, *p<0.05). Data are displayed 
as mean ± standard deviation. 
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Western blot and ELISA confirmed an increase in protein levels of CCL2 (+3.6-fold) 
from aged hepatocyte fraction lysates, as well as phosphorylated members of the NFκB 
canonical signaling pathway (p-p65 Ser 536, +6.9-fold and p-p50 Ser 337, +3.7-fold), suggesting 
activation of inflammatory gene signatures in hepatocytes (Figure 7B,C). Additional 
inflammatory genes were found to be upregulated in the aged samples, including TNFα, IL-1β, 
and IL-6 (Figure 7D). Taken together, inflammatory chemokines and cytokines were detected in 
the aged liver hepatocyte cell fractions at both the protein and RNA levels. 
 
Macrophages increase in the aged liver and retain polarization and phagocytic capacity in 
vitro 
The increase of chemokine CCL2 levels prompted a closer look at the macrophage 
content of the aged livers. Flow cytometry of the non-parenchymal cell fraction revealed a 
significant increase in F4/80+ macrophages in the aged liver (Figure 8A), which was confirmed 
by histological staining (Figure 8B). A time course of F4/80+ cell content showed stable levels of 
hepatic macrophages at 3, 7, and 15 months of age, a significant increase at 19 months, and 
further elevation at 24 months of age (Figure 9). By 24 months of age, the majority of mice 
developed either tumors or extensive NASH and were thus were excluded from further 
investigation as part of the current study.  
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Figure 8. Macrophages accumulate in the uninjured, aged liver and exhibit similar polarization capacity. 
(A) Percentage of total F4/80+ cells in the non-parenchymal cell fraction determined by flow cytometry (n=5, 
*p<0.01). Gating strategy is available in Supporting Figure S2. (B) Histological immunostaining for F4/80 (green) 
further demonstrated increase in macrophages across 19-month-old liver sections (n=5), scale bar: 100µm (C) 
F4/80+ cells isolated from 3-month-old and 19-month-old livers were treated with “M1” stimulus (20 ng/ml IFNγ 
and 100 ng/ml LPS) or “M2” stimulus (20 ng/ml IL-4) and showed effective polarization. Aged M0 cells produced 
less nitrite than young M0 (n=4-5, *p<0.01), normalized for nuclei count, while M2 polarization was preserved in 
all treatments and age groups (D) Phagocytosis of FITC-labeled e.coli particles was preserved with aging, where 
aged M1 was significantly greater than aged M2 (n=3, *p<0.05) and young M1 (p=0.054). Data are displayed as 
mean ± standard deviation. 
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Macrophages can polarize to a spectrum of phenotypes, which exhibit specific cellular 
functions. Proinflammatory macrophages are commonly referred to as classically activated or 
“M1” polarized cells, whereas anti-inflammatory or pro-regenerative macrophages are referred 
to as alternatively activated or “M2” polarized cells, both derived from an “M0” inactive state 
(Murray et al., 2014). The F4/80+ hepatic macrophages isolated from 3-month-old and 19-
month-old mice were cultured and stimulated in vitro with M1-polarizing stimuli (IFNγ and 
LPS) or M2-polarizing stimuli (IL-4) to evaluate the ability of the cells to effectively transition 
to a variety of phenotypes. After treatment with the polarizing cytokines for 12 hours, both 
young and aged F4/80+ cells were able to polarize effectively, as measured by nitric oxide 
production for M1 polarization and urea production by arginase-1 enzyme activity for M2 
polarization (Figure 8C). The baseline production of nitric oxide was significantly lower in the 
aged M0 group compared to young M0 group. The F4/80+ cells from young and aged livers were 
able to phagocytose FITC-labeled e. coli particles to a similar extent in both M0 and M2 
treatments, with a slight increase in the aged M1 group (Figure 8D). 
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Figure 9. Gating strategy and time course of F4/80+ flow cytometry. 
(A) Gating strategy for flow analysis was performed in FlowJo. The viable cell population was selected by exclusion 
of fixable live-dead near-IR viability dye and single cells were selected on the axis of FSC-H vs. FSC-A. Debris was 
excluded then CD45+CD146- immune cells were selected (further excluding LSECs and stellate cells). (B) The 
proportion of F4/80+ cells were measured from live, single, CD45+CD146- events and stratified by CD11b and 
CD68 expression on the fixed, permeabilized cells for 3-month-old and 19-month-old samples. (C) Time course of 
F4/80+ expression measured by flow cytometry. 
 
In addition, the mean fluorescence intensity of liver arginase staining was dramatically 
increased in the aged M2-polarized macrophages compared to young M2-polarized 
macrophages, while staining for inducible nitric oxide (iNOS) was dim in all samples regardless 
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of treatment (Figure 10). Thus overall, the aged hepatic macrophages retained polarization and 
phagocytosis function in vitro, with a predisposition toward M2 polarization characteristics. 
 
 
Figure 10. Macrophage polarization staining in vitro. 
(A) iNOS staining on cultured hepatic macrophages (F4/80+ non-parenchymal cells) after 12-hour treatment with 
media (M0: RPMI + 10% fetal bovine serum + 1% pen-strep), or media supplemented with polarization cytokines 
(M1: LPS 100 ng/ml, IFNγ 20 ng/ml or M2: IL-4 20 ng/ml). No significant difference was detected in the mean 
intensive fluorescence (MFI) for iNOS (n=4). (B)  Liver arginase staining on cultured hepatic macrophages that 
received treatment with media (M0: RPMI + 10% fetal bovine serum + 1% pennstrep), or media supplemented with 
polarization cytokines (M1: LPS 100 ng/ml, IFNγ 20 ng/ml or M2: IL-4 20 ng/ml). The MFI of arginase was 
significantly increased in M2-treated hepatic macrophages from 19-month-old mice compared to those from 3-
month-old mice (n=4). Scale bar = 100 µm. 
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Livers from aged mice have increases in CD11b+ macrophage populations 
In order to further profile the aged liver macrophage compartment, expression levels of 
CD11b and CD68 were examined by flow cytometry, as these markers have been used as 
indicators of macrophage origin from bone marrow or tissue respectively (Holt et al., 2008; 
Kinoshita et al., 2010). Aged livers had a significant increase in the CD68-CD11b+ monocyte-
derived population, in both percentage and absolute number of F4/80+ cells (Figure 11A). No 
change was observed in the CD68+CD11b- population, reported by others to be Kupffer cells, 
while there was a marginal but insignificant increase in the CD68+CD11b+ population. The 
increase in F4/80+CD11b+ hepatic macrophages, but not F4/80+CD68+ Kupffer cells, in aged 
livers was also confirmed by histological staining (Figure 11B).  
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Figure 11. Macrophages in aged livers have increased CD11b+ subsets. 
(A) Proportion and number of CD11b and CD68-expressing F4/80+ cells detected by flow cytometry showed an 
increase in CD11b+ macrophages in 19-month-old livers (n=5, *p<0.05, **p<0.01). Gating strategy is available in 
Supporting Figure S2. (B) Increases in F4/80+ CD11b+ macrophages were confirmed with histological 
immunostaining (n=5, *p<0.05, **p<0.01), scale bar: 50µm. Data are displayed as mean ± standard deviation.  
 
Altogether, these data suggest that the increase in hepatic macrophages in aged livers is 
derived primarily from infiltrating monocytes and not due to an expanding resident Kupffer cell 
population, consistent with the detected increase in monocyte chemoattractant protein (CCL2) 
and the observations of others in models of steatosis (Nakashima et al., 2016). 
 
 
 54 
CCL2-CCR2 inhibition reduces inflammation and steatosis in aged livers, but does not prevent 
accumulation of CD11b+ macrophages 
To test the hypothesis that inhibiting CCL2 signaling would reduce inflammation and 
steatosis in aging livers, female mice with global CCR2 knockout (KO) or wild-type (WT) 
controls were obtained from Jackson Laboratories and aged in-house. The aged WT mice had a 
1.6-fold increase in body weight compared to their young controls (Table 3), while the aged KO 
mice had a 1.2-fold increase in body weight compared to their young controls (Table 4). In 
addition, the aged KO mice had elevated serum cholesterol levels compared to the young KO 
mice. Levels of serum ALT, AST, albumin, and triglycerides were similar between the groups.  
 
Table 3. Body Weight, Liver Biochemistry, and Serum Lipids in Young and Aged WT Mice (JAX) 
 Young WT 
(3 mo., n=5) 
Aged WT 
(19 mo., n=8) Significance 
Body weight (grams) 21.4 ± 1.8 33.2 ± 6.9 p<0.01 
Serum Alanine Aminotransferase (IU/L) 21.2 ± 8.4 31.8 ± 10 p=0.09 
Serum Aspartate Aminotransferase (IU/L) 43.8 ± 10 55.1 ± 22 p=0.31 
Serum Albumin (g/dL) 2.68 ± 0.2 2.47 ± 0.1 p=0.17 
Serum Cholesterol (mg/dL) 75.0 ± 0.5 63.0 ± 8.0 p=0.13 
Serum Triglycerides (mg/dL) 63.0 ± 16 57.8 ± 32 p=0.76 
 
Of note, three mice in the aged WT cohort were excluded from study: one showed 
advanced fatty liver disease with hepatocyte ballooning characteristic of NASH, another had 
extensive tumorigenesis, and one died prematurely. No mice in the aged KO group exhibited 
these pathological signs.  
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Table 4.  Body Weight, Liver Biochemistry, and Serum Lipids in Young and Aged CCR2 KO Mice (JAX) 
 Young KO 
(3 mo., n=4) 
Aged KO 
(19 mo., n=10) Significance 
Body weight (grams) 23.4 ± 2.2 27.3 ± 3.2 p<0.05 
Serum Alanine Aminotransferase (IU/L) 24.5 ± 10 23.3 ± 5.6 p=0.77 
Serum Aspartate Aminotransferase (IU/L) 46.0 ± 18 48.6 ± 13 p=0.77 
Serum Albumin (g/dL) 2.47 ± 0.1 2.50 ± 0.1 P=0.72 
Serum Cholesterol (mg/dL) 53.0 ± 2.8 70.7 ± 2.9 p<0.01 
Serum Triglycerides (mg/dL) 46.3 ± 12 46.2 ± 17 p=0.99 
 
Both 19-month-old WT and KO cohorts had increases in lipid accumulation compared to 
their respective 3-month-old control, as shown by H&E and Oil Red O staining, however fat 
accumulation was notably less pronounced in the aged KO group when compared to the aged 
WT (Figure 12A). The concentration of hepatic lipids was measured in the 3-month-old and 19-
month-old WT and KO mice after fasting mice for six hours. The 19-month-old WT mice had a 
significant and a 1.5-fold increase in the triglyceride content compared to the 3-month-old WT 
mice, whereas the KO groups were not significantly different (Figure 12B, top). Intriguingly, no 
differences in cholesterol content was detected between the young and old groups in both the 
WT and KO in this strain of mice (Figure 12B, bottom).   
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Figure 12. Aged CCR2 knockout mice exhibit reduced steatosis and inflammation, but no change in accumulated 
macrophage populations. 
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(A) Representative images of Oil Red O and H&E staining, scale bar: 50µm. (B) Quantification of hepatic 
triglycerides and cholesterol per milligram of liver tissue (n=4-5, *p<0.05). (C) Significant increases in mRNA 
levels of interleukin-1 beta, interleukin-6, TNF-alpha, and CCL2 in aged WT compared to young WT normalized to 
beta-actin housekeeping gene (n=4-5, *p<0.05, ** p<0.01). (D) Percentage of total F4/80, CD11b, and CD68-
expressing cells in the non-parenchymal cell fraction determined by flow cytometry (n=4-5, *p<0.05, **p<0.01). 
 
The inflammatory gene signature of hepatocyte cell fractions isolated from 3-month-old 
and 19-month-old WT and KO mice was evaluated by qRT-PCR. The 19-month-old WT cells 
had a significant increase in Il1β, Il6, Tnfα, and Ccl2 transcripts compared to the 3-month-old 
WT group, while there were no changes in inflammatory gene expression between the 3-month-
old and 19-month-old KOs (Figure 12C). Despite the reduction in the inflammatory gene 
signature by hepatocytes from aged CCR2 knockout mice, the levels of F4/80+ cells and 
specifically F4/80+CD11b+ macrophage subsets were elevated in both WT and KO 19-month-old 
livers, compared to their 3-month-old counterparts, as determined by flow cytometry (Figure 
12D). Taken together, these data suggest that inhibiting CCR2 signaling is sufficient to reduce 
hepatic triglyceride content and inflammatory gene expression but did not prevent the 
accumulation of CD11b+ macrophages in the aging liver.  
Since inhibiting CCL2-CCR2 was insufficient to prevent macrophage accumulation in 
aged livers, levels of endotoxin and bacterial DNA for 16s rRNA in hepatic blood were 
measured to test for “leaky gut syndrome,” as this has been implicated in the acquisition of age-
related inflammation (Thevaranjan et al., 2017). However, no differences in serum endotoxin or 
16s rRNA were detected in hepatic blood (Figure 13).  
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Figure 13. Endotoxin and 16S rRNA levels in aged hepatic blood. 
(A) Concentration of bacterial endotoxin in serum isolated from coagulated blood drawn sterilely from the inferior 
vena cava and portal vein from young and aged mice showed no difference (n=6). (B) qPCR was performed on 
DNA isolated from non-coagulated blood drawn sterilely from the inferior vena cava and portal vein and showed no 
differences in 16S rRNA between young and aged mice (n=4-6). 
 
RNA-Seq analysis demonstrates robust inflammatory and metabolic changes in aged livers 
beyond the CCL2-CCR2 signaling paradigm 
Finally, RNA-Seq was performed as an unbiased screen to further elucidate mechanisms 
underlying the onset of inflammation and steatosis in aged livers. Independent samples of 
hepatocytes were enriched from 3-month-old and 19-month-old wild-type mice (National 
Institutes of Aging, n=3) by two-step collagenase perfusion after fasting for six hours. Albumin 
was detected as the most highly expressed transcript across all samples, demonstrating 
hepatocyte specificity. 
In total, 296 genes were differentially upregulated, and 74 genes were differentially 
downregulated between the 3-month-old and 19-month-old samples (fold change ±2, false 
discovery rate p-value <0.05, Figure 14A). Among the most highly differentially expressed 
genes were chemokines Cxcl7 (+34.5-fold), Cxcl13 (+8.1-fold), Ccl22 (+6.8-fold), Ccl5 (+6.3-
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fold), and Ccl6 (+2.1 fold). Other chemokines that were upregulated, however insignificantly, 
included Ccl3 (+16.7-fold, p=0.1) and Ccl2 (+2.4-fold, p=0.15).  While an increase in the 
proliferation/ploidy gene E2f7 (+9.5-fold) was detected, no changes in senescence associated 
genes (p16, p21, p53) were found. A complete list of differentially expressed genes can be found 
in Appendix B (page 117). 
 
Figure 14. RNA-Seq reveals robust changes in inflammatory and metabolic gene signatures of aged livers. 
(A) Heatmap demonstrates 296 genes were differentially upregulated and 74 genes were differentially 
downregulated between the 3-month-old and 19-month-old WT NIA hepatocyte samples (fold change ±2, false 
discovery rate p-value <0.05, n=3). (B) Ingenuity Pathway Analysis identified 25 canonical signaling pathways with 
overlapping gene features. The top eight most significantly affected pathways are listed in order of most 
significantly different (p-value). Activation (upregulated, downregulated, or undetermined), and the overlap (percent 
genes differentially expressed in the pathway) are listed.  
 
Ingenuity Pathway Analysis (IPA) identified several pathways influenced by aging in the 
liver using stringent filters for species (mouse), tissue (liver), and confidence (experimentally 
observed), including downregulation of the melatonin degradation I pathway, super-pathway of 
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melatonin degradation, and nicotine degradation II/III pathway; upregulation of the leukocyte 
extravasation pathway; and changes in the granulocyte adhesion and diapedesis, hepatic stellate 
cell activation, and complement system pathways (Figure 14B).  
Interestingly, when the pathways are viewed as interconnecting nodes, the inflammatory 
and metabolic changes are linked by suppression of FXR/RXR signaling, suggesting this 
transcription factor family may be a master regulator of several age-related gene expression 
changes in the liver and warrants further study (Figure 15).  
 
Figure 15. IPA Canonical Pathways Map. 
Ingenuity Pathway Analysis (IPA) identified several pathways influenced by aging of the liver using stringent filters 
for species (mouse), tissue (liver), and confidence (experimentally observed), including melatonin degradation I, 
granulocyte adhesion and diapedesis, nicotine degradation II/III, leukocyte extravasation signaling, hepatic fibrosis / 
hepatic stellate cell activation, acetone degradation I, and complement system, which are connected by gene 
interactions. Inflammatory and metabolic pathways were linked by a decrease in FXR/RXR activation. 
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2.4 DISCUSSION 
It is well established that body weight increases with age in mammals, as lipids move from 
subcutaneous to visceral and ectopic fat deposits in muscle, bone marrow, and the liver 
(Tchkonia et al., 2010). This accumulation of fat is thought to reduce muscle strength, lead to 
insulin resistance, decrease energy expenditure in brown adipose tissue, and impair the function 
of bone marrow stem cells (Palikaras et al., 2017). However, the molecular mechanisms coupling 
ectopic fat accumulation with aging remain obscure, and the influence of ectopic fat 
accumulation on liver function with aging has not been thoroughly studied.  
In the present study, aged, 19-month-old female mice received from the National Institute 
of Aging (NIA) exhibited increased body weight, liver weight, serum alanine aminotransferase, 
hepatic triglycerides, inflammatory gene expression, and levels of F4/80+ CD11b+ macrophages 
when compared to their young, 3-month-old counterparts. The increase in hepatic lipids detected 
in the aged mice (186% increase in triglycerides) mimics what has been observed in elderly 
individuals in the absence of insulin resistance (K. F. Petersen et al., 2003). We also observed an 
increase in body weight, hepatic triglycerides, inflammatory gene expression, and levels of 
F4/80+ CD11b+ macrophages in a separate cohort of 19-month-old wild-type mice derived from 
Jackson Laboratories (JAX) compared to their young, 3-mont-old counterparts. Notably, the diet 
at Jackson Laboratories contains a higher percentage of calories provided fat (16% vs. 11%), 
which may account for some of the observed differences between the two cohorts (more robust 
steatosis, greater body weight in JAX mice).  
Sublethal lipid overload in hepatocytes has very recently been shown to drive 
inflammation by the release of extracellular vesicles containing microRNAs, chemokines, and 
damage signals (Ibrahim, Hirsova, & Gores, 2018). Hepatocyte cell fractions from the aged 
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livers expressed a milieu of pro-inflammatory cytokines and chemokines, including TNFα, IL1β, 
IL6, and CCL2, as well as activation of canonical NFκB transcription factors p65 and p50. Work 
from other groups showed during high fat diet induced NASH, p65 was found to translocate to 
the nucleus of hepatocytes and drive production of TNFα and IL-6 downstream of high-mobility 
group box 1 (HMGB1) binding to toll-like receptor 4 (TLR4) (Li et al., 2011). Hepatocytes have 
also been shown to produce TNF, IL-6, and CCL2 in many additional contexts (LPS, bacterial 
hepatotoxin, hepatocyte growth factor, and infection with P. gingivalis) (Norris et al., 2014; 
Takano et al., 2012). Of note, the hepatocytes used in this study were purified by differential 
centrifugation and may contain 5-15% non-parenchymal cells, which could explain some of the 
observed changes in inflammatory gene expression. However, F4/80+CD11b+ hepatic 
macrophages purified by double magnetic selection showed an age-dependent reduction in 
transcript levels of IL1β and IL-6, and no change in TNFα levels (data not shown), suggesting 
these cells are not the source of inflammatory gene signatures. The influence of other non-
parenchymal cells especially endothelial cells and stellate cells on the inflammatory gene 
expression in the aged liver remains an area of future study.  
The accumulation of F4/80+CD11b+ macrophages in the aged liver presented here is a 
novel finding. To our knowledge, only one other study has systematically examined the effect of 
aging on liver-resident macrophages. Hilmer et al. determined that the number and basal activity 
of “Kupffer cells” was increased with old age in a rat model (Hilmer et al., 2007). However, this 
work was performed before the heterogeneity of liver macrophages was fully understood. Our 
work builds upon this study, demonstrating an increase in the total F4/80+ macrophage pool, and 
specifically the cells that also express CD11b, thought to be derived from circulating monocyte 
progenitors. We found CD11b to be highly expressed on both small, motile 
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monocyte/macrophages organized in clusters as well as on spindle shaped cells throughout the 
aged hepatic parenchyma. CD11b functionally encodes integrin alpha M (ITGAM), one protein 
subunit of integrin alpha-M beta-2, also known as Mac-1 and complement receptor 3, which 
mediates leukocyte adhesion, migration, and phagocytosis (Solovjov, Pluskota, & Plow, 2005). 
The increase in CD11b expression may represent a phenotypical change in resident Kupffer 
cells, in addition to an influx in monocyte-derived macrophages. Fate tracing experiments using 
chimeric mice will be necessary to confirm the origin of the F4/80+CD11b+ hepatic macrophages.  
As CCL2 was identified as a chemokine produced by aging hepatocytes that might 
influence macrophage dynamics, we sought to inhibit the CCL2-CCR2 signaling pathway in a 
natural aging mouse model. Inhibiting the CCL2-CCR2 axis by various means has been 
successful in ameliorating liver steatosis and inflammation in several models of NAFLD/NASH. 
Baeck et al. pharmacologically inhibited CCL2 with NOX-E36 in the methionine-choline 
deficient (MCD) diet induced NASH, and successfully diminished macrophage infiltration and 
steatohepatitis (Baeck et al., 2012). Another group found that CCL2 knockout mice on the MCD-
diet had reduced fibrosis and inflammation in Balb/C strains (Galastri et al., 2012). Similarly, 
CCR2 knockout mice in the C57BL/6 background maintained on choline-deficient amino acid-
defined (CDAA) diet showed reduced steatosis, inflammatory cell infiltration, and fibrosis 
compared to the controls (Miura, Yang, van Rooijen, Ohnishi, & Seki, 2012).  
In the present study, aged CCR2 KO mice exhibited attenuated levels of liver 
triglycerides and significant decreases in the inflammatory gene signature of hepatocyte cell 
fractions compared to their young counterparts. Although hepatocytes produce CCL2, they are 
not known to express CCR2 (Seki, de Minicis, Inokuchi, et al., 2009), suggesting the changes in 
hepatocyte gene expression are secondary to other paracrine signaling pathways. This may be 
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related to inhibiting the binding of other CCR2 ligands such as CCL8, CCL7, and CCL12 in 
adipose tissue, stellate cells, or hepatic macrophage populations (Seki, de Minicis, Inokuchi, et 
al., 2009; Tsou et al., 2007). Global changes in adipose tissue organization, metabolism, and 
inflammatory secretion may have influenced the observed changes in the liver and will be an 
area of future exploration. 
Surprisingly, there was no change in the hepatic macrophage profile of aged CCR2 KO 
mice compared to the aged WT mice. Both aged cohorts displayed an overall increase in F4/80+ 
cells, specifically the F4/80+CD11b+CD68- subset, when compared to their young controls, 
which was also observed in the cohorts from the NIA. These results suggest that the 
accumulation of F4/80+CD11b+ macrophages in the aged liver is independent of CCL2-CCR2 
signaling and was neither influenced by the reduction in lipids nor inflammatory gene expression 
in the aged liver. RNA-seq analysis of aged WT livers revealed several other chemokines that 
might be involved in the recruitment of F4/80+CD11b+ macrophages, including CXCL7, 
CXCL13, CCL22, CCL5 (RANTES), and CCL6. Of note, CCL2 was upregulated but was not 
flagged as a significantly differentially expressed gene in the RNA-seq screen due to the 
stringent filtering and false-discovery rates. Others have found that CCL2 promotes the 
recruitment of CCR2+CD11b+ myeloid cells from the bone marrow to metastatic cancer sites in 
the liver, but inhibition of CCL2 or CCR2 did not alter myeloid cell recruitment and had little 
effect on metastatic tumor burden. Deletion of the CD11b+ cells by diphtheria toxin receptor 
(CD11b-DTR) markedly decreased metastatic growth and incidence (Lim, Yuzhalin, Gordon-
Weeks, & Muschel, 2016; Zhao et al., 2013). Further studies will be necessary to determine 
which chemokines or signaling gradients are responsible for driving the increase in CD11b-
expressing macrophages in the aged liver.  
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Our results suggest that inhibiting CCR2 signaling globally may be beneficial to reduce 
hepatic triglyceride levels and inflammatory gene expression in advanced age. Cenicriviroc, a 
dual CCR2/CCR5 antagonist, has now been studied in a Phase 2b, randomized, double-blind, 
placebo-controlled, multinational clinical trial to improve non-alcoholic fatty liver disease 
activity score, with no concurrent worsening of fibrosis stage (Friedman et al., 2016). The trial 
resulted in twice as many subjects achieving improvement in fibrosis and no worsening of 
steatohepatitis compared with placebo (Friedman SL, 2018). Subgroup analysis demonstrated 
that the therapy was similarly effective in patients above and below 56 years of age, suggesting 
this therapy may show promise in treating age-related NAFLD/NASH as well. Our study lends 
further support that targeting the CCL2-CCR2 pathway may be a promising strategy to reduce 
the onset and progression of hepatic fat accumulation and inflammation during the process of 
aging.  
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3.0  THE HOST RESPONSE TO ENGINEERED LUNG SCAFFOLDS 
Chapter 3 is adapted from one published research manuscript: 
Stahl EC1,2, Bonvillain RW3, Skillen CD1,2, Burger BL1,2, Hara H4, Lee W4, Trygg 
CB5, Didier PJ5, Grasperge BF5, Pashos NC5, Bunnell BA5, Bianchi J6, Ayares D6, Guthrie 
KI3, Brown BN*,$,1,2, Petersen TH$,3. Evaluation of the host immune response to 
decellularized lung scaffolds derived from alpha-Gal knockout pigs in a non-human 
primate model. Biomaterials. 2018 Dec; 187:93-104. (Epub 2018 Sep 28.)  
1McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA; 
2Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA; 3Regenerative 
Medicine, United Therapeutics Corporation, Research Triangle Park, NC; 4Thomas E. Starzl 
Transplantation Institute, University of Pittsburgh, Pittsburgh, PA; 5Tulane National Primate 
Research Center, Tulane University, Covington, LA; 6Revivicor Inc., Blacksburg, VA 
3.1 INTRODUCTION 
Chronic lower respiratory disease affects over 15 million people in the United States. A potential 
curative therapy does exist in the form of lung transplantation, however the short supply of 
human donor organs means that only 2,000 lung transplants are performed annually, while many 
more people die each year on the waiting list ("Facts and Myths," 2018). Bioengineering 
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approaches may offer an alternative solution to human organ shortages, by developing 
biocompatible tissues and organs derived from animal source material (Ott et al., 2010; T. H. 
Petersen et al., 2010).  
Decellularization, the removal of cellular material from organs and tissues, has been 
utilized to engineer organ scaffolds for transplantation. Tissues can be decellularized by 
mechanical force and agitation as well as chemical detergent and enzyme washes to remove 
cellular proteins while keeping the extracellular matrix intact (Brown & Badylak, 2014; Gilbert 
et al., 2006). Once implanted, non-crosslinked acellular products are degraded and replaced with 
cells from the host, acting as a scaffold to direct site-appropriate tissue remodeling, or can be 
recellularized ex vivo with host derived cells to engineer functional tissues (Brown & Badylak, 
2014).  
Pigs have been investigated as sources of organs for xenotransplantation and as sources 
of tissues for decellularization as they breed and mature rapidly, produce large litters, and can be 
genetically modified and raised to be specific pathogen free (Ezzelarab et al., 2005).  Whole 
human and pig lungs have been effectively decellularized and are currently being evaluated in 
allotransplantation and xenotransplantation applications (T. H. Petersen, Calle, Colehour, & 
Niklason, 2011; T. H. Petersen et al., 2010; Song et al., 2011). However, the host immune 
response to these materials has not yet been elucidated.  
Carbohydrates play a major role in the rejection of porcine xenografts, and as a result are 
likely important in the immune response to decellularized porcine material (Cooper, Koren, & 
Oriol, 1994). α1,3Gal is a common carbohydrate structure found on the surface of mammalian 
cells, synthesized by the enzyme α1,3-galactosyltransferase (α1,3GT) (Macher & Galili, 2008). 
Importantly,  humans, apes, and Old World monkeys (e.g. the rhesus macaque) exhibit a 
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frameshift mutation in the α1,3GT gene, and thus express alternative carbohydrate epitopes 
compared to those on porcine cells (Larsen, Rivera-Marrero, Ernst, Cummings, & Lowe, 1990). 
As such, these primates produce natural antibodies to the α1,3Gal epitope, including anti-Gal 
IgG, IgM, IgE, and IgA (Galili, 1993; Galili, Macher, Buehler, & Shohet, 1985; Galili, 
Rachmilewitz, Peleg, & Flechner, 1984). The deposition of Gal-specific antibodies onto 
xenografts following transplantation drives complement activation leading to hyperacute 
rejection and severe coagulation dysfunction within minutes (Lexer et al., 1986; Rose, Cooper, 
Human, Reichenspurner, & Reichart, 1991). 
Although decellularization techniques aim to remove cellular antigens, the presence of 
the Gal epitope has been detected in decellularized porcine heart valves, anterior cruciate 
ligament, and small intestine submucosa (SIS) implants used clinically (Konakci et al., 2005; 
McPherson et al., 2000; Stone et al., 2007). The Gal epitope is associated with glycoproteins and 
glycolipids and has also been detected on ECM proteins including fibrinogen and laminin (Galili 
et al., 1988; Spiro & Bhoyroo, 1984; Thall & Galili, 1990; Towbin et al., 1987). The persistence 
of the Gal epitope in decellularized constructs may result in long-term degeneration and 
calcification of heart valves in patients (Badylak & Gilbert, 2008; Konakci et al., 2005). 
Therefore, combining decellularization strategies with the removal of the Gal epitope from 
porcine tissue might aid in the long-term goals of sustainable organ sources for transplantation 
(Michel, Madariaga, Villani, & Shanmugarajah, 2015; Nam et al., 2012).  
Strategies to mask or remove the Gal epitope from animal tissues and organs have 
included crosslinking tissue matrices via glutaraldehyde, enzymatic treatment with α-
galactosidase, and the development of genetically engineered pigs which lack the α1,3GT 
epitope (α-Gal KO) (Choi et al., 2012; Kolber-Simonds et al., 2004; Park, Kim, Choi, & Kim, 
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2009; Phelps et al., 2003). Xenotransplantation of α-Gal KO kidneys and hearts greatly reduced 
the occurrence of hyperacute reaction and prolonged the survival of the xenografts in non-human 
primates (Kuwaki et al., 2005; Yamada et al., 2005). However, the grafts eventually failed due to 
thrombotic microangiopathy, a form of acute vascular rejection, suggesting that further 
processing is needed to design a fully compatible organ (Kuwaki et al., 2005; Yamada et al., 
2005).  
In the present study, decellularized WT and α-Gal KO porcine lungs were implanted 
subcutaneously in a rhesus macaque model to assess the host response to the scaffolds in vivo for 
up to eight weeks. Sham injury, native porcine lung, and allogeneic decellularized macaque lung 
groups were included as controls. Following explant, fresh constructs were re-implanted into the 
previously exposed hosts to examine the outcome of chronic exposure and sensitization to Gal 
epitopes. The production of anti-Gal antibodies, circulating blood cells, and infiltrating immune 
cell subsets were evaluated to determine the biocompatibility of each implant type. 
3.2 METHODS 
Porcine Lung Tissue. All samples were collected by United Therapeutics and Revivicor and 
underwent quality control according to standard operating procedures. Lung tissues from wild 
type or α-Gal knockout pigs (α-Gal KO, GalSafe®) were received within 24 hours of sacrifice on 
wet ice. The lungs were flushed with sterile PBS and surgically reduced to the left superior and 
inferior cranial lobe, while maintaining intact vasculature and airways, to mimic the smaller size 
of macaque lungs and maintain similar tissue-to-fluid dynamics during decellularization. All 
genetically engineered (GE) pig derivatives, heart, lung, blood from a total of four animals 
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described herein were exclusively used for in vitro or in vivo studies in laboratory animals. No 
GE pig derivatives entered the food chain; all GE pig derivatives including all excess materials 
were disposed as regulated medical waste.  
Macaque Lung Tissue. All samples were collected by Tulane National Primate Research 
Center (TNPRC). All donor animals were humanely euthanized due to chronic gastritis or as 
normal controls assigned to other studies. No experimental inoculations or treatments were 
performed on lung donor animals. Immediately upon animal sacrifice, the intact heart and lungs 
were removed from the thorax. The apex of the heart was removed midway through the 
ventricles, then the upper ventricles and atria were irrigated with sterile heparinized (500 U/L) 
PBS to wash out remnant blood. The trachea was removed, and the lungs were placed into a 
sterile container and transported to the lab for further washing.  
Decellularization of Porcine and Macaque Lungs. Decellularization of porcine and 
macaque lungs was performed following recently published methods (Gilpin et al., 2014). 
Briefly, the left main pulmonary artery was cannulated as an inlet for decellularization fluids via 
the native vasculature, and the pulmonary veins and left main bronchus served as outlets for 
flow. Lungs were decellularized by vascular perfusion at 20 mmHg in a custom bioreactor 
system with 0.5% sodium dodecyl sulfate (5 days), 1% Triton X-100 (24 hours), water wash (24 
hours), and PBS wash (5 days). Solutions were changed daily.  
Implantation of Decellularized Lung Constructs or Sham Injury. The lung scaffolds 
were dissected to create implantable plugs of 2 x 2 x 0.5 centimeters. Prior to implantation, the 
lung scaffolds were rinsed in three consecutive washes of PBS. A pair of rhesus macaques 
(gender: male; age: 5-9 years) received either sham injury, native WT porcine lung, 
decellularized WT porcine lung, decellularized α-Gal KO porcine lung implants, or 
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decellularized macaque lung bilaterally on either side of the spine (n=10). Eight incisions (1-2 
cm) were created along the midline of the back to form a subcutaneous pocket for insertion of 
the implant to be extracted in pairs at 1, 2, 4, and 8 weeks, and the medial and lateral margins 
were marked. For the re-implantation study, the same hosts received fresh implants just below 
the previous implantation site using the same methods (Figure 1A). All studies were performed 
in accordance with Tulane University’s IACUC. Animals were monitored for general well-being 
and weight changes over the course of the study.  
CBC and Chem12 Data. Blood was collected from animals at baseline and 1, 2, 4 and 8 
weeks post-implantation. Complete blood count (CBC) was performed at the Tulane National 
Primate Research Center Veterinary Medicine Laboratory using the Sysmex XT2000iV 
hematology analyzer, in accordance with quality control from Insight at Sysmex. Chem12 data 
was collected with the Beckman AU400 chemistry analyzer, in accordance with quality control 
from Unity by BioRad.  
Anti-Gal ELISA. Serum was collected at baseline and 8 weeks post-implantation, as well 
as pre-re-implantation, and 4 weeks and 8 weeks post-re-implantation. All serum samples were 
heat-inactivated at 57 degrees Celsius for 30 minutes. Anti-Gal ELISAs (Dextra Laboratories) 
were performed according to the manufacturer’s protocol for binding by IgG and IgM (Yeh et 
al., 2010).  
Harvest of Explanted Tissue. Implants were excised in duplicate pairs en bloc with the 
surrounding tissues at 1, 2, 4, and 8 weeks post-implant in naïve animals, and again at 1, 2, 4, 
and 8 weeks in the previously exposed hosts. Samples were immediately fixed in 10% neutral-
buffered formalin, embedded in paraffin, and sent for histological analysis.  
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Histological Assessment. Samples embedded in paraffin blocks were sectioned at 7 µm 
thickness and affixed to glass slides. Histologic staining included hematoxylin and eosin 
(Thermo Fisher), Verhoff van Gieson (Sigma Aldrich), Masson’s trichrome (Sigma Aldrich), 
Alcian blue (Sigma Aldrich), and Wright Giemsa (Polysciences, Inc.). stains were performed 
according to standard protocols per the manufacturer’s instructions. Images were captured at 
100x-magnification for histological assessment. Blinded qualitative analysis of the histologic 
appearance of the implanted test articles was documented. An independent qualitative analysis 
was performed by a pathologist, including the documentation of a semi-quantitative histological 
inflammation score for each explant. 
Immunohistochemistry. Slides were stained with primary antibodies against immune cell 
markers including CD45 (Abcam ab10558, 1:900), CD3 (Invitrogen a0452, 1:150), CD4 (Abcam 
ab133616, 1:500), CD8 (Abcam ab4055, 1:500), CD20 (Abcam ab27093, 1:300), CD68 (Abcam 
ab955, 1:50), CD86 (Abcam ab53004, 1:150), and CD206 (Santa Cruz sc-34577, 1:150), as well 
as CD31 (Abcam ab9498, 1:20) and alpha smooth muscle actin (Abcam ab5694, 1:150). Briefly, 
slides were deparaffinized, underwent antigen retrieval, blocked, and stained overnight at 4 
degrees Celsius. Secondary antibodies (biotinylated anti-rabbit IgG, biotinylated anti-mouse IgG, 
or biotinylated anti-goat IgG, Vector Laboratories) were applied for 30 minutes at room 
temperature. Vecta-Shield ABC Reagent (Vector Laboratories) was applied to sections for 30 
minutes, followed by a 4% DAB solution (Vector Laboratories), and Hematoxylin QS (Vector 
Laboratories). Slides were dehydrated, cover slipped, and imaged at 200x-magnification.  
Quantification of Immune Cell Subsets. Quantitative analysis of the stained sections was 
performed by blinded investigators using image analysis algorithms optimized for each immuno-
stain. Five images were captured from a single slide at 200x-magnification per explant for each 
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IHC marker. Images were processed with a custom script using ImageJ software (NIH) to collect 
counts of nuclei, positively stained cells, and percent area of positive staining per field.  The 
percentage of positively stained cells was calculated for a given marker. Figures were prepared 
in GraphPad Prism 7, where each data point represents the mean ± standard error.  
Statistical Analysis. Differences in the percentage of positively stained cells or implant 
area was assessed for the implantation and re-implantation studies between groups at given time 
points using Kruskal-Wallis one-way ANOVA followed by Dunn’s multiple comparisons test 
(n=4 explants per time point), after testing for Gaussian distribution with the Shapiro-Wilk 
normality test. To compare the implantation and re-implantation studies, a two-sample unequal 
variance t-test was performed. Statistical significance was determined by rejecting the null 
hypothesis at α = 0.05. 
3.3 RESULTS 
Subcutaneous Implantation of Lung Scaffolds in Rhesus Macaque Model 
Ten rhesus macaques received either sham control (SC), decellularized macaque lung 
(DC-M), native WT porcine lung (WT), decellularized WT porcine lung (DC-WT), or 
decellularized α-Gal KO porcine lung implants (DC-KO) subcutaneously implanted in duplicate 
down the mid-line of the spine to be harvested at 1, 2, 4, and 8 weeks post-implantation in naïve 
and previously exposed hosts (Figure 16A).  
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Figure 16. Lung construct implantation and harvest schematic. 
A) Ten rhesus macaques received a sham injury control (SC), decellularized macaque lung (DC-M), native WT 
porcine lung (WT), decellularized WT porcine lung (DC-WT), or decellularized α-Gal KO porcine lungs (DC-KO). 
Implants were placed in duplicate down the midline of the spine and explanted at 1, 2, 4, and 8 weeks. B) Whole 
decellularized lung scaffolds prior to implantation, showing effective decellularization (top) and maintenance of 
native lung structures with Masson’s Trichrome stain (bottom), scale bar = 200 µm. 
 
The macaque, WT porcine, and α-Gal KO porcine lungs were effectively decellularized 
prior to implantation and maintained native bronchiolar structures as shown with Masson’s 
Trichrome staining (Figure 16B). The body weight of each animal underwent minimal changes 
during the study as evidenced by less than 10% total decrease in body weight during both studies 
(Figure 17). 
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Figure 17. Relative body weight of rhesus macaques during study 
Relative body weight of ten rhesus macaques (individual animal IDs listed) that received subcutaneous implantation 
of native wild type porcine (WT) lungs, sham injury control (SC), decellularized macaque (DC-M) lungs, 
decellularized wild type porcine (DC-WT) lungs, or decellularized α-Gal knockout (DC-KO) lungs before treatment 
or re-treatment, and 1, 2, 4, and 8 weeks following implantation. Body weight did not decrease below 10% of the 
starting value in any treated animal, while two animals recovered slightly more than 10% of the original body 
weight in the KO and SC groups. 
 
Blood Biochemistry of Rhesus Macaques Implanted with Lung Scaffolds   
Blood was collected for complete blood count (CBC) and comprehensive metabolic 
analysis (Chem12) three weeks prior to implantation and at 1, 2, 4, and 8 weeks post-
implantation. Analyzing the change from baseline in circulating blood cell counts demonstrated 
an acute increase in white blood cells (WBCs) and neutrophils in the WT group at one and two 
weeks, suggesting rapid infiltration and encapsulation of the implants, while the decellularized 
porcine groups had sustained levels of WBCs and neutrophils out to eight weeks (Figure 18). 
One animal in the DC-KO group presented with above normal WBC counts (>15.5x103) at two 
and eight weeks, as well as elevated circulating neutrophils (>7.3x103) from weeks one to eight 
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(Figure 18A, B). Similarly, one animal in the DC-WT group had elevated circulating neutrophil 
levels (>7.3x103) from weeks two to eight (Figure 18B). Both animals in the WT group showed 
a spike in levels of circulating eosinophils (>0.8 x103) at two weeks, and one had above normal 
levels of circulating neutrophils at one-week post-implantation (>7.3x103) (Figure 18B,C).  
 
Figure 18. Change from baseline in complete blood counts post-implantation 
Circulating levels of A) white blood cells (WBCs), B) neutrophils, C) eosinophils, D) red blood cells (RBCs), and 
E) platelets were measured pre-implantation and at 1, 2, 4, and 8 weeks post-implantation. Change from baseline 
was calculated at each time point to measure relative values of circulating cells (average ± standard deviation, n=2).  
 
No changes in circulating immune subsets were observed in subjects that received sham 
injury or DC-M implants. In addition, no changes were observed in numbers of circulating 
lymphocytes, monocytes, or basophils over the course of the study in any group (data not 
shown). No differences in red blood cell number, hematocrit, hemoglobin, platelets, or platelet 
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volume were detected between the groups (Figure 18F, G), with the exception of one animal in 
the DC-KO group, which had elevated total platelets from weeks one to two (>6.8x104).  
The Chem12 data indicated no changes in levels of sodium, potassium, chloride, total 
protein, albumin, globulin, blood urea nitrogen, glucose, creatinine, aspartate amino transferase, 
or alanine amino transferase in any implantation groups across the studies. All values were 
within empirically determined normal ranges for the rhesus macaque, listed in Appendix C 
(page 128).  
 
Sensitization of Treated Rhesus Macaques to the Gal Epitope 
The presence of antibodies targeted against the Gal epitope was measured in recipient 
serum at baseline and after implantation or re-implantation of the lung constructs. Hosts were 
considered sensitized to the Gal epitope if antibody binding levels doubled upon exposure to the 
implants. Levels of anti-Gal IgM antibodies increased 2-fold only in the WT group from baseline 
to eight weeks of the initial implantation study and increased again to similar levels in the re-
implantation study (Figure 19A).  
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Figure 19. Production of Gal-specific antibodies in response to implanted lung constructs 
Levels of A) IgM or B) IgG antibody were measured in rhesus macaque serum against the Gal epitope in naïve hosts 
from zero to eight weeks post-implantation, and zero to eight weeks post-re-implantation in the previously exposed 
hosts. Native wild type porcine (WT), sham control (SC), decellularized macaque (DC-M), decellularized WT 
porcine (DC-WT), and decellularized ⍺-Gal KO porcine (DC-KO) lungs. Values are the average optical density 
(O.D. ± standard deviation, n=2) determined by ELISA. 
 
Levels of anti-Gal IgG antibodies increased in both the WT and DC-WT groups from 
zero to eight weeks in the initial implantation study, where WT values increased by an average 
of 70-fold and DC-WT values increased by an average of 18-fold. Circulating levels of anti-Gal 
antibodies were reduced in both groups between the implantation and re-implantation studies but 
did not return to baseline. Levels of anti-Gal IgG increased again in the re-implantation study, 
returning to a 70-fold increase in the WT group and increasing further to a 25-fold increase in the 
DC-WT group (Figure 19B).  
The SC and the DC-M groups showed no changes from baseline levels of anti-Gal IgM, 
and no detectable anti-Gal IgG over the course of the study, demonstrating the surgical 
procedure and allogeneic transplant did not affect the level of anti-Gal antibodies. Importantly, 
recipients of the DC-KO implants showed no increase in production of anti-Gal IgM or IgG 
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antibody throughout the study, confirming removal of the Gal epitope and absence of host 
sensitization. 
 
Qualitative Biocompatibility of Implanted Lung Scaffolds  
Qualitative analysis of the scaffolds post-implantation was performed on H&E, Masson’s 
Trichrome, and Verhoff van Gieson stained tissue sections to identify scaffold degradation, 
infiltration by immune cells, and resolution of the foreign body host response.  
The implantation surgery produced a linear defect extending from the epithelium to the 
deep dermis, filled with minimal fibrin, edema, and acute inflammatory cells across all implants 
and sham surgeries. The sutures induced minimal granulomatous reaction in the deep dermis on 
the medial margin of the implants. All implantation groups were infiltrated by immune cells 
migrating from the outer edges of the implants to the center over time. Migration was impeded 
by residual cartilage and thick elastin fibers surrounding large native vasculature as seen by 
Verhoff van Gieson stain (Figure 20). 
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Figure 20. Degradation of elastin over time in lung implants 
Verhoff van Gieson staining was used to assess scaffold degradation via lung elastin content (black) in the A) 
implantation and B) re-implantation study for the five implantation groups (magnification: 10x objective, scale bar: 
200 µm). Thick elastin fibers were identified primarily around large vasculature, and thin fibers were present 
throughout the lung parenchyma. By eight weeks, elastin remained in several of the groups, demonstrating that the 
scaffolds were not completely degraded. 
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 One week following injury, the SC group showed mild to moderate granulomatous 
inflammation with hyperplastic blood vessels in the dermis. At two and four weeks, moderate 
granulomatous inflammation with granulation tissue filled the defect. By eight weeks, there was 
complete regeneration of normal skin structures, with resolved inflammation and minimal 
fibrous scar remaining (Figure 21a,b).  
 
Figure 21. Qualitative assessment of tissue remodeling and biocompatibility in the implantation study 
A) Representative H&E stained sections of the implantation sites at one and eight weeks post-implantation (scale 
bar = 200 µm). Sham control (SC, a,b), decellularized macaque lung (DC-M, c,d), native WT porcine lungs (WT, 
e,f), decellularized WT porcine group (DC-WT, g,h), decellularized α-Gal KO (DC-KO, i,j). B) The pathological 
score for each implant (scale 0-4, n=4) is semi-quantitatively displayed for each group at each time point. 
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The allogeneic DC-M lung implants were partially condensed and replaced with 
granulation tissue by one-week post-implantation, with minimal cell infiltrate, consisting 
primarily of histiocytes and small amounts of lymphocytes. At two weeks, inflammation 
persisted with few multinucleated giant cells (MNGCs), and granulation tissue. At four and eight 
weeks, the implant was mostly replaced with granulation tissue, contained residual cartilage, and 
a small lymphocytic infiltrate (Figure 21c,d). 
The WT lung implants retained alveolar vascular structures at one-week post-
implantation, with a large infiltration of PMNs, some histiocytes, and MNGCs. At two weeks, 
the implant was partially condensed with pyogranulomatous exudate consisting of large amounts 
of PMNs, some macrophages, and few MNGCs. Neovascularization and remnant cartilage were 
noted at two weeks. By four weeks, the infiltrating cells included large amounts of lymphocytes 
and numerous MNGCs; and implants showed signs of skin erosion. By eight weeks, extensive 
granulomas had formed including dense aggregates of macrophages, lymphocytes, and MNGCs 
with fibrous encapsulation (Figure 21e,f). 
The DC-WT porcine lung implants were partially condensed at one-week post-
implantation, with minimal granulation tissue, and mild infiltration of histiocytes and 
lymphocytes. At two weeks, the implant was partially replaced with granulation tissue, and 
showed moderate infiltration of histiocytes, macrophages, lymphocytes, and MNGCs. Residual 
cartilage was identified in the explants at two weeks. By four weeks, the implants were 
completely infiltrated and showed signs of granuloma, which persisted at eight weeks (Figure 
21g,h). 
The DC-KO porcine lung implants were partially condensed at one-week post-
implantation, with mild infiltration of histiocytes, macrophages, and lymphocytes. At two weeks, 
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the implants were infiltrated by small amounts of PMNs, and moderate amounts of histiocytes, 
lymphocytes, and MNGCs. Neovascularization and remnant cartilage were noted at two weeks. 
By four weeks, the implants were replaced by moderate granulation tissue with dense 
lymphocytes. At eight weeks, cartilage was also noted in the explant, which was replaced with 
granulation tissue with scattered amounts of PMNs, histiocytes, MNGCs, and clusters of 
lymphocytes forming granulomas. All groups retained non-degraded scaffold structures by the 
final eight-week time point (Figure 21i,j). 
A biocompatibility score was compiled to semi-quantitatively identify differences 
between the groups (Figure 21B). At one week, the SC group had no pathology detected (score 
=0); while the WT lung had a greater pathological score compared to all other groups (score =4). 
Of note, the DC-WT porcine lung had a greater pathological score (score =3) than the DC-KO 
porcine lung group (score =2) at one week. By four and eight weeks, both the SC and DC-M 
lung groups had significantly lower pathological scores than the porcine groups, which were 
indistinguishable based on this semi-quantitative metric.  
 
Qualitative Biocompatibility of Re-Implanted Lung Scaffolds  
In the re-implantation study, the SC was similar to the previously described reaction and 
regenerated into healthy skin (Figure 22a,b). The DC-M lungs showed some hyperplastic blood 
vessels and were minimally infiltrated with MNGCs at one-week post re-implantation. At two 
weeks, the scaffolds were partially condensed and moderately replaced with granulation tissue, 
along with more MNGCs, and some lymphocytes and macrophages. Finally, by eight weeks, 
some mature collagen was identified, and the residual scaffold remained moderately infiltrated 
by immune cells (Figure 22c,d). 
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Figure 22. Qualitative assessment of tissue remodeling and biocompatibility in the re-implantation study 
Representative H&E stained sections of the implantation sites at one and eight weeks post-re-implantation (scale bar 
= 200 µm). Sham control (SC, a,b), decellularized macaque lung (DC-M, c,d), native WT porcine lungs (WT, e,f 
*division/contortion), decellularized WT porcine group (DC-WT, g,h), decellularized α-Gal KO (DC-KO, i,j). B) 
The pathological score for each implant (scale 0-4, n=4) is semi-quantitatively displayed for each group at each time 
point. 
 
The WT lung implants had thick layers of PMNCs, macrophages, MNGCs, and some 
lymphocytes as early as one week post re-implantation into the sensitized hosts. Residual 
alveolar structures were identified with some neovascularization. At two weeks, more MNGCs 
and lymphocytes appeared in the implant, which also retained PMNs, remnant cartilage, and 
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fibrotic outer zone. By four weeks, the implant was beginning to be replaced with granulation 
tissue. By eight weeks, residual granulation tissue, lymphocytes, and some signs of liquefaction 
and division of the implant was identified (Figure 22e,f).  
The DC-WT implants showed peripheral infiltration of immune cells (PMNs, 
macrophages, and some MNGCs) as early as one week post re-implantation into the sensitized 
hosts. The implants were also partially condensed with some granulation tissue. At two weeks, 
large groups of MNGCs formed in the center of the implant surrounded by macrophages, PMNs, 
and outer regions of lymphocytes. By four weeks, the implants were severely infiltrated by 
inflammatory cells and by eight weeks, the scaffolds were completely replaced by ongoing 
inflammatory cells organized into granulomas (Figure 22g,h).   
The DC-KO implants were also partially condensed and infiltrated with scattered 
MNGCs and lymphocytes at one week post re-implantation. By two weeks, granulation tissue 
began to form with discrete populations of macrophages, peripheral lymphocytes, and MNGCs, 
along with some remnant cartilage. At four weeks, large populations of macrophages and 
MNGCs replaced much of the scaffold with the formation of dense granulomas, which continued 
to eight weeks (Figure 22i,j).  
Again, the biocompatibility scores were compiled to semi-quantitatively identify 
differences between the groups (Figure 22B). At one week, the SC and DC-M groups had similar 
scores (score < 1)., substantially lower than the porcine groups. In addition, both decellularized 
porcine lung constructs had similar pathological scores (score = 2.5); and the WT lung group had 
a significantly greater pathological score (score = 4). At two, four, and eight weeks, the SC group 
had a significantly lower pathological score than the others. No differences between the porcine 
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groups were identified from two to eight weeks post-re-implantation, similar to what was 
observed in the implantation study.   
 
Quantitative Biocompatibility of Implanted Lung Scaffolds 
In order to further characterize differences in the host response to the implanted lung 
scaffolds, immunostaining for specific cell markers was quantitatively analyzed at each time 
point including CD45, CD3, CD4, CD8, CD20, CD68, CD86, CD206, CD31, and alpha smooth 
muscle actin (α-SMA) and compared to total nuclei counts to determine the percentage of 
positive cells per field. Representative figures are included for one-week post-implantation 
(Figure 23) and eight weeks post-implantation (Figure 24).  
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Figure 23. Representative IHC for implantation study, one-week post-implantation 
Representative immunostaining for native porcine (WT) lungs, sham injury control (SC), decellularized macaque 
(DC-M) lungs, decellularized wild type porcine (DC-WT) lungs, or decellularized α-Gal knockout (DC-KO) at one-
week post-implantation, scale bar = 50µm. 
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Figure 24. Representative IHC for implantation study, eight weeks post-implantation 
Representative immunostaining for native porcine (WT) lungs, sham injury control (SC), decellularized macaque 
(DC-M) lungs, decellularized wild type porcine (DC-WT) lungs, or decellularized α-Gal knockout (DC-KO) at one-
week post-implantation, scale bar = 50µm. 
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At one-week post-implantation, the WT group had a higher cellularity compared to the 
SC and DC-M groups. Cellularity peaked at four weeks in the WT and DC-WT groups but was 
delayed in the DC-KO group to eight weeks (Figure 25A).  
 
Figure 25. Quantitative assessment of specific cell subsets in the implantation study 
A) Cellular infiltration was assessed by counting the number of hematoxylin-stained nuclei and averaged per five 
fields using ImageJ. B) The percentage of CD45+ leukocytes, C) CD68+ macrophages, and D) CD86+ APCs, E) 
CD206+ APCs, and F) CD3+ T-cells were quantified by normalizing the number of positive cells to the number of 
nuclei and averaged per five fields. (G) The percent area of CD31+ blood vessels and H) α-SMA+ fibroblasts were 
quantified and averaged per five fields in the native porcine lung (WT), sham control (SC), decellularized macaque 
lung (DC-M), decellularized WT porcine lung (DC-WT), and decellularized a-Gal KO lung implants (DC-KO). 
Values are average ± standard error (n=4 implants per group). Significance (p<0.05) was measured by one-way 
Kruskal-Wallis ANOVA with Dunn’s multiple comparisons at each time point designated by a (vs. SC/DC-M), b 
(vs. WT), c (vs. SC), d (vs. DC-KO) groups.  
 
The percentage of CD45+ cells, a pan-leukocyte marker, was significantly greater in the 
DC-M group compared to the WT group at one week. At all other time points, the percentage of 
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leukocytes was similar between groups (Figure 25B). Similarly, CD68+ macrophages were 
increased in the DC-M group compared to the WT at one week (Figure 25C). The percentage of 
CD86+ cells, a marker for pro-inflammatory macrophages and antigen presenting cells, was 
significantly increased in the DC-WT group compared to the WT group at 4 weeks (Figure 25D), 
while the percentage of CD206+ cells, or anti-inflammatory macrophages, was significantly 
increased in the DC-M group compared to the WT group at one, two, and eight weeks post-
implantation (Figure 25E). 
In addition, the percentage of CD3+ T-lymphocytes was elevated in the DC-KO group 
compared to the SC at two weeks post-implantation (Figure 25F). At four weeks, the porcine 
groups had elevated CD31+ neovascularization, where the DC-WT group was significantly 
greater than the DC-M and SC groups (Figure 25G). Finally, the WT group had increased area of 
α-SMA positive cells, a marker of activated fibroblasts, compared to the DC-KO group at two 
weeks post-implantation (Figure 25H). No differences in the percentage of CD4, CD8, or CD20 
expression was detected between the groups.  
 
Quantitative Biocompatibility of Re-Implanted Lung Scaffolds 
Immunohistochemical assessment was also performed on explants in the re-implantation 
study. Representative figures are included for one-week post re-implantation (Figure 26) and 
eight weeks post re-implantation (Figure 27).  
One week following re-implantation of the scaffolds into previously exposed hosts, the 
WT group had greater cellularity than the SC and DC-M groups. However, by four weeks the 
DC-KO group had significantly more cellular infiltration than the SC and DC-M groups. Cell 
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numbers remained elevated in both the WT and DC-KO at eight weeks compared to the SC 
(Figure 28A).  
 
Figure 26. Representative IHC for re-implantation study, one-week post re-implantation 
Representative immunostaining for native porcine (WT) lungs, sham injury control (SC), decellularized macaque 
(DC-M) lungs, decellularized wild type porcine (DC-WT) lungs, or decellularized α-Gal knockout (DC-KO) at one-
week post-implantation, scale bar = 50µm. 
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The percentage of infiltrating CD45+ leukocytes was lower in the WT group compared to 
DC-M at one, two, and four weeks although there were far fewer cells in the DC-M implants. By 
eight weeks, there were significantly fewer leukocytes in the DC-KO as compared to the DC-WT 
group (Figure 28B). In addition, the DC-KO group had increased neovascularization as 
compared to the SC and DC-M groups at two and four weeks post re-implantation (Figure 28C). 
 93 
 
 
Figure 27. Representative IHC in re-implantation study, eight weeks post re-implantation 
Representative immunostaining for native porcine (WT) lungs, sham injury control (SC), decellularized macaque 
(DC-M) lungs, decellularized wild type porcine (DC-WT) lungs, or decellularized α-Gal knockout (DC-KO) at one-
week post-implantation, scale bar = 50µm. 
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The percentage of CD3+ T-lymphocytes was increased in the DC-WT group compared to 
the SC at eight weeks (Figure 28D), while CD8+ cytotoxic T-cells were elevated in the DC-M 
group relative to the WT group at one week post re-implantation (Figure 28E). No differences in 
CD4, CD20, CD68, CD86, CD206, or α-SMA expression were detected between the groups in 
the re-implantation study.  
 
Figure 28. Quantitative assessment of specific cell subsets in the re-implantation study 
A) Cellular infiltration was assessed by counting the number of hematoxylin-stained nuclei and averaged per five 
fields using ImageJ. B) The percentage of CD45+ leukocytes, C) CD31+ endothelial cells, and D) CD3+ T-cells, and 
E) CD8+ T-cells were quantified by normalizing the number of positive cells to the number of nuclei and averaged 
per five fields in the native porcine lung (WT), sham control (SC), decellularized macaque lung (DC-M), 
decellularized WT porcine lung (DC-WT), and decellularized a-Gal KO lung implants (DC-KO). Values are average 
± standard error (n=4 implants per group). Significance (p<0.05) was measured by one-way Kruskal-Wallis 
ANOVA with Dunn’s multiple comparisons at each time point designated by a (vs. SC / DC-M), b (vs. WT), c (vs. 
SC), d (vs. DC-KO) groups. 
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Adaptive Immune Response from Repeated Exposure 
Chronic failure of xenotransplanted organs is most commonly attributed to the adaptive 
immune system, which retains immunological memory and exhibits potent cytotoxic abilities 
upon re-exposure events. Indeed, re-implantation of the DC-WT group induced a significant 
increase in CD3+ T-cells at one and eight weeks compared to the initial implantation study, up to 
a 4-fold change increase (Figure 29A). The repeated sham injury also caused an increase in the 
presence of CD3+ T-cells is the epidermis, and the DC-M had increased infiltration of CD3+ T-
cells in the re-implantation study at four weeks, up to a 3-fold increase. However, the percentage 
of CD3+ T-cells levels were unchanged in the WT and DC-KO groups upon re-exposure. 
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Figure 29. Comparison of the adaptive immune response between the implantation and re-implantation studies 
A) The percentage of CD3+ T-cells, B) CD8+ T-cells, and C) CD20+ B-cells compared between the implantation and 
re-implantation studies over time for lung implant groups: native porcine lung (WT), sham control (SC), 
decellularized macaque lung (DC-M), decellularized WT porcine lung (DC-WT), and decellularized a-Gal KO lung 
implants (DC-KO). Differences were measured by a two-sample unequal variance t-test, (*p<0.05, **p<0.01, 
***p<0.001). Values are average ± standard error (n=4 implants per group). 
 
Furthermore, the levels of CD8+ cytotoxic T-cells increased significantly in the WT, DC-
WT, and DC-M groups from the implantation to the re-implantation study (Figure 29B). The WT 
group exhibited a significant 7-fold increase at two weeks, the DC-WT group showed up to an 8-
fold increase at two and four weeks, and the DC-M group showed a 2-fold increase at one week. 
Neither the SC nor the DC-KO groups had significant increases in CD8+ T-cells. Finally, the 
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level of CD20+ B-cells was increased 8-fold in the WT group at one week after re-exposure, but 
no changes in B-cells were observed in the other groups (Figure 29C).  
3.4 DISCUSSION 
In this study, lungs from wild type or α-Gal knockout pigs were decellularized and 
subcutaneously implanted into a rhesus macaque model to comprehensively evaluate 
biocompatibility. The proportions of several immune cell subsets were compared between groups 
over time to assess the host response within the scaffolds and systemically in circulating blood. 
Measurements within the scaffolds are more sensitive at determining the host response as 
opposed to bulk blood work, given the subcutaneous implantation model, which results in a more 
moderate inflammatory response compared to whole organ transplant procedures. Furthermore, 
comparing percentages of immune cell subsets allows for a more accurate evaluation of the host 
response between groups, controlling for heterogenous cellularity across measurements and 
implant groups. The relative proportion of immune cells dictates the overall host response and 
signaling milieu more accurately than absolute cell numbers alone. Taken together, the results 
demonstrated differential profiles of circulating and infiltrating immune cell subsets and 
histological outcomes depending on the implanted tissue source and processing. The findings 
herein are limited by a small sample size of two animals per implant group but represent an 
important step towards the clinical development of biocompatible tissue engineered lungs.  
Acellular scaffolds implanted in vivo elicit a well-defined host immune response, 
characterized by early recruitment of polymorphonuclear (PMN) and mononuclear innate 
immune cells, followed by adaptive immune cells (Badylak & Gilbert, 2008; Londono & 
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Badylak, 2015). The tissue source and processing of the scaffolds has been shown to direct the 
immune response and downstream outcomes (Keane, Swinehart, & Badylak, 2015). A positive 
outcome is associated with resolution of the immune response, vascularization, and site 
appropriate remodeling, while a negative outcome is characterized by chronic inflammation, 
formation of multi-nucleated giant cells, granulomas, and tissue necrosis (Brown & Badylak, 
2014; Keane et al., 2015; Londono & Badylak, 2015). A greater proportion of “M2” anti-
inflammatory macrophages, versus “M1” pro-inflammatory macrophages, has been linked to 
positive outcomes of implanted biomaterials as well as predominantly Th2 responses (Allman et 
al., 2001; Allman, McPherson, Merrill, Badylak, & Metzger, 2002; Brown, Londono, et al., 
2012).  
Subcutaneous transplantation of porcine tissue into the macaque without decellularization 
or Gal epitope removal is expected to result in rejection (Lexer et al., 1986; Rose et al., 1991). 
Indeed, the implanted native porcine lungs caused an acute increase in circulating levels of 
neutrophils and eosinophils in the rhesus macaques, as well as substantial production of anti-Gal 
IgM and IgG antibodies following exposure to the porcine tissue. The WT implants were 
consistently designated with a pathological score of 4 (severe inflammation). Quantitatively the 
WT tissue started with a higher cellularity than the other scaffolds, likely because these tissues 
were not decellularized. As such, the percentage of CD45+ cells appeared lower than the other 
groups. However, qualitatively, polymorphonuclear cells, histiocytes, and multi-nucleated giant 
cells were identified as early as one week in the implants. By two weeks, the WT group had 
greater α-SMA staining than the DC-KO group, consistent with the resulting granulomas and 
fibrous encapsulation that was observed. During the re-implantation phase of the study, the fresh 
native porcine lung implants underwent liquefaction and distortion within the dermis, which 
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made quantifying distinct immune subsets more difficult and reflected in a slightly lower 
designated pathological score. The levels of anti-Gal antibodies continued to increase, suggesting 
host sensitization, and there were substantially more CD8+ T-cells and CD20+ B-cells present in 
the re-implanted tissues, which showed signs of rejection as anticipated.  
A sham surgery was included to control for the effects of an immune response directed 
against the implantation procedure. As expected, no changes in circulating immune cells or 
antibodies were detected. The sham injury primarily affected the epidermis and resulted in 
minimal to no measurable influx of inflammatory cells. The cells that were present at the injury 
site were predominately CD45+ leukocytes, with a large proportion of macrophages. Few 
lymphocytes were detected, however more CD3+ T-cells appeared during the re-injury phase of 
the study. By the final time point, the injury to the epidermis was healed with granulation tissue 
and regenerated skin structures and no ongoing host response.  
Similarly, the rhesus macaques implanted with decellularized allogeneic scaffolds 
underwent no changes in blood biochemistry, and no production of anti-Gal antibodies, as 
expected. The implants were designated with overall low pathological scores (2 = mild), 
associated with the expected immune response to implantation of decellularized scaffolds. In 
both the implantation and re-implantation study, there was an influx of immune cells from one to 
four weeks (primarily PMNs and macrophages), low CD3+ lymphocyte counts, and low 
vascularization observed. In the implantation study, the DC-M implants were associated with a 
high CD68+ and CD206+ “M2” macrophage response. In the re-implantation study, the DC-M 
lung implants performed similarly with a mild pathological score. As with the implantation 
study, there were fewer total cells recruited to the DC-M implants, but the cells present were 
primarily leukocytes. At one week post re-implantation, the DC-M group had a greater 
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percentage of CD8+ T-cells compared to the WT group. However, the absolute number of CD8+ 
T-cells was similar between the groups (data not shown), likely representing residual memory T-
cells from the primary implantation study and species-specific recognition in the DC-M group. 
By eight weeks, some elastin and other ECM components of the lung scaffolds remained but 
were being remodeled into granulation tissue and mature collagen. 
Alternatively, the decellularized WT implants induced an increase in circulating 
neutrophils and substantial production of anti-Gal IgG antibodies by the hosts, especially 
following re-implantation. At early time points, the DC-WT porcine group had a significantly 
greater pathological score than the DC-KO group, but lower pathological score than the WT 
native porcine group (3 = moderate). By later time points, this metric was indistinguishable 
between the porcine groups. Quantitatively, the DC-WT scaffolds had similar levels of cellular 
infiltration as the WT group at four and eight weeks, but a higher proportion of CD86+ “M1” 
macrophages, which appeared to be expressed on multi-nucleated giant cells. In the re-
implantation study, the DC-WT implant induced greater levels of CD45+ cells than the DC-KO 
group at eight weeks, along with an increase in the CD3+ and CD8+ T-cell response compared to 
the implantation study. Resolution of the immune response and scaffold degradation was 
incomplete by the final eight-week time point.  
The decellularized α-Gal KO lung implants did not induce any change in the levels of 
anti-Gal IgM or IgG, as anticipated, demonstrating absence of the Gal epitope. However, one 
animal in the DC-KO group showed slightly higher levels of endogenous anti-Gal antibodies 
compared to other test subjects. The same animal had a significant increase in circulating white 
blood cells, particularly neutrophils, following exposure to the decellularized scaffolds. 
Qualitatively the DC-KO lung implant performed most similarly to the DC-WT group in the 
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implantation and re-implantation study. Quantitatively, the DC-KO implants were maximally 
infiltrated by cells at later time points than the other porcine groups and showed increased 
percentages of CD3+ T-cells compared to the sham injury at two weeks, but not the WT or DC-
WT implants. As there was no difference in percentages of CD4/CD8 T-cells, the physiological 
relevance of the observed increase in CD3+ T-cells at 2 weeks is unclear. The DC-KO had fewer 
α-SMA+ fibroblasts compared to the native WT group early in the implantation study. In the re-
implantation study, the scaffolds were again infiltrated more slowly, contained fewer CD45+ 
cells compared to the DC-WT group at eight weeks, and had increased neovascularization. By 
the final time points, scaffold materials were still present in the implant site and there was 
ongoing cellular reaction, including large granulomas, which were present in all the porcine 
groups.  
At present, T-cell mediated chronic rejection of materials is a major remaining 
immunological barrier of xenotransplantation, which appears months to years after transplant, 
and is controlled with life-long immunosuppression. The animals in this study did not receive 
any immunosuppression, and thus experienced a robust T-cell response in the porcine groups, 
particularly post re-implantation. Interestingly, the percentage of CD3+/CD8+ T-cells was 
significantly increased in the DC-WT group following re-implantation, but not in the DC-KO 
group, suggesting that the absence of the Gal epitope may reduce some T-cell recognition upon 
re-exposure, which has also been demonstrated by others in vitro (Wilhite et al., 2012). Of note, 
there was no measured increase in CD3+ T-cells in the re-implanted WT group despite showing 
signs of liquefaction and rejection, which might be explained by 1) higher levels of other 
immune or non-immune cells in the implants or 2) restriction of cellular migration through non-
decellularized implants. The percentage of CD20+ B-cells increased significantly in the WT 
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group post-re-implantation, further supporting sensitization to Gal and other porcine epitopes in 
the native implants. 
This study is the first to examine the host response to decellularized lung constructs 
derived from WT and α-Gal KO pigs in vivo using an immunologically relevant model. Other 
groups have characterized extracellular matrices derived from wild type or α-Gal knockout small 
intestine submucosa and urinary bladder matrix and found no changes in the content of growth 
factors, mechanical properties, host response, or tissue remodeling, demonstrating that removal 
of the Gal-epitope does not significantly affect the function of the acellular scaffolds  (Daly et 
al., 2009; Liang, Fisher, Yang, Hall, & Woo, 2011). In this study, the two groups behaved 
similarly overall, with a slight reduction in adaptive immunity observed in the re-implanted 
decellularized KO group.  
In the context of lung tissue engineering, several challenges remain, including effective 
recellularization and surgical implantation of the decellularized lung constructs to recapitulate 
human organ function. Platz et al. successfully recellularized lung constructs derived from both 
wild type and α-Gal knockout porcine lungs, and determined that the scaffolds were capable of 
supporting the growth of human lung cells, including bronchial epithelial cells, fibroblasts, 
mesenchymal stromal cells, and pulmonary vascular endothelial cells in a cell culture system 
(Platz et al., 2016).  
While α-Gal is a primary immunogen of porcine tissue, other antigens are capable of 
inducing an immune response following transplantation. In addition to α-Gal, other porcine 
antigens that contribute to preformed anti-pig antibody reactivity include N-glycolylneuraminic 
acid (Neu5Gc) and the glycan SDa (a blood group antigen) (Byrne, Ahmad-Villiers, Du, & 
McGregor, 2018). Considering that both pig tissues and nonhuman primate donors express 
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Neu5Gc, the present study would not have distinguished this immunogenic reaction. Some but 
not all primates produce the glycan SDa via beta-1,4-N-acetyl-galactosaminyltransferase 2 
(B4GALNT2) while others have IgM anti-bodies directed to it (Byrne et al., 2018; Dall'Olio, 
Malagolini, Chiricolo, Trinchera, & Harduin-Lepers, 2014). Future studies may investigate the 
contribution of these antigens to the immunogenic response to porcine tissues. Combining the 
decellularized α-Gal knockout with additional tissue engineering approaches, such as 
recellularization with human cells, has the potential to further reduce the immune response over 
decellularization alone. Further studies will be necessary to assess the host immune response to 
recellularized lung scaffolds, particularly following implantation into the thorax, where direct 
blood contact might induce a more rapid immune response. Additional time points will be 
necessary to fully measure the degradation of the scaffolds and biocompatibility of both the 
decellularized and recellularized α-Gal KO versus WT porcine lungs in these contexts. 
In conclusion, the decellularized α-Gal KO lung constructs performed similarly to the 
decellularized WT group after subcutaneous implantation in a non-human primate model from a 
histological and tissue remodeling standpoint. The genetic removal of the Gal epitope from 
porcine lung tissue appeared to delay immune cell infiltration and reduce the chronic T-cell 
mediated reaction against decellularized materials following re-implantation. Removal of the Gal 
epitope may be an effective strategy to extend the life-span of clinical grade decellularized 
constructs for use in heart valves, ligaments, and perhaps one day, tissue engineered whole 
organs. Further studies are needed to assess biocompatibility over longer time points in both 
decellularized and recellularized lung grafts.  
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4.0  GENERAL DISCUSSION 
4.1 SIGNIFICANCE 
By 2050, the number of individuals over the age of 65 is expected to increase by 71% to nearly 2 
billion individuals worldwide, with the number of US citizens over the age of 65 surpassing 20% 
by 2030 (Ortman JM, 2014). These statistics mark an important turning point in US history 
where the population over the age of 65 will surpass those under the age of 18 for the first time 
(Census.gov, 2018). Furthermore, the number of working individuals to the number of retired 
individuals will decrease from 3.5:1 to 2.5:1, with major implications for health care and 
economics. 
The primary explanation behind these shifting demographics is aging of the baby boomer 
generation with prolonged lifespans and decreased birth rates in the United States (Census.gov, 
2018). Despite living longer, elderly populations are not necessarily living healthier lives. Over 
75% of the elderly population will be diagnosed with at least one chronic condition, often 
presenting with systemic inflammation and in some cases requiring organ transplantation 
(NCOA, 2015).  Currently over 114,000 people are enrolled on the organ transplant list and 20 
people die each day waiting for a transplant (HHS.gov, 2018). The increased incidence of end-
stage disease with aging necessitates a demand for viable organs and other regenerative medicine 
strategies to rejuvenate tissue function and reduce inflammation. 
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Macrophages are key cells that play important roles in the progression of chronic, 
inflammatory disease and regulate immune tolerance towards transplanted organs and materials 
by taking on classically activated or alternatively activated phenotypes.  
Just within the past decade, the developmental heterogeneity of macrophage populations has 
been discovered (Hoeffel et al., 2012; Yona et al., 2013). In the liver, the embryonically derived 
population of macrophages, known as Kupffer cells, were found to be stable and maintained 
independently from infiltrating, monocyte-derived macrophages in the absence of infection or 
injury (Gomez Perdiguero et al., 2015; Jenkins et al., 2011; Schulz et al., 2012; Yona et al., 
2013). However, very little is known about how these two hepatic macrophage populations are 
maintained during the natural process of aging, which may influence the onset and progression 
of chronic liver disease. Work presented in this dissertation identified a previously unknown 
accumulation of CD11b+ “recruited” macrophages in aged livers, which may be driven in part by 
increased fat deposits leading to activation of inflammatory chemokine signatures from aged 
hepatocytes. A better understanding of the hallmarks of aging in the liver will be crucial in the 
development of preventative measures and treatments for end-stage liver disease in elderly 
patients. 
While inhibiting the chemokine receptor CCR2 did not affect the aged liver macrophage 
profile, the results suggest that inhibiting CCR2 signaling may be beneficial to reduce hepatic 
triglyceride levels and inflammatory gene expression in advanced age; and further supports the 
use of CCR2 antagonists to treat age-related steatosis. Clinical studies have shown that treating 
patients with Cenicriviroc, a dual CCR2/CCR5 antagonist, resulted in twice as many subjects 
achieving improvement in fibrosis and no worsening of steatohepatitis compared with placebo 
(Friedman SL, 2018). Subgroup analysis demonstrated that the therapy was similarly effective in 
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patients above and below 56 years of age, suggesting this therapy may show promise in treating 
age-related NAFLD/NASH as well. Our study lends further support that targeting the CCL2-
CCR2 pathway may be a promising strategy to reduce the onset and progression of hepatic fat 
accumulation and inflammation during the process of aging.  
Another approach to treating end-stage disease is the generation of new organs and tissues 
for transplant. The work presented in this dissertation is the first to examine the host response to 
decellularized lung constructs derived from wild type and alpha-Gal knockout pigs in vivo using 
an immunologically relevant model. The results demonstrated differential profiles of circulating 
and infiltrating immune cell subsets and histological outcomes depending on the implanted tissue 
source and processing. Specifically, the genetic removal of the Gal epitope from porcine lung 
tissue delayed immune cell infiltration and reduced chronic T-cell mediated reaction following 
re-implantation. These studies suggest that removal of the Gal epitope may be an effective 
strategy to extend the life-span of clinically used decellularized constructs as heart valves and in 
other applications. Furthermore, this work supports the use of alpha-Gal knockout materials in 
future tissue engineering efforts to address the organ shortage crisis in the United States.   
Taken together, these studies further our understanding of macrophage biology in the aging 
liver and in the host response to Gal-epitopes and aid in the design of novel strategies to reduce 
inflammation in chronic disease and tissue engineering contexts. 
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4.2 FUTURE DIRECTIONS AND CONCLUDING REMARKS 
In “Chapter 2: A Study of Macrophages in the Aging Liver,” there are several questions that 
remain to be addressed. Our studies demonstrated that the parenchymal fraction of the liver was 
more significantly associated with inflammatory gene expression than macrophages, which 
suggested that hepatocytes are the source of inflammatory signals. However, the influence of 
other non-parenchymal cells, such as endothelial cells and stellate cells, on the inflammatory 
gene expression in the aged liver remains an area of future study. While CD11b has been 
associated with monocyte-derived macrophages, fate tracing experiments will be necessary to 
confirm the origin of the F4/80+CD11b+ hepatic macrophages. Similarly, further studies will be 
necessary to determine the significance of this population as well as which chemokines or 
signaling gradients are responsible for driving the increase in CD11b-expressing macrophages in 
the aged liver, as inhibiting the receptor for MCP-1/CCL2 did not influence the proportions of 
hepatic macrophages. Results from RNA-Seq analysis suggest that Cxcl7, Cxcl13, Ccl22, Ccl5, 
and Ccl6 may be important chemokines to target in the future. In addition, CCR2- Ly6Clo 
monocytes derived from the spleen may be one explanation for the increase in CD11b “M2-like” 
macrophages in the aged liver.  
In “Chapter 3: The Host Response to Engineered Lung Scaffolds,” there are several critical 
experiments and challenges that will be necessary to address in order to successfully translate the 
lung constructs from bench to bedside. In future studies, the lung scaffolds will be recellularized 
with host derived cells and implanted in a physiologically relevant way (i.e. connected to the 
trachea and pulmonary artery to mediate oxygenation of blood). Once porcine lung scaffolds are 
recellularized, Gal-epitopes may be further concealed, reducing the host response and perhaps 
negating the need for genetic deletion, however this hypothesis remains to be tested. 
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Alternatively, additional porcine antigens and porcine endogenous retrovirus (PERV) genes may 
need to be genetically removed. The advent of high-throughput genetic engineering technologies 
such as CRISPR allows for the targeted deletion of several porcine genes at once (Niu et al., 
2017), but this remains to be studied in the context of biocompatibility. Presently the challenges 
in recellularizing constructs into functional tissues are the major hurdle to overcome in the 
generation of clinically relevant animal-derived whole organs for transplantation. 
In general, the accumulation of infiltrating or M1-polarized monocytes/macrophages tends to 
exacerbate chronic disease and contribute to organ failure or rejection by promoting 
inflammation and recruiting adaptive immune cells. However, very few, if any, studies have 
systematically identified changes in the basal levels of macrophage populations in aging tissues 
and organs, or the dynamics of aged macrophages following injury, in either animal models or 
human patients, representing a hugely understudied area of research.  
Therapies that suppress M1-polarization or infiltration of macrophages might reduce the 
progression of chronic disease from manageable early stages to chronic end-stages requiring 
organ transplantation. In the context of aging specifically, promoting M2-gene expression might 
delay the advancement of acute disease into chronic disease. Strategies to modulate the immune 
system and the host response are emerging across many disciplines of medical research and 
treatment.   
Immunomodulatory drugs have been used for generations to either activate or suppress the 
immune system. In order to help manage organ transplantation and autoimmune disease, 
glucocorticoids, cytostatic drugs, and suppressive antibodies, such as anti-TNF biologics, have 
been widely used (Julier, Park, Briquez, & Martino, 2017). More recently, T-cells have been the 
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primary target of activating immunotherapies for treating cancer, using checkpoint inhibitors and 
chimeric antigen receptors with adoptive cell transfer (Hu, Ott, & Wu, 2018).  
The local delivery of either activating or suppressing cytokines using engineered drug 
delivery systems has now been extensively studied preclinically. Our group has explored the use 
of an interleukin-4 drug-eluting coating on synthetic mesh to push responding macrophages 
towards M2 polarization, which has shown to improve tissue integration downstream (Hachim, 
LoPresti, et al., 2017). The local delivery of cytokines may be a future avenue of exploration for 
promoting M2 macrophage polarization in liver disease and in the host response to tissue 
engineered constructs. Importantly, M2 macrophages have been associated with tumor 
progression, including clinical hepatocellular carcinoma (HCC) specimens (Yeung et al., 2015). 
Thus, macrophage polarization must be closely monitored to balance the resolution of 
inflammation with promoting an environment permissive to tumorigenesis and fibrosis.  
As our understanding of immune system continues to grow, particularly in the context of 
aging and other health disparities, coupled with the development of new technologies to 
modulate immune cells including macrophages, therapies may be able to improve the human 
health-span and contribute to the rejuvenation and replacement of tissues and organs.  
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APPENDIX A 
ADDITIONAL METHODS FROM CHAPTER 2 
Serum quantification. Serum was collected from experimental animals and the levels of 
circulating proteins, including alanine transaminase (ALT), aspartate transaminase (AST), 
albumin, and total bilirubin, or serum cholesterol and triglycerides were determined by the 
University of Pittsburgh Medical Center Clinical Laboratory.  
Hepatic lipid quantification. Frozen liver pieces (~100 mg) were shipped overnight on 
dry ice to the Lipids and Lipoproteins Sub-core at the Vanderbilt Mouse Metabolic Phenotyping 
Center (MMPC) Analytical Resources Core. Lipids were extracted from liver tissue by thin layer 
chromatography, and total cholesterol, triglycerides, and fatty acids were quantified by gas 
chromatography.  
Hepatic bile acids quantification. Frozen liver pieces (~100 mg) were homogenized in 
75% ethanol (DeconLabs, King of Prussia, PA) and incubated at 50 degrees Celsius for 2 hours. 
Digested lysates were centrifuged at 6000g for 10 minutes and the supernatant collected. Bile 
acids were quantified using the Mouse Total Bile Acids Kit (Crystal Chem, Elk Grove Village, 
IL).  
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Glucose tolerance test. Fasting glucose levels were measured from blood using 
EmbracePRO glucose monitor (Omnis Health, Nashville, TN). Mice received intra-peritoneal 
injection of 10% D-glucose solution (1g/kg, Fisher Scientific). Levels of glucose in the blood 
were measured at 15, 30, 60, and 120 minutes post-injection and recorded.  
Liver histology and immunostaining.  Paraffin blocks were sections at a thickness of 4 
μm and affixed to glass slides. Sections were deparaffinized using xylene and graded ethanol 
(100-95%) washes then placed in tap water. Hematoxylin and eosin, Masson’s trichrome, and 
Picrosirius red staining was performed in house according to standard protocols (Sigma-Aldrich). 
Staining was performed by the McGowan Institute for Regenerative Medicine histology core 
using ApopTag® Peroxidase In Situ Apoptosis Detection Kit (EMD Millipore, Burlington MA). 
OCT blocks were sectioned at a thickness of 7 μm and affixed to glass slides. Sections were 
brought to room temperature for 10 mins, then stained with Oil Red O (Sigma-Aldrich), or 
blocked with 5% donkey serum (Fisher Scientific), 1% bovine serum albumin (Sigma-Aldrich), 
0.01% TritonX-Tween20 (Fisher Scientific) for one hour for immune-staining. Primary 
antibodies, rabbit anti-mouse CD68 (ab125212, 1:250, Abcam, Cambridge, MA) and rat anti-
mouse CD11b (550282, 1:100, BD Biosciences, San Jose, CA) were applied to tissue sections 
overnight at 4 degrees Celsius. Slides were washed three times in PBS, then secondary 
antibodies were applied for one hour at 1:250 dilution (donkey anti-rabbit 647, donkey anti-rat 
594, ThermoFisher Scientific). Slides were washed three times in PBS, then blocked in 5% rat 
serum (ThermoFisher Scientific) for 1 hour at room temperature. F4/80-FITC (ab105155, 1:50, 
Abcam) was applied for one hour at room temperature. Slides were washed three times in PBS, 
counterstained with DAPI (BioLegend, San Diego, CA), mounted, and coverslipped. Light 
microscopy was performed on Eclipse50i microscope, fluorescence microscopy was performed 
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on EclipseTiU (Nikon Instruments Inc., Melville, NY). Quantification of staining was performed 
in ImageJ (NIH) or Elements (Nikon) software.  
Gene expression.  RNA-later solution was removed from cell pellets. RNA was isolated 
using the RNeasy mini kit (Qiagen, Gaithersburg, MD). Briefly, cells were lysed with the RLT 
buffer and 70% ethanol, then applied to spin columns, washed, and eluted per the manufacturer’s 
directions. RNA was quantified using a NanoDrop Lite Spectrophotometer (ThermoFisher). 
cDNA was generated using the RNA-to-cDNA kit (Applied Biosystems, Foster City, CA). 
Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) was performed with 
10ug of cDNA, TaqMan Gene Expression Master Mix (ThermoFisher), and TaqMan primers 
(ThermoFisher) on the Quant Studio 3 machine (Applied Biosystems). The primers used were 
Ccl2 (Mm00441242_m1), Tnfa (Mm00443258_m1), Il1b (Mm00434228_m1), Il6 
(Mm00446190_m1), beta-actin (Mm00607939_s1). Fold change was calculated using the 2^(-
delta(delta Ct)) method compared to young or young wild-type control samples unless otherwise 
stated.  
Protein analysis. Hepatocyte protein lysates were quantified using a BCA Assay 
(ThermoFisher). CCL2 was measured with the murine JE/MCP-1 (CCL2) ELISA kit (Peprotech, 
Rocky Hill, NJ), according to the manufacturer’s directions. Alternatively, 50 ug of protein was 
denatured with Bolt LDS Sample Buffer and Bolt Reducing Agent, then ran on a 4-12% Bolt-
Tris Plus gel at 200 volts for 22 minutes in 1x SDS running buffer, according to the 
manufacturer’s instructions (ThermoFisher). Protein was transferred to a nitrocellulose 
membrane using the iBlot Transfer Stack System (ThermoFisher). Blots were blocked in 5% 
bovine serum albumin prepared in wash buffer for one hour and cut. Primary antibodies were 
applied overnight: CCL2 (1:500, sc-52701), p-p50 (Ser 337, 1:500, sc-271908), and p-p65 
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(Ser536, 1:500, sc-136548) (Santa Cruz Biotechnology Inc., Dallas, TX). After washing, 
secondary antibodies were applied for 1 hour in 2.5% milk (goat anti-mouse IgG HRP, goat anti-
rat HRP, and GAPDH-HRP (1:2000) (ThermoFisher). Blots were washed and developed with 
SuperSignal West Dura Extended Duration Substrate (ThermoFisher). Blots were imaged using 
ChemiDoc Imaging System (Bio-Rad, Hercules, CA).  
Flow cytometry experiments. Non-parenchymal cells were washed in FACS buffer (5% 
fetal bovine serum and 1% bovine serum albumin in Hank’s Buffered Saline Solution (Sigma-
Aldrich) and stained with fixable near-infrared viability dye (1:1000, FisherScientific). Cells 
were blocked with Fc blocker (1:100, CD16/32, BD Biosciences), then surface stained with flow 
antibodies (1:20, F4/80-PE (BM8, eBioscience, ThermoFisher), CD11b-APC (1:20, M1/70, 
eBioscience, ThermoFisher), CD146-PerCypCy5.5 (1:20, ME-9F1, BD Biosciences), CD45-
FITC (1:20, 30-F11, BD Biosciences)) for 20 mins at 4 degrees Celsius. Cells were fixed with 
Fixation Buffer (BioLegend) and stored overnight in FACS buffer. The following morning, cells 
were permeabilized with Intracellular Staining Permeabilization Wash Buffer (BioLegend) and 
stained with CD68-BV421 (1:20, FA-11, BioLegend). Cells were washed and analyzed on the 
MACSQuant Flow Cytometer (Miltenyi Biotec, Auburn, CA) and analyzed with FlowJo 
Software.  
Hepatic macrophage cell culture experiments. Isolated F4/80+ hepatic macrophages 
were cultured at 100,000 cells in a tissue culture treated 96-well plate (Corning, Tewksburg, MA, 
31.6 mm2 growth volume or 3165 cells/mm2) in RPMI-1640 media (Sigma-Aldrich) 
supplemented with 10% fetal bovine serum (Corning), 1% 1M HEPES (Sigma-Aldrich), and 1% 
Pen-Strep (Fisher Scientific). After allowing hepatic macrophages to adhere to the cell culture 
plates for 3 hours, media was replaced with fresh warmed media (M0 group), or fresh media 
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supplemented with recombinant murine interferon-gamma (20 ng/ml, Peprotech) and 
lipopolysaccharides from e. coli O55:B5 (100 ng/ml, Sigma-Aldrich) (M1 group), or 
supplemented with interleukin-4 (20ng/ml, Peprotech) (M2 group) for 12 hours. After 12 hours, 
the supernatants were collected for nitric oxide production assay using the Griess Reagent 
system. Briefly, supernatant was mixed with equal amounts of 1% sulfanilamide in 5% 
phosphoric acid and 0.1% N-(1-napthyl)ethylenediamine dihydrochloride (NED, Sigma-Aldrich) 
and absorbance was read at 540 nm on Synergy HTX plate reader (BioTek, Winooski VT), 
compared to a standard curve prepared from 0.1M sodium nitrite (Sigma-Aldrich). Cells were 
fixed with 2% paraformaldehyde, then blocked with 5% donkey serum (Fisher Scientific), 1% 
bovine serum albumin (Sigma-Aldrich), 0.01% TritonX-Tween20 (Fisher Scientific) for one 
hour for immune-staining. Primary antibodies, rabbit anti-mouse iNOS (1:200, ab3523, Abcam) 
and rabbit anti-mouse liver arginase (1:400, ab91279, Abcam) were applied to cells overnight at 
4 degrees Celsius. Cells were washed three times in PBS, then secondary antibodies were applied 
for one hour at 1:250 dilution (donkey anti-rabbit 488, ThermoFisher), counterstained with DAPI 
(BioLegend), and imaged. Alternatively, cells were incubated with Vybrant Phagocytosis FITC-
e.coli particles (ThermoFisher) at a 1:20 dilution in media for 2 hours at 37 degrees Celsius, then 
washed, and fixed with 2% paraformaldehyde, and counterstained with DAPI for analysis of 
phagocytosis. Urea production was measured by lysing cells in 0.001% Triton-X (Fisher 
Scientific) and combining with arginase activation solution (10mM MnCl2, 50mM Tris-HCl, 
Sigma-Aldrich) for 10 mins at 56 degrees Celsius, then incubating at 37 degrees Celsius for 22 
hours with arginase substrate solution (0.5M L-arginine, Sigma-Aldrich). Urea was measured 
with detection solution (513 mg/L primaquine, 100 mg/L phthalaldehyde, 2.5 mol/L sulfuric 
 115 
acid, 2.5 g/L boric acid, 0.03% Brij35, Sigma-Aldrich) against a urea standard curve and 
absorbance was read at 430nm on Synergy HTX plate reader (BioTek).  
Endotoxin Assay and 16S rRNA from hepatic blood. Blood was collected from female 
3-month-old and 19-month-old (NIA) mice fasted for six hours sterilely by inserting a catheter 
directly into the inferior vena cava. Blood was allowed to coagulate in a sterile tube for 15 
minutes, centrifuged at 10,000xg for 10 mins, and the serum supernatant was collected and 
stored at -80C. Serum was diluted 1:10 and levels of endotoxin were quantified using the 
ToxinSensor LAL Chromogenic Endotoxin Quantitation Kit (VWR, Radnor, PA), according to 
the manufacturer’s instructions. Alternatively, blood was collected in EDTA tubes (BD 
Biosciences), then DNA was isolated using the DNeasy Blood and Tissue Kit (Qiagen). qRT-
PCR was performed on DNA for 16S rRNA (Taqman: Ba04930791_s1) according to methods 
described previously.  
RNA-Seq and Pathway Analysis. RNA was processed by the University of Pittsburgh 
Health Sciences Sequencing Core for mRNA-Seq. Libraries were prepared with TruSeq Stranded 
mRNA kit (Illumina, San Diego, CA) according to manufacturer instructions. Sequencing was 
on a NextSeq 500 using a single mid-output flowcell and 150 base single read. Adapter 
sequences were trimmed during demultiplexing. Raw data was processed in CLC Genomics 
Workbench 11 (Qiagen). Reads were mapped to the mouse reference genome and differentially 
expressed genes were determined between young and aged hepatocyte samples using filters to 
select genes with reads per kilobase of transcript per million (RPKM ≥ 1), absolute fold change 
(FC > 1.5), and false discovery rate (FDR) ≤ 0.05. Differentially expressed genes were imported 
into Ingenuity Pathway Analysis (IPA) to determine signaling pathways and upstream regulators. 
Activation (positive z-score), inhibition (negative z-score), and interactions of canonical 
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pathways was examined based on experimentally determined gene expression changes reported 
in the literature. 
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APPENDIX B 
RNA-SEQ DATA 
Table 5. Differentially Expressed Genes in Aged Hepatocyte Fractions Compared to Young Identified by RNA-Seq 
Name Chromosome Max group mean 
Log₂ fold 
change 
Fold 
change P-value FDR p-value 
Dmbt1 7 0.59 -7.26 -152.90 9.58E-09 6.0E-06 
Slco1a1 6 18.74 -7.25 -152.15 0 0.0E+00 
Epdr1 13 0.36 -5.13 -35.05 2.04E-05 4.6E-03 
Cib3 8 2.98 -4.65 -25.06 5.72E-09 3.7E-06 
Clec2h 6 1.95 -4.52 -22.93 3.62E-14 6.1E-11 
Serpina4-ps1 12 1.07 -3.67 -12.70 5.61E-08 3.2E-05 
Cdh1 8 7.51 -3.60 -12.17 0 0.0E+00 
4930452B06Rik 14 0.72 -3.55 -11.75 2.07E-08 1.2E-05 
Arhgap44 11 0.07 -2.88 -7.38 3.07E-04 3.0E-02 
Krt23 11 4.47 -2.81 -7.01 2.29E-12 3.0E-09 
Smpd3 8 1.02 -2.78 -6.88 1.36E-05 3.3E-03 
Hapln1 13 0.22 -2.48 -5.58 6.10E-05 1.0E-02 
Adgrf1 17 1.20 -2.48 -5.56 1.09E-08 6.7E-06 
Ugt2b38 5 0.90 -2.43 -5.38 1.61E-05 3.8E-03 
Serpina1e 12 297.01 -2.38 -5.22 1.38E-11 1.5E-08 
Cyp2d9 15 20.91 -2.31 -4.96 0 0.0E+00 
Col4a3 1 1.38 -2.29 -4.89 4.73E-07 2.0E-04 
Gm3839 14 7.08 -2.24 -4.72 1.94E-11 2.0E-08 
Pls1 9 0.84 -2.21 -4.61 1.27E-04 2.0E-02 
Cyp2b13 7 187.56 -2.20 -4.60 0 0.0E+00 
Mup3 4 2822.47 -2.19 -4.56 0 0.0E+00 
Cyp3a11 5 1496.76 -2.10 -4.29 0 0.0E+00 
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Aqp4 18 1.17 -2.09 -4.25 1.93E-05 4.5E-03 
Reck 4 1.07 -2.08 -4.23 1.33E-07 6.6E-05 
Acsm2 7 0.28 -2.04 -4.10 1.61E-05 3.8E-03 
Mup20 4 95.94 -2.02 -4.05 0 0.0E+00 
C8a 4 76.95 -1.97 -3.93 9.35E-14 1.4E-10 
Susd4 1 0.42 -1.92 -3.80 4.68E-04 5.0E-02 
Sort1 3 1.06 -1.85 -3.61 4.83E-12 5.8E-09 
Lars2 9 409.73 -1.84 -3.57 5.59E-06 1.6E-03 
Adamts7 9 0.85 -1.79 -3.46 1.18E-07 5.9E-05 
Defb1 8 3.98 -1.73 -3.31 3.50E-05 6.7E-03 
Etnppl 3 56.28 -1.68 -3.21 3.62E-07 1.6E-04 
Ociad2 5 5.39 -1.67 -3.18 4.90E-12 5.8E-09 
Hsd3b2 3 9.70 -1.60 -3.04 8.72E-13 1.2E-09 
C8b 4 63.90 -1.58 -2.98 0 0.0E+00 
Mup11 4 836.76 -1.55 -2.92 1.51E-07 7.3E-05 
Col4a5 X 0.65 -1.54 -2.91 8.60E-05 1.0E-02 
Itih5 2 3.41 -1.52 -2.87 1.32E-11 1.5E-08 
Btc 5 0.80 -1.52 -2.87 2.77E-04 3.0E-02 
Enpp2 15 25.92 -1.51 -2.84 5.00E-15 9.4E-12 
Sel1l3 5 1.55 -1.48 -2.78 4.91E-10 3.8E-07 
Abca8a 11 24.41 -1.47 -2.78 5.75E-06 1.6E-03 
Fam81a 9 1.20 -1.47 -2.76 3.55E-05 6.7E-03 
Inmt 6 465.76 -1.44 -2.72 1.63E-06 5.8E-04 
Dpy19l3 7 0.30 -1.42 -2.67 1.54E-04 2.0E-02 
Gm26822 16 1.10 -1.42 -2.67 2.65E-04 3.0E-02 
Asap3 4 1.67 -1.38 -2.60 1.11E-06 4.2E-04 
Dsg1c 18 3.41 -1.37 -2.59 1.01E-04 1.0E-02 
Hsd3b3 3 23.65 -1.33 -2.51 7.26E-12 8.2E-09 
Selenbp2 3 17.48 -1.32 -2.50 4.26E-09 2.8E-06 
Mmd2 5 5.48 -1.28 -2.43 9.10E-08 4.8E-05 
Ppp1r3g 13 8.82 -1.25 -2.38 1.94E-04 2.0E-02 
Tceal8 X 5.84 -1.25 -2.38 2.56E-11 2.5E-08 
Cldn1 16 13.46 -1.22 -2.33 1.37E-08 8.2E-06 
Cyp2c55 19 2.43 -1.21 -2.32 1.74E-04 2.0E-02 
Gm20547 17 6.89 -1.18 -2.27 1.44E-10 1.2E-07 
Ces3b 8 133.49 -1.17 -2.25 1.53E-08 9.0E-06 
Mug1 6 368.34 -1.16 -2.24 3.03E-06 9.7E-04 
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Fkbp11 15 5.59 -1.16 -2.23 1.47E-04 2.0E-02 
Cyp2f2 7 758.89 -1.12 -2.18 1.60E-05 3.8E-03 
Cyp2c54 19 209.59 -1.13 -2.18 1.27E-04 2.0E-02 
1810011O10Rik 8 26.07 -1.12 -2.17 4.50E-04 4.0E-02 
Ces3a 8 334.77 -1.11 -2.16 6.45E-06 1.8E-03 
Egfr 11 18.05 -1.11 -2.15 1.12E-08 6.9E-06 
Mup10 4 6681.44 -1.08 -2.12 1.36E-04 2.0E-02 
Rnf125 18 54.07 -1.07 -2.10 5.99E-08 3.4E-05 
Cyp4a31 4 5.17 -1.05 -2.08 2.01E-04 2.0E-02 
Nudt7 8 26.28 -1.04 -2.06 4.05E-09 2.7E-06 
Trib3 2 4.28 -1.04 -2.05 7.20E-05 1.0E-02 
Arhgef16 4 1.45 -1.03 -2.05 3.37E-04 4.0E-02 
Arl4d 11 55.90 -1.02 -2.02 2.29E-04 3.0E-02 
Slc22a7 17 19.04 -1.00 -2.01 3.50E-06 1.1E-03 
Adora1 1 4.38 -1.00 -2.00 6.82E-07 2.8E-04 
Lgals1 15 13.15 1.02 2.03 4.03E-04 4.0E-02 
Fcgr2b 1 5.06 1.04 2.06 3.09E-05 6.1E-03 
Sult2a2 7 828.09 1.05 2.06 4.20E-06 1.3E-03 
Grid1 14 1.22 1.06 2.08 4.41E-05 8.0E-03 
Prex1 2 1.80 1.06 2.09 1.63E-06 5.8E-04 
Npr2 4 11.91 1.08 2.12 3.50E-05 6.7E-03 
Bag3 7 13.15 1.09 2.13 8.71E-10 6.5E-07 
Plxnd1 6 1.25 1.10 2.14 1.12E-04 2.0E-02 
Stab1 14 2.31 1.10 2.14 2.52E-05 5.2E-03 
Glul 1 137.59 1.10 2.15 1.23E-06 4.6E-04 
Rhbg 3 2.30 1.11 2.16 3.23E-04 3.0E-02 
Kdr 5 3.39 1.12 2.17 9.81E-05 1.0E-02 
Plekhb1 7 8.54 1.12 2.17 1.93E-11 2.0E-08 
Rgs3 4 1.29 1.13 2.18 4.83E-05 8.5E-03 
Pecam1 11 1.73 1.13 2.19 2.15E-04 3.0E-02 
Myo7a 7 1.16 1.13 2.20 5.00E-06 1.5E-03 
Clec14a 12 1.57 1.15 2.23 1.99E-04 2.0E-02 
Gm14387 2 6.52 1.16 2.24 1.82E-06 6.3E-04 
Gas6 8 17.23 1.18 2.26 1.15E-04 2.0E-02 
Pag1 3 1.66 1.19 2.29 1.40E-09 1.0E-06 
Iqgap1 7 1.02 1.21 2.31 1.50E-04 2.0E-02 
S1pr5 9 3.30 1.21 2.31 9.85E-08 5.1E-05 
Bmp2 2 2.51 1.21 2.32 2.01E-04 2.0E-02 
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Gdf15 8 14.53 1.22 2.32 2.46E-04 3.0E-02 
Aqp1 6 17.12 1.22 2.33 2.26E-04 3.0E-02 
Egfl7 2 1.71 1.25 2.38 4.60E-04 5.0E-02 
Eng 2 6.38 1.25 2.38 2.86E-04 3.0E-02 
Gm6484 9 28.43 1.25 2.38 6.28E-07 2.6E-04 
Pltp 2 23.60 1.26 2.40 5.19E-10 3.9E-07 
Flt4 11 1.60 1.26 2.40 3.87E-04 4.0E-02 
Cyp2a22 7 67.49 1.27 2.42 7.97E-06 2.1E-03 
Mrc1 2 4.95 1.28 2.43 5.30E-07 2.2E-04 
Unc13b 4 0.42 1.29 2.44 3.66E-05 6.9E-03 
Ltbp4 7 2.06 1.28 2.44 3.88E-05 7.2E-03 
Csad 15 44.81 1.30 2.46 3.85E-04 4.0E-02 
Ifi203 1 0.77 1.31 2.48 2.41E-04 3.0E-02 
Alpk1 3 0.50 1.31 2.48 1.91E-04 2.0E-02 
Dchs1 7 0.32 1.31 2.48 3.11E-04 3.0E-02 
Ptprb 10 2.80 1.31 2.48 8.25E-06 2.2E-03 
Ehd3 17 7.25 1.32 2.49 8.39E-06 2.2E-03 
Sdc3 4 3.97 1.32 2.50 5.02E-04 5.0E-02 
Sirpa 2 1.74 1.33 2.51 3.56E-05 6.7E-03 
Tinagl1 4 1.46 1.33 2.51 2.92E-04 3.0E-02 
Srgn 10 1.69 1.33 2.52 4.56E-04 5.0E-02 
Ptgs1 2 1.63 1.34 2.54 1.80E-04 2.0E-02 
Cd300lg 11 3.02 1.34 2.54 4.70E-05 8.3E-03 
Setbp1_1 18 0.50 1.35 2.55 3.27E-05 6.4E-03 
Abcc5 16 0.32 1.37 2.58 3.30E-04 4.0E-02 
Nrp2 1 2.87 1.38 2.60 0 0.0E+00 
Rgl1 1 1.01 1.38 2.60 3.48E-05 6.7E-03 
Slc43a3 2 2.72 1.38 2.60 2.78E-05 5.7E-03 
Slc13a3 2 2.01 1.38 2.60 2.17E-04 3.0E-02 
Gimap4 6 2.20 1.39 2.61 3.41E-04 4.0E-02 
Itga9 9 0.92 1.39 2.61 2.55E-04 3.0E-02 
Ehbp1l1 19 1.64 1.38 2.61 8.88E-11 7.7E-08 
Cdh5 8 2.82 1.39 2.62 1.68E-06 6.0E-04 
Clec1b 6 1.03 1.39 2.63 7.65E-05 1.0E-02 
C1qtnf1 11 1.99 1.41 2.65 1.19E-04 2.0E-02 
Arrb1 7 0.49 1.42 2.67 3.78E-05 7.1E-03 
Ly6a 15 6.43 1.42 2.68 3.54E-05 6.7E-03 
Arhgap31 16 0.40 1.43 2.69 1.56E-04 2.0E-02 
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Pde2a 7 2.64 1.45 2.73 6.45E-05 1.0E-02 
Slfn5 11 0.98 1.45 2.73 1.20E-04 2.0E-02 
Adam23 1 0.69 1.47 2.76 2.47E-06 8.2E-04 
Cyp4b1 4 4.23 1.46 2.76 1.94E-05 4.5E-03 
Slc43a2 11 0.81 1.47 2.76 6.82E-09 4.3E-06 
Mylip 13 1.91 1.47 2.77 2.91E-04 3.0E-02 
Arap3 18 0.97 1.47 2.77 2.14E-04 3.0E-02 
Robo4 9 1.43 1.47 2.78 1.56E-05 3.8E-03 
Gpihbp1 15 2.36 1.49 2.80 1.21E-05 3.0E-03 
Flna X 1.01 1.49 2.80 3.14E-07 1.4E-04 
Sp100 1 0.52 1.49 2.81 6.46E-05 1.0E-02 
Slc1a2 2 7.64 1.49 2.81 1.84E-05 4.3E-03 
Serpina7 X 8.26 1.49 2.81 1.16E-07 5.8E-05 
Cd5l 3 23.30 1.49 2.82 3.30E-04 4.0E-02 
Lpl 8 0.86 1.52 2.87 1.68E-04 2.0E-02 
Itpripl2 7 0.51 1.53 2.89 2.96E-04 3.0E-02 
Mndal 1 1.23 1.54 2.90 5.99E-05 1.0E-02 
Id3 4 16.13 1.55 2.92 0 0.0E+00 
Axl 7 2.30 1.55 2.93 1.83E-04 2.0E-02 
Marcks 10 1.48 1.55 2.93 4.39E-05 8.0E-03 
Vcam1 3 2.05 1.56 2.94 1.63E-04 2.0E-02 
Fitm1 14 11.92 1.56 2.95 8.00E-08 4.3E-05 
Msn X 2.03 1.56 2.95 2.73E-06 8.9E-04 
Dse 10 0.90 1.57 2.98 1.27E-04 2.0E-02 
WI1-49P9.2 3 13.71 1.58 2.99 2.45E-10 2.0E-07 
Kctd12 14 5.18 1.59 3.00 2.22E-16 4.6E-13 
Cfp X 6.66 1.59 3.02 1.66E-05 3.9E-03 
Timp3 10 1.68 1.60 3.03 1.38E-07 6.7E-05 
Adgrf5 17 2.56 1.61 3.06 9.84E-06 2.5E-03 
Id1 2 8.50 1.64 3.13 2.62E-07 1.2E-04 
Arhgdib 6 1.76 1.65 3.13 1.87E-04 2.0E-02 
Vipr1 9 1.62 1.65 3.14 1.25E-04 2.0E-02 
Itpkb 1 0.77 1.66 3.15 6.52E-05 1.0E-02 
Clec4f 6 19.05 1.66 3.16 8.21E-05 1.0E-02 
Sema6d 2 0.57 1.67 3.17 1.22E-04 2.0E-02 
Adgre5 8 2.90 1.66 3.17 2.60E-06 8.6E-04 
Sult2a1 7 838.56 1.67 3.18 2.98E-12 3.7E-09 
Cd84 1 0.53 1.67 3.19 5.38E-05 9.2E-03 
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Colec10 15 1.42 1.67 3.19 2.97E-04 3.0E-02 
Wdfy4 14 0.27 1.68 3.20 3.76E-04 4.0E-02 
Cux2 5 8.86 1.69 3.22 5.14E-04 5.0E-02 
Wfdc17 11 8.14 1.69 3.22 9.75E-05 1.0E-02 
Arhgef2 3 0.26 1.69 3.23 3.78E-04 4.0E-02 
Gm4070 7 0.70 1.69 3.23 1.29E-06 4.7E-04 
Vim 2 2.39 1.70 3.25 5.68E-07 2.4E-04 
Itgal 7 1.51 1.71 3.26 4.31E-06 1.3E-03 
Zeb2 2 0.23 1.71 3.28 7.10E-06 1.9E-03 
Csf1r 18 6.61 1.72 3.28 2.68E-05 5.5E-03 
Hmha1 10 1.22 1.72 3.29 2.90E-07 1.3E-04 
Wipf1 2 0.48 1.72 3.30 2.21E-04 3.0E-02 
Tnfrsf19 14 0.59 1.74 3.34 1.60E-04 2.0E-02 
Hecw2 1 0.19 1.75 3.36 2.59E-04 3.0E-02 
Adgre1 17 3.47 1.76 3.38 4.39E-06 1.3E-03 
Siglec1 2 0.92 1.76 3.39 2.42E-04 3.0E-02 
Sh3tc1 5 0.55 1.77 3.40 9.63E-05 1.0E-02 
Ar X 3.18 1.78 3.42 0 0.0E+00 
Tmsb4x X 25.95 1.78 3.42 1.56E-13 2.3E-10 
Nckap1l 15 1.03 1.78 3.44 3.94E-05 7.3E-03 
Ntn4 10 1.10 1.79 3.45 2.24E-05 4.9E-03 
Itga4 2 0.19 1.79 3.46 2.54E-04 3.0E-02 
Slc11a1 1 1.07 1.80 3.49 1.19E-04 2.0E-02 
Fgf21 7 2.42 1.81 3.51 4.03E-04 4.0E-02 
C1qa 4 13.93 1.82 3.52 2.24E-05 4.9E-03 
Lbh 17 0.78 1.82 3.52 1.13E-04 2.0E-02 
Laptm5 4 3.10 1.82 3.54 4.25E-06 1.3E-03 
Tyrobp 7 7.10 1.83 3.55 2.90E-04 3.0E-02 
Cybb X 2.16 1.83 3.56 1.53E-05 3.7E-03 
Efnb2 8 0.73 1.84 3.58 2.08E-05 4.7E-03 
Cerk 15 0.47 1.85 3.60 1.02E-04 1.0E-02 
Neurl3 1 0.66 1.86 3.63 2.94E-04 3.0E-02 
Srgap3 6 1.42 1.87 3.66 1.47E-11 1.6E-08 
Serpine2 1 1.21 1.88 3.67 1.71E-06 6.0E-04 
Itgb2 10 1.95 1.88 3.67 7.81E-05 1.0E-02 
Hgf 5 0.36 1.88 3.69 9.85E-05 1.0E-02 
C1qb 4 16.09 1.90 3.74 6.89E-06 1.9E-03 
Notch4 17 0.23 1.91 3.75 8.64E-05 1.0E-02 
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Fermt3 19 1.08 1.91 3.75 9.86E-05 1.0E-02 
Ppp1r18 17 0.44 1.91 3.76 2.66E-04 3.0E-02 
Ctss 3 12.24 1.92 3.78 2.24E-05 4.9E-03 
Cd53 3 2.25 1.92 3.78 8.75E-05 1.0E-02 
Vav1 17 0.64 1.93 3.81 3.55E-04 4.0E-02 
Rgs2 1 0.72 1.94 3.85 1.10E-04 2.0E-02 
Pde1a 2 0.60 1.94 3.85 1.76E-07 8.3E-05 
Vsig4 X 11.68 1.96 3.90 2.12E-05 4.7E-03 
Lyz2 10 28.81 1.97 3.91 2.99E-09 2.1E-06 
Adgre4 17 1.23 1.97 3.91 2.05E-04 2.0E-02 
Prelp 1 1.82 1.97 3.93 4.81E-06 1.4E-03 
AI607873 1 1.71 1.98 3.94 3.98E-07 1.7E-04 
P2rx7 5 0.37 1.98 3.94 1.08E-04 2.0E-02 
Sult2a5 7 31.58 1.98 3.95 3.89E-15 7.6E-12 
Abi3 11 0.43 1.98 3.95 3.81E-04 4.0E-02 
Entpd1 19 0.56 1.99 3.97 1.51E-04 2.0E-02 
C1qc 4 8.17 1.99 3.98 7.64E-07 3.1E-04 
Parvb 15 0.51 1.99 3.98 4.16E-05 7.6E-03 
Gsn 2 0.63 2.02 4.07 1.60E-04 2.0E-02 
Lrmp 6 0.36 2.03 4.08 4.65E-04 5.0E-02 
Bgn X 4.09 2.03 4.09 5.49E-06 1.6E-03 
Bmp6 13 1.13 2.04 4.10 2.34E-05 5.0E-03 
Lrrc32 7 1.15 2.04 4.11 7.42E-08 4.0E-05 
1-Mar 8 0.30 2.04 4.11 4.33E-04 4.0E-02 
Cd52 4 1.58 2.06 4.16 2.77E-04 3.0E-02 
Fcgr3 1 2.28 2.08 4.21 2.16E-04 3.0E-02 
Trpm2 10 0.43 2.08 4.22 2.06E-05 4.7E-03 
Ccl6 11 3.10 2.08 4.22 4.66E-05 8.3E-03 
Colec11 12 2.13 2.08 4.22 1.20E-04 2.0E-02 
Slc15a3 19 0.61 2.08 4.23 2.35E-05 5.0E-03 
Atp11a 8 1.42 2.09 4.25 1.75E-10 1.4E-07 
Dock10 1 0.24 2.09 4.26 1.56E-04 2.0E-02 
Nebl 2 0.19 2.09 4.27 4.77E-06 1.4E-03 
Akna 4 0.33 2.09 4.27 1.60E-04 2.0E-02 
Fxyd5 7 0.40 2.11 4.33 2.23E-04 3.0E-02 
Selplg 5 0.73 2.12 4.35 3.81E-04 4.0E-02 
Ptprc 1 0.60 2.12 4.36 8.74E-07 3.4E-04 
Pirb 7 0.78 2.13 4.38 4.16E-04 4.0E-02 
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Ncf2 1 0.46 2.14 4.41 2.94E-04 3.0E-02 
Syk 13 0.40 2.16 4.46 5.73E-05 9.8E-03 
Ecm1 3 5.51 2.16 4.47 3.95E-06 1.2E-03 
St3gal6 16 4.48 2.16 4.48 0 0.0E+00 
Lilra5 7 0.91 2.17 4.51 2.99E-04 3.0E-02 
Pla2r1_1 2 0.19 2.18 4.52 1.65E-04 2.0E-02 
Fgl2 5 0.67 2.24 4.71 1.01E-04 1.0E-02 
Coro1a 7 0.92 2.24 4.74 1.54E-04 2.0E-02 
Ncf1 5 0.55 2.25 4.77 1.08E-04 2.0E-02 
Cd300a 11 0.54 2.27 4.81 9.49E-05 1.0E-02 
Abcc4 14 2.25 2.29 4.88 8.55E-15 1.5E-11 
Rassf2 2 0.12 2.30 4.91 2.78E-04 3.0E-02 
Pira2 7 0.89 2.31 4.95 6.82E-05 1.0E-02 
Plek 11 0.81 2.31 4.95 1.81E-06 6.3E-04 
Csf3r 4 0.41 2.31 4.96 2.97E-04 3.0E-02 
Sla 15 0.28 2.31 4.97 6.11E-05 1.0E-02 
Ctla2a 13 0.81 2.32 4.99 4.72E-04 5.0E-02 
Hao2 3 21.36 2.32 5.00 3.08E-11 2.9E-08 
Col14a1 15 0.67 2.34 5.05 3.44E-05 6.7E-03 
Aatk 11 0.45 2.35 5.08 3.92E-06 1.2E-03 
Rcan2 17 4.94 2.34 5.08 9.58E-14 1.4E-10 
Serpinb1a 13 28.11 2.36 5.15 0 0.0E+00 
Cd44 2 0.87 2.37 5.17 7.38E-08 4.0E-05 
Cd74 18 30.21 2.37 5.17 3.07E-11 2.9E-08 
Tlr8 X 0.50 2.37 5.17 2.27E-04 3.0E-02 
Myo1f 17 0.41 2.37 5.18 4.86E-05 8.6E-03 
Cyp26b1 6 1.27 2.39 5.23 1.38E-08 8.2E-06 
Kif21b 1 0.16 2.39 5.25 1.44E-04 2.0E-02 
Dcn 10 8.85 2.40 5.26 8.61E-07 3.4E-04 
Ntrk2 13 1.57 2.40 5.27 3.65E-11 3.3E-08 
Apbb1ip 2 0.20 2.44 5.42 1.57E-04 2.0E-02 
Abcc9 6 0.57 2.44 5.44 5.70E-08 3.2E-05 
Fcgr4 1 2.26 2.46 5.49 4.01E-05 7.4E-03 
Clec9a 6 0.40 2.46 5.49 8.20E-05 1.0E-02 
Bin2 15 0.85 2.46 5.50 3.03E-05 6.1E-03 
Clec4n 6 1.00 2.46 5.51 2.29E-04 3.0E-02 
H2-Eb1 17 10.91 2.46 5.52 1.37E-09 1.0E-06 
Ampd3 7 0.15 2.48 5.59 4.34E-04 4.0E-02 
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H2-Aa 17 10.14 2.48 5.59 6.34E-11 5.6E-08 
Siglece 7 0.89 2.51 5.69 8.61E-05 1.0E-02 
Clec4a3 6 1.05 2.52 5.73 1.63E-04 2.0E-02 
Fli1 9 0.37 2.52 5.73 4.44E-05 8.0E-03 
Fmnl1 11 0.31 2.54 5.80 5.13E-05 8.9E-03 
Ccrn4l 3 33.18 2.55 5.86 0 0.0E+00 
Galnt15 14 0.37 2.61 6.09 2.57E-07 1.2E-04 
Plcb2 2 0.18 2.61 6.12 1.54E-04 2.0E-02 
Treml4 17 1.17 2.62 6.14 9.86E-06 2.5E-03 
Cd207 6 2.43 2.65 6.29 2.34E-06 7.9E-04 
Adcy7 8 0.48 2.66 6.33 1.11E-05 2.8E-03 
Ccl5 11 0.91 2.66 6.34 4.03E-04 4.0E-02 
Itgb7 15 0.50 2.68 6.42 5.84E-05 9.9E-03 
H2-Ab1 17 8.32 2.68 6.43 1.22E-10 1.0E-07 
Sod3 5 0.63 2.71 6.54 2.98E-05 6.0E-03 
Il1b 2 0.63 2.72 6.60 2.16E-04 3.0E-02 
D630033O11Rik 9 1.89 2.72 6.60 2.43E-05 5.1E-03 
Bcl2 1 0.10 2.72 6.61 1.09E-04 2.0E-02 
Rasgrp1 2 0.23 2.73 6.62 7.35E-05 1.0E-02 
Atp2a3 11 0.27 2.74 6.70 5.08E-05 8.8E-03 
Pla2g7 17 1.43 2.74 6.70 9.22E-08 4.8E-05 
Efemp1 11 0.57 2.78 6.88 1.54E-04 2.0E-02 
Dmrta1 4 1.44 2.79 6.93 5.44E-15 9.8E-12 
Adgb 10 0.16 2.83 7.10 2.05E-04 2.0E-02 
Gp49a 10 0.63 2.83 7.12 1.53E-04 2.0E-02 
Cyp3a44 5 300.34 2.86 7.28 3.57E-11 3.3E-08 
Hsf2bp 17 0.26 2.88 7.34 9.36E-05 1.0E-02 
Dkk3 7 0.62 2.93 7.63 1.01E-06 3.9E-04 
Fermt1 2 0.23 2.95 7.71 1.62E-05 3.8E-03 
Grip2 6 0.09 2.99 7.95 4.91E-04 5.0E-02 
Cd22 7 0.25 3.00 8.01 2.24E-05 4.9E-03 
Cxcl13 5 1.86 3.01 8.05 1.81E-07 8.5E-05 
Igha 12 0.81 3.02 8.10 1.57E-04 2.0E-02 
Adcy1 11 0.10 3.04 8.25 2.51E-05 5.2E-03 
Sult2a7 7 82.38 3.06 8.34 0 0.0E+00 
Sult1e1 5 6.22 3.07 8.40 0 0.0E+00 
Gm15401 6 1.91 3.08 8.45 3.89E-09 2.7E-06 
Cytip 2 0.14 3.08 8.48 6.78E-05 1.0E-02 
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Cd48 1 0.99 3.09 8.54 1.59E-05 3.8E-03 
Cygb 1 0.41 3.11 8.63 1.95E-04 2.0E-02 
Cyp3a16 5 157.70 3.12 8.67 2.53E-05 5.2E-03 
C130026I21Rik 1 0.25 3.16 8.95 4.98E-05 8.7E-03 
Pla2g4f 2 0.31 3.19 9.14 3.13E-05 6.2E-03 
Gm7609 1 0.85 3.24 9.45 1.16E-07 5.8E-05 
E2f7 10 0.06 3.24 9.47 2.29E-04 3.0E-02 
Nkd1 8 0.36 3.27 9.62 6.84E-07 2.8E-04 
Chil3 3 0.38 3.31 9.89 4.83E-04 5.0E-02 
Ctgf 10 1.66 3.43 10.77 0 0.0E+00 
Nudt11 X 0.37 3.43 10.77 4.39E-06 1.3E-03 
Napsa 7 0.26 3.47 11.11 3.51E-04 4.0E-02 
S100a9 3 4.16 3.48 11.19 8.35E-07 3.3E-04 
Adgrg2 X 0.32 3.51 11.36 1.70E-07 8.1E-05 
Esm1 13 0.43 3.55 11.72 2.17E-05 4.8E-03 
Pou2af1 9 0.26 3.75 13.42 2.87E-04 3.0E-02 
Itgb3 11 0.44 3.83 14.22 1.05E-10 8.9E-08 
Id4 13 2.24 3.90 14.96 6.30E-13 8.9E-10 
S100a8 3 2.32 3.92 15.10 2.11E-06 7.2E-04 
Cyp4f18 8 0.29 3.95 15.44 4.38E-04 4.0E-02 
Tmem28 X 0.30 4.19 18.21 2.41E-06 8.1E-04 
Cdh19 1 1.56 4.21 18.50 0 0.0E+00 
Igkv4-55 6 3.85 4.21 18.53 9.22E-05 1.0E-02 
Cyp3a41b 5 271.54 4.26 19.13 4.39E-14 7.1E-11 
Iglv1 16 2.48 4.32 19.91 8.00E-05 1.0E-02 
Bnc2 4 0.09 4.35 20.34 5.10E-05 8.8E-03 
Igj 5 3.79 4.38 20.81 8.63E-13 1.2E-09 
Iglc1 16 1.90 4.64 24.99 1.19E-04 2.0E-02 
Pcdh11x X 0.04 4.78 27.50 4.10E-04 4.0E-02 
Sult2a3 7 95.27 4.89 29.60 0 0.0E+00 
Adamtsl2 2 0.08 5.03 32.63 3.09E-04 3.0E-02 
Igkv14-126 6 1.83 5.05 33.18 2.74E-04 3.0E-02 
Ppbp/CXCL7 5 1.53 5.11 34.50 8.16E-07 3.3E-04 
Ighv1-26 12 6.33 6.00 64.18 2.84E-06 9.2E-04 
Ighg2b 12 1.24 6.09 68.33 3.31E-10 2.6E-07 
Ighv1-53 12 21.82 6.35 81.40 5.80E-12 6.7E-09 
Ighm 12 58.20 6.66 101.16 0 0.0E+00 
Igkv1-110 6 5.60 6.80 111.48 1.23E-06 4.6E-04 
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Igkc 6 103.70 7.12 138.75 0 0.0E+00 
Ighv1-55 12 10.45 7.76 217.46 3.12E-07 1.4E-04 
Ighg1 12 1.09 9.02 519.44 2.53E-04 3.0E-02 
Ighv3-6 12 9.17 9.26 614.19 1.36E-04 2.0E-02 
Igkv5-39 6 20.38 10.41 1362.79 1.98E-05 4.5E-03 
Igkv3-2 6 44.53 11.62 3149.68 2.62E-06 8.6E-04 
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APPENDIX C 
COMPREHENSIVE METABOLIC PANEL (CHEM12) 
Table 6. Chem12 Data from Rhesus Macaques Implanted with Lung Scaffolds 
Group Animal Weeks 
Naa 
(144-160 
mEq/L) 
Kb 
(3.3-6.4 
mEq/L) 
Clc 
(106-117 
mEq/L)  
Prod 
(5.9-7.8 
g/dL) 
Albe 
(3.0-5.9 
g/dL) 
Globf 
(1.9-3.9 
g/dL)  
A/G 
ratiog 
(0.5-
3.5) 
WT 
FR83 
0 143* 3.6 106 7.2 4.2 3.0 1.4 
1 146 3.6 108 7.3 3.7 3.6 1.0 
2 146 3.9 108 7.4 3.8 3.6 1.1 
4 144 3.8 107 6.7 3.8 2.9 1.3 
8 145 3.9 108 6.9 3.8 3.1 1.2 
FP26 
0 145 3.2* 110 6.7 4.1 2.6 1.6 
1 147 3.6 108 7.4 3.9 3.5 1.1 
2 146 3.2* 109 7.7 4.1 3.6 1.1 
4 147 3.4 109 7.4 4.2 3.2 1.3 
8 148 3.4 109 7.4 4.3 3.1 1.4 
SC 
IK09 
0 144 3.5 107 6.9 4.2 2.7 1.6 
1 146 3.8 107 7.3 4.0 3.3 1.2 
2 145 3.9 105* 7.1 4.0 3.1 1.3 
4 144 3.7 106 6.8 4.1 2.7 1.5 
8 146 4.0 108 6.9 4.3 2.6 1.7 
II58 
0 143* 3.5 106 6.5 3.7 2.8 1.3 
1 144 3.9 108 6.7 3.5 3.2 1.1 
2 145 4.1 107 6.8 3.5 3.3 1.1 
4 144 4.1 108 6.6 3.8 2.8 1.4 
8 146 4.4 109 6.8 3.9 2.9 
1.3 
1.3 
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DC-M 
IB44 
0 146 3.9 107 7.6 4.3 3.3 1.3 
1 146 4.0 107 7.6 4.0 3.6 1.1 
2 146 3.7 106 7.1 3.9 3.2 1.2 
4 146 3.7 107 7.0 4.1 2.9 1.4 
8 146 4.3 107 7.1 4.2 2.9 1.4 
HE17 
0 144 3.5 109 7.4 3.8 3.6 1.1 
1 144 3.8 108 7.1 3.5 3.6 1.0 
2 145 3.6 107 7.0 3.6 3.4 1.1 
4 144 4.1 108 7.6 4.0 3.6 1.1 
8 147 4.1 108 7.3 4.1 3.2 1.3 
DC-WT 
HA91 
0 146 3.4 108 7.2 4.1 3.1 1.3 
1 146 3.8 107 6.9 3.8 3.1 1.2 
2 146 3.6 107 7.0 4.2 2.8 1.5 
4 144 4.2 104* 6.9 4.1 2.8 1.5 
8 147 3.7 105* 7.0 4.3 2.7 1.6 
HP13 
0 143* 3.7 107 6.6 3.6 3.0 1.2 
1 145 4.1 106 6.7 3.6 3.1 1.2 
2 145 4.3 105* 6.7 3.8 2.9 1.3 
4 144 4.5 107 6.3 3.5 2.8 1.3 
8 147 3.9 107 6.2 3.8 2.4 1.6 
DC-KO 
HT93 
0 147 3.2* 111 7.6 3.9 3.7 1.1 
1 147 3.9 108 7.5 3.7 3.8 1.0 
2 146 3.6 108 7.4 3.8 3.6 1.1 
4 145 3.6 107 7.1 3.7 3.4 1.1 
8 148 3.6 110 7.2 4.0 3.2 1.3 
GM29 
0 145 3.4 106 6.6 2.8* 3.8 0.7 
1 145 4.1 107 6.5 2.6* 3.9 0.7 
2 145 3.9 105* 6.3 2.8* 3.5 0.8 
4 144 4.1 106 6.7 3.1 3.6 0.9 
8 145 4.2 106 6.2 2.8* 3.4 0.8 
 
*Indicates a value below the anticipated threshold 
a Sodium (Na+) 
b Potassium (K+) 
c Chloride (Cl-) 
d Total protein (pro) 
e Albumin (alb) 
f Globulin (glob) 
g Ratio of albumin to globulin (alb/glob) 
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Table 7. Chem12 Data (cont.) from Rhesus Macaques Implanted with Lung Scaffolds  
Group Animal Weeks 
Bunh 
(13-27 
mg/dL) 
Glui 
(48-119 
mg/dL) 
Crtj 
(0.4-1.4 
mg/dL) 
Astk 
(25-120 
IU/L) 
Altl 
(20-126 
IU/L) 
Bn/Crt 
ratiom 
(11-60) 
WT 
FR83 
0 21.0 67 1.10 41 43 19.1 
1 19.0 71 0.94 35 48 20.2 
2 22.0 62 0.99 34 44 22.2 
4 24.0 57 1.04 27 32 23.1 
8 22.0 63 1.04 33 40 21.2 
FP26 
0 16.0 83 0.97 25 45 16.5 
1 13.0 66 0.99 22* 37 13.1 
2 16.0 68 0.91 22* 36 17.6 
4 15.0 84 0.95 21* 34 15.8 
8 16.0 88 1.02 23* 34 15.7 
SC 
IK09 
0 16.0 73 0.91 30 19* 17.6 
1 16.0 76 0.91 26 28 17.6 
2 18.0 68 0.83 25 17* 21.7 
4 17.0 71 0.83 28 17* 20.5 
8 18.0 67 0.84 27 18* 21.4 
II58 
0 15.0 75 0.72 37 39 20.8 
1 15.0 70 0.75 26 24 20.0 
2 13.0 63 0.66 31 25 19.7 
4 15.0 57 0.77 30 28 19.5 
8 17.0 55 0.71 28 34 23.9 
DC-M 
IB44 
0 14.0 69 0.96 24* 22 14.6 
1 15.0 68 0.85 26 26 17.6 
2 15.0 72 0.88 22* 42 17.0 
4 13.0 73 0.97 35 28 13.4 
8 15.0 72 0.86 30 26 17.4 
HE17 
0 16.0 105 1.20 42 19* 13.3 
1 17.0 71 1.07 36 27 15.9 
2 18.0 89 1.18 29 18* 15.3 
4 17.0 79 1.19 72 40 14.3 
8 17.0 58 1.12 29 20 15.2 
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DC-WT 
HA91 
0 16.0 98 1.08 33 22 14.8 
1 19.0 61 0.97 28 25 19.6 
2 18.0 81 0.93 26 23 19.4 
4 19.0 86 0.97 59 34 19.6 
8 16.0 80 0.95 24* 21 16.8 
HP13 
0 15.0 74 0.97 35 38 15.5 
1 19.0 71 0.89 25 37 21.3 
2 15.0 75 0.92 21* 31 16.3 
4 16.0 66 0.91 43 40 17.6 
8 17.0 68 0.74 18* 35 23.0 
DC-KO 
HT93 
0 12.0* 128+ 0.94 27 43 12.8 
1 16.0 58 0.67 24* 22 23.9 
2 12.0* 66 0.64 24* 33 18.8 
4 11.0* 68 0.73 37 35 15.1 
8 13.0 73 0.64 25 37 20.3 
GM29 
0 18.0 79 0.87 22* 16* 20.7 
1 21.0 55 0.75 22* 16* 28.0 
2 17.0 61 0.78 19* 16* 21.8 
4 18.0 68 0.80 32 21 22.5 
8 19.0 62 0.68 22* 12* 27.9 
 
*Indicates a value below the anticipated threshold 
+Indicates a value above the anticipated threshold 
h Blood urea nitrogen (bun) 
i Glucose (glu) 
j  Creatinine (crt) 
k Aspartate amino transferase (ast) 
l Alanine amino transferase (alt) 
m Ratio of blood urea nitrogen to creatinine (bn/crt) 
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